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8 Abbreviations
List of abbreviations
•	 3C		 	 Chromosome	Conformation	Capture
•	 4C	 	 Chromosome	Conformation	Capture	on	Chip
•	 ACH	 	 Active	Chromatin	Hub
•	 APC/C		 Anaphase	Promoting	Complex	or	Cyclosome
•	 ATP	 	 Adenosine	triphosphate
•	 Bp	 	 Base	pairs
•	 CAR	 	 Cohesin-associated	regions
•	 CdLS	 	 Cornelia	de	Lange	Sydrome
•	 CH	 	 Chromatin	Hub
•	 Chip	 	 Chromatin	immuno-precipitation
•	 Chip-seq	 Chromatin	immuno-precipitation	and	direct	sequencing
•	 CTCF	 	 CCCCTC-binding	factor
•	 DNA	 	 Deoxyribonucleic	acid
•	 DNAaseI	 Deoxyribonuclease	I
•	 DSB	 	 DNA	double-strand	break
•	 EB	 	 Enhancer	blocker
•	 FISH	 	 Fluorescent	in	situ	hybridization
•	 HAT	 	 Histone	acetyltransferase
•	 HDAC	 	 Histone	deacetylase
•	 HP1	 	 Heterochromatin	protein	1
•	 HR	 	 Homologous	recombination
•	 HS	 	 Hypersensitive	site
•	 ICR	 	 Imprinting	control	region
•	 IL	 	 Interleukin
•	 KO	 	 Knockout
•	 LCR	 	 Locus	control	region
•	 LPS	 	 Lipopolysaccharides
•	 Mb	 	 Mega	base
•	 MEL	 	 Mouse	erythroleukemia
•	 MTA1	 	 Metastasis	tumor	antigen	1
•	 NIPBL	 	 Nipped-B	Like	Protein
•	 PCR	 	 Polymerase	chain	reaction
•	 PEV	 	 Position	effect	variegation
•	 RNA		 	 Ribonucleic	acid
•	 SHH	 	 Sonic	Hedgehog
•	 SMC	 	 Structural	Maintenance	of	Chromosomes
•	 SIR	 	 Silent	information	regulator
•	 Th-1/2	 	 T	helper	type-1/2	 	 	 	 	
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the aim of the thesis
In	 the	DNA	 of	metazoans,	 long-range	 interactions	 between	 distant	 regulatory	
elements	 are	 responsible	 for	 specific	 gene	 expression	 in	 many	 developmentally	
regulated	 genes	 and	 gene	 families.	 Gene-regulatory	 mechanisms	 are	 usually	
complex	 and	 involve	 the	 interaction	 of	 control	 elements	 such	 as	 enhancers	 with	
the	 respective	promoter	of	a	particular	gene.	 	Often	 these	 interactions	occur	over	
considerable	distances	as	in	the	some	cases	control	elements	are	located	hundreds	
or	even	thousands	of	kilobases	away	from	the	transcriptional	initiation	site.	The	main	
focus	of	research	described	in	this	thesis	are	several	factors	that	have	a	role	in	long-
range	interactions	and	chromatin	organization.
Chapter	1	provides	an	introduction	and	gives	an	overview	of	information	required	
for	understanding	the	studies	presented	in	subsequent	chapters	of	this	Thesis.
A	genetic	 screen,	 aimed	 to	 isolate	genes	 involved	 in	 long-	 range	 interactions	
in		Drosophila,			identified	a	class	of	proteins	with		novel	function:	Chip	(mammalian	
homolog		Ldb1)	and	Nipped-B	(mammalian	homolog	Delangin).	Ldb1	is	ubiquitously	
expressed	during	development	and	interacts	with	a	great	number	of	transcriptional	
regulators.	This	suggests	an	important	function	for	Ldb1	in	different	developmental	
pathways.	 Chapter	 2	 describes	 novel	 protein	 complexes	 of	 Ldb1,	 formed	 during	
hematopoietic	development.	Furthermore,	morpholino	mediated	 inhibition	of	Ldb1	
expression	in	zebrafish	show	that	these	factors	are	essential	for	hematopoiesis	and	
they	are	coexpressed	in	prehematopoietic	cells	of	the	early	mouse	embryo.	
Delangin	 (Nipped-B)	protein	 is	 involved	 in	 loading	of	Cohesin	onto	chromatin	
thereby	 playing	 an	 important	 role	 in	 chromatin	 dynamics.	 The	 role	 of	 Delangin	
in	 mammals	 is	 described	 in	 Chapter	 3	 focuses	 on	 description	 of	 the	 	 Delangin	
heterozygous	mutant	mouse	that	shows	a	complex	phenotype	similar	to	that	seen	in	
Cornelia	de	Lange	patients	that	have		mutations	in	the	same	gene.	
Chapter	4	describes	the	role	of	CTCF,	the	prototype	vertebrate	insulator	implicated	
in	chromatin	structure	with	Cohesins.	In	the	same	chapter,	we	are	co-relating	functions	
of	Cohesins,	better	known	for	their	role	in	mediating	sister	chromatid	cohesion,	with	
CTCF	protein.	Our	study	focuses	on	co-operation	of	Cohesin	and	CTCF	in	dictating	
chromosome	 conformation	 at	 several	 loci.	 The	 studies	 presented	 in	 the	 Chapter	
5	address	 the	 role	of	CTCF	 in	T-cell	differentiation,	showing	 that	CTCF	 is	 required	
for	T-helper-2	cytokine	expression.	Finally,	 in	 the	concluding	Chapter	6,	an	overall	
discussion	of	this	thesis	is	presented	with	general	implications	of	this	work	and	future	
directions.
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			General Introduction
The	genome	of	higher	eukaryotes	consists	of	DNA,	which	in	case	of	the	human	
genome	measures	2m	in	length	and	is	divided	over	46	chromosomes.	These	long	
DNA	molecules	are	packed	in	a	nucleus	that	measures	about	10μm	in	diameter.	In	
order	to	fit	the	complete	DNA	into	such	a	small	volume,	DNA	is	folded	and	compacted	
by	proteins	in	a	structure	called	chromatin.	During	mitosis,	is	even	further	compacted	
into	condensed	chromosomes	(Kornberg,	1974).	All	the	information	needed	for	the	
formation	and	proper	function	of	an	organism	is	stored	in	these	structures	and	it	is	
reasonable	to	expect	that	this	overcrowded	situation	is	organized	in	a	very	specific	
manner,	with	controlled	three-dimensional	contacts	within	the	nucleus.	The	need	for	
controlled	chromatin	contacts	is	also	suggested	by	the	fact	that	gene	regulation	is	
a	tightly	regulated	process.	Different	levels	of	control	must	be	involved	in	regulating	
proper	 spatio-temporal	 expression	 of	 genes	 throughout	 the	 process	 of	 cellular	
differentiation.	 These	 processes	 are	 coordinated	 by	 interactions	 of	 an	 “army”	 of	
general,	cell-type	and	stage	specific	proteins	that	bind	to	chromatin	and	DNA.
Several	techniques	allow	the	identification	and	study	of	chromatin	regions	that	
interact	 with	 each	 other.	 These	 include	 functional	 genetic	 analysis,	 microscopic	
analysis	after	DNA	or	RNA	fluorescent	in situ	hybridization	(FISH)	in	combination	with	
3D	microscopy,	as	well	as	biochemical	methods,	such	as	chromosome	conformation	
capture	(3C)	and	the	more	sophisticated	variation	thereof	(4C).	The	combination	of	
these	methods	reveals	a	network	of	contacts	in	the	nucleus.	These	interactions	are	
mediated	by	 insulators	and	other	 regulatory	 sequences,	 including	enhancers	and	
promoters,	which	mediate/promote	certain	functional	three-dimensional	interactions	
while	preventing	other	enhancer-promoter	contacts.	 In	 this	chapter,	 I	will	 introduce	
several	factors:	Ldb1,	Delangin,	Cohesin	and	CTCF	which	have	important	role	long-
range	interactions.	
1.  Cis-regulatory elements and gene regulation
Regulatory	sequences	that	are	encoded	in	the	primary	DNA	sequence	provide	
the	 first	 level	of	 transcriptional	control.	Several	distinct	cis-regulatory	elements	are	
identified	 including	 promoters,	 enhancers,	 silencers,	 Locus	 Control	 region	 (LCR)	
and	insulators.		These	so-called	cis	regulatory	elements,	attract	general	and	specific	
transcription	factors	that	are	responsible	for	the	functional	and	structural	organization	
of	 chromatin.	 They	 are	 relatively	 small	 DNA	 fragments	 (200-300bp)	 that	 contain	
information	“when,	where	and	how	much”	should	be	made	of	a	gene	product	encoded	
in	 the	primary	DNA	sequence.	This	 information	 is	used	by	 the	RNA	polymerase	 II	
machinery	 to	 transcribe	 the	gene	 into	RNA.	Studies	over	a	number	of	 years	have	
revealed	that	enhancers,	LCR	and	promoters	are	in	contact	with	one	another	when	
genes	are	transcribed.
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1.1	Long-range	enhancer-promoter	interaction
In	 a	 structural	 sense,	 enhancers	 and	 promoters	 are	 quite	 similar.	 The	 main	
differences	 between	 their	 sequences	 and	 their	 location	 are	 that	 the	 sequence	 of	
enhancers	is	usually	longer	than	that	of	promoters	and	that	enhancers	can	be	located	
tens	 or	 hundreds	 of	 kilobases	 away	 from	 the	 genes	 whose	 activity	 they	 control.	
Furthermore,	enhancer	activity	is	not	dependent	on	orientation.	
One	 of	 the	 most	 spectacular	 examples	 of	 transcriptional	 control	 over	 long	
distance	 is	 the	 regulation	of	SHH	(Sonic	Hedgehog)	expression	 in	 the	developing	
limb.	The	enhancer	is	positioned	1Mb	away	from	the	Shh	gene	itself	(Lettice	et	al.,	
2003).	An	important	aim	of	current	biology	is	to	understand	how	remote	cis-acting	
elements	and	the	promoters	control	gene	transcription	levels	at	the	appropriate	times	
in	differentiation	and	development.
Enhancers	are	capable	of	enhancing	the	basal	transcription	levels	of	the	linked	
promoter.	They	were	originally	identified	in	transient	transfection	assays	as	sequences	
capable	of	transcriptional	activation	of	a	linked	promoter	over	large	distances	in	an	
orientation	independent	manner	(Banerji	et	al.,	1981;	Moreau	et	al.,	1981).	
According	 to	 the	 current	 view,	 the	 factors	 participating	 in	 transcription	 are	
recruited	 to	 the	 activated	 promoter	 via	 protein-protein	 interactions	 (Ptashne	 and	
Gann,	1997).	The	enhancer-bound	activator	proteins	increase	the	local	concentration	
of	the	transcriptional	machinery	near	the	promoter.	In	higher	organisms,	long-distance	
chromatin	 interactions	have	been	demonstrated	 for	 enhancer	elements	which	are	
separated	from	a	gene	by	hundreds	up	to	millions	of	base	pairs	(Kleinjan	and	van	
Heyningen,	2005).	However,	binding	of	an	activator	protein	to	remote	elements,	would	
not	increase	the	concentration	of	the	transcriptional	machinery	at	the	promoter	in	a	
strictly	 linear	manner.	Hence,	 there	must	be	mechanisms	 that	allow	 long-distance	
enhancer-promoter	 interactions.	 There	 are	 several	 different	 models	 proposed	 for	
enhancer	action	over	distance	which	are	not	mutually	exclusive.	The	combination	
of	 different	models	 is	 used	 to	 explain	 data	 generated	 at	 different	 loci	 in	 different	
organisms.
The	looping	model:
For	 many	 years	 after	 the	 discovery	 that	 enhancers	 are	 separated	 from	 the	
genes,	it	was	believed	that	enhancers	and	promoters	interact	irrespective	of	the	DNA	
between	 them.	A	 loop	of	DNA	would	be	 formed,	which	otherwise	would	separate	
promoter	 and	 enhancer	 on	 a	 one	 dimensional	 level	 (Ptashne,	 1986).	 In	 higher	
organisms,	where	gene	clusters	have	complex	regulation,	a	number	of	observations	
could	only	be	explained	by	 looping.	 	 In	 the	 case	of	 trans-activation,	 an	enhancer	
situated	on	one	chromosome	can	establish	contact	with	the	promoter	on	the	paired	
homologous	allele	(Bickel	and	Pirrotta,	1990).	This	phenomenon	called	transvection	
was	observed	in	Drosophila	where	genetic	results	argued	for	an	inter-chromosomal	
interaction	between	promoter	and	enhancer	situated	on	different	chromosomes	(Wu	
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and	Morris,	1999).	However	in	mammalian	cells,		data	that	would	support	functional	
interchromosomal	promoter-enhancer	interactions	are	still	missing.	
The	looping	model	provides	the	most	plausible	explanation	for	gene	competition	
for	a	single	 regulator.	For	example,	 in	 transfection	assays	where	plasmids	contain	
different	 genes	 and	 enhancers,	 it	 was	 shown	 that	 genes	 compete	 for	 regulatory	
sequences	(Wasylyk	et	al.,	1983).	Such	competition	also	operates	 in	endogenous	
chromosomal	 loci.	 An	 explanation	 how	 competition	 may	 work	 was	 provided	 by	
Figure	1
Possible	models	for	long-range	enhancer-promoter	communication
In	the	simplest	form	of	“looping”	(top),	enhancer	(E	blue)	and	promoter	(P	purple)	establish	contact	
by	random	collision,	at	which	point	proteins	bound	to	either	site	contact	each	other	directly	to	activate	
transcription	of	a	linked	gene	(yellow	cylinder).	As	a	consequence,	the	intervening	chromatin	template	
is	looped	out.	Note	that	the	looping	model,	unlike	other	models	does	not	depend	on	the	presence	
of	 an	 intervening	chromatin	 template	 for	 transcription.	Other	models	differ	 from	 this	 largely	 in	 the	
mechanism	by	which	enhancer-promoter	interaction	occurs.	For	example,	in	the	tracking	model,	the	
enhancer-bound	protein	complex	actively	scans	the	DNA	in	search	of	the	promoter.	The	facilitated	
tracking	model	unites	looping	and	tracking	(center).	This	model	states	that	complexes	nucleated	at	
the	enhancer	track	along	intervening	chromatin	templates	towards	a	potentially	active	gene.	In	the	
linking	model,	a	chain	of	the	protein	complexes	(green	balls)	extends	along	the	chromatin	fiber	to	the	
promoter	where	gene	activation	starts.	
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fluorescent	in	situ	hybridization	(FISH)	data	on	ongoing	transcription	of	the	fetal γ-	or	
β-gene	in	a	single	cell	where	it	was	shown	that	one	or	the	other	gene		is	active	at	a	
given	time	(Wijgerde	et	al.,	1995).	The	studies	that	followed	confirmed	these	results	
(Gribnau	et	al.,	1998)	indicating	that	alternate	transcription	that	takes	place	is		and	is	
caused	by	a	stochastic		‘flip-flop’	mechanism	of	LCR	action.	Although	such	studies	
are	most	easily	explained	by	a	looping	model,	they	do	not	show	directly	an	interaction	
between	distal	and	proximal	elements.	Strong	evidence	for	such		interactions		was	
obtained	from	the	mouse	β-globin	locus	using	two	different	biochemical	approaches,	
the	 recovery	 of	 associated	 protein	 (RNA	 TRAP)	 assay	 (Carter	 et	 al.,	 2002)	 and	
chromosome	 conformation	 capture	 (3C)	 technology	 (Tolhuis	 et	 al.,	 2002).	 Both	
studies	showed	that	the	endogenous	mouse	β-globin	LCR	(Locus	Control	Region)	is	
in	close	spatial	proximity	to	the	active	β-globin	gene	promoter	located	50	kbp	away.	
This	type	of	interaction	has	now	been	shown	for	a	number	of	loci,	for	example	in	the	
Th2	locus,	it	was	shown	by	3C	technology	that	a	lineage-restricted	chromatin	loop	is	
formed	between	the	Th2	LCR	and	genes	encoding	for	the	interleukins	IL-4,	IL-5	and	
IL-13	(Spilianakis	and	Flavell,	2004).	These	studies	show	that	long-range	interactions	
are	established	by	contacts	of	interacting	regions	with	intervening	DNA	looping	out.
The	tracking	model
In	the	tracking	model,	the	enhancer	acts	as	a	loading	platform	for	a	DNA-tracking	
protein	which	 travels	 along	 the	 chromatin	 fiber	 and	 ends	 up	 in	 the	 vicinity	 of	 the	
promoter	(Herendeen	et	al.,	1992).	The	best	experimental	example	for	the	tracking	
model	is	the	enhancer	action	of	the	late	genes	in	the	bactoriophage	T4	(reviewed	in	
(Kolesky	et	al.,	2002).	However,	there	is	no	evidence	for	tracking	in	eukaryotes	and	
no	known	example	of	an	activator	leaving	the	enhancer	to	activate	transcription.	On	
the	other	hand,	this	model	explains	well	the	enhancer-blocking	activity	of	boundary	
or	insulator	elements	in	which	an	insulator	bound	protein	blocks	the	tracking	protein	
complex.	
A	 ’facilitated	 tracking’	model	 is	a	combination	of	 the	 looping	and	 the	 tracking	
models.	It	suggests	that	enhancer	bound	complexes	travel	in	small	steps	along	the	
intervening	chromatin	fiber	until	it	reaches	the	promoter	after	which	a	stable	loop	is	
formed.	In	Chip	(Chromatin	immunoprecipitation)	analysis	of	a	distribution	of	C/EBPα	
and	HNF-3β	enhancer	binding	proteins	at	 the	HNF-4α	gene	 locus,	 these	proteins	
could	be	detected	at	the	spacer	DNA	as	well	as	at	the	promoter.	The	proteins	were	
bound	after	activation	of	 the	enhancer,	but	before	actual	 transcription	of	 the	gene	
(Hatzis	and	Talianidis,	2002).	Since	the	enhancer-promoter	communication	is	a	slow	
process	 and	 transcription	 starts	 only	 80	 hours	 after	 induction	 of	 the	 enhancer,	 it	
seems	that	other	mechanisms	of	communication	are	involved	for	fast	transcription	or	
at	larger	loci.	In	addition,	it	is	not	possible	to	explain	activation	in	trans	or	alternative	
transcription	by	this	model.
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The	linking	model
The	linking	model	proposes	that	an	enhancer	acts	as	a	 loading	platform	for	a	
DNA	binding	protein	that	facilitate	polymerization	of	proteins	in	the	direction	of	the	
promoter	by	coating	the	chromatin	fiber	(Bulger	and	Groudine,	1999;	Dorsett,	1999).	
This	model	was	proposed	to	explain	the	action	of	Drosophila	Chip	(Ldb1)	protein,	
that	doesn’t	bind	to	DNA	directly	but	interacts	with	several	transcription	factors	and	
facilitate	their	action	in vivo		(Morcillo	et	al.,	1997;	Torigoi	et	al.,	2000).	It	is	suggested	
that	Chip	is	recruited	by	an	activator	bound	at	an	enhancer	where	it	functions	as	a	
protein	‘bridge’	between	the	activator	bound	at	the	enhancer	and		proteins	having	
multiple	binding	 sites	between	an	enhancer	 and	a	promoter	 (Dorsett,	 1999).	Still,	
there	is	no	functional	data	to	support	this	model.	Recent	experiments	have	shown	
that	Ldb1,	the	mouse	homologue	of	Chip,	forms	large	complexes	with	transcription	
factors	(Meier	et	al.,	2006)	that	bind	specific	sites	in	the	genome,	indicating	that	Ldb1	
complexes	more	likely	play	a	role	in	looping	(Song	et	al.,	2007).
1.2	LCR	(Locus	Control	Region)
The	presence	of	an	enhancer	as	a	part	of	a	transgenic	construct	is	usually	not	
sufficient	to	ensure	(optimal	levels	of)	expression.	The	expression	of	the	transgene	is	
often	low	when	compared	to	endogenous	levels,	and	the	spatio-temporal	expression	
is	 usually	 altered.	 This	 is	 caused	 by	 the	 inability	 of	 the	 transgenic	 construct	
to	 overcome	 the	 local	 effects	 of	 chromatin	 structure	 at	 the	 site	 of	 the	 integration	
(position	effects).	 	 In	 the	1980s,	 transgenic	mouse	studies	using	human β-globin 
gene	construct	led	to	the	discovery	of	the	locus	control	region	(LCR).		It	is	a	dominant	
regulatory	 region	 that	 confers	 position-independent	 and	 copy-number	 dependent	
expression	to	linked	transgenes	(Grosveld	et	al.,	1987).	Importantly,	an	LCR	is	able	to	
overcome	heterochromatin-mediated	position	effect	variegation	(PEV)	(Festenstein	et	
al.,	1996;	Milot	et	al.,	1996).	Transgenic	mice	carrying	a	human	CD2	or	β-globin gene 
linked	with	LCR	show	normal	levels	of	expression	irrespective	of	their	chromosomal	
integration	site	while	partial	deletion	of	 the	LCR	resulted	 in	variegated	expression.	
These	experiments	have	shown	that	both	human	CD2	and	β-globin	LCR	are	essential	
for	establishing	an	open	chromatin	configuration.	Locus	control	regions	are	structurally	
composed	of	varying	numbers	of	tissue	specific	DNAseI	hypersensitive	sites	each	
consisting	of	multiple	binding	sites	for	transcription	factors	and	they	typically	include	
enhancer	and	 insulator	elements	 (Bonifer,	2000;	Dillon	and	Sabbattini,	 2000).	The	
most	prominent	characteristic	of	LCR	is	its	ability	to	overcome	repressive	chromatin	
structures	and	provide	strong	 transcriptional	enhancer	activity.	The	absence	of	an	
LCR	in	humans	leads	to	an	absence	of	transcription	(Kioussis	et	al.,	1983)	or	in	mice	
to	a	severely	reduced	transcription	of	the	human	β-globin	gene	(Epner	et	al.,	1998;	
Magram	et	al.,	1985;	Townes	et	al.,	1985).	The	mouse	β-globin	locus	is	situated	on	
chromosome	7	and	contains	four	functional	genes:	εγ,	βh1,	βmaj		and		βmin	(from	5’to	
3’).	The	major	determinant	for	activation	of	a	gene	is	the	relative	distance	from	the	
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LCR	for	example,	introduction	of	a	β-globin	gene	between	the	LCR	and	the	γ-gene	
leads	 to	 premature	 β-globin	 gene	 activation	 and	 reduction	 of	 γ-gene	 expression	
(Hanscombe	et	al.,	1991).
The	 competition	 between	genes	 in	 the β-globin	 locus	 suggests	 that	 the	 LCR	
functions	by	physical	interaction	with	the	genes.	After	the	discovery	of	the	β-globin	
LCR	many	 combinations	 of	cis-regulatory	 elements	were	 characterized	 in	 various	
vertebrate	species	which	show	the	functional	characteristics	of	a	LCR.	Other	domains	
with	LCR-like	activity	have	been	characterized	in	several	loci	in	humans,	including	the	
human	growth	hormone	(GH)	locus	and	in	the	Rad50 gene	in	Th2	cytokine	locus	(Ho	
et	al.,	2006;	Lee	et	al.,	2003)	(reviewed	in	(Li	et	al.,	2002).	The	variety	and	complexity	
of	LCR	action	points	to	the	importance	of	studying	transcriptional	regulation	of	intact	
genetic	loci	in vivo.
1.3	The	Active	Chromatin	Hub	(ACH)	of	the β-globin	locus
Although	several	mechanisms	have	been	proposed	involving	complex	interactions	
between	genes	and	regulatory	elements	in	the	β-globin	locus,	only	the	DNA	looping	
model	is	compatible	with	all	available	experimental	data.	As	described	above,	in	the	
looping	model,	the	physical	interactions	of	an	enhancer	bound	activator	and	a	protein	
at	the	promoter	result	in	looping	out	of	the	intervening	DNA.	This	model	assumes	that	
the	chromatin	fiber	is	flexible	enough	to	enable	distant	DNA	fragments	to	interact	with	
each	other.	Such	chromatin	 interactions	were	postulated	on	 the	based	of	genetic	
experiments	(Dillon	et	al.,	1997;	Gribnau	et	al.,	1998;	Hanscombe	et	al.,	1991;	Wijgerde	
et	al.,	1995)	and	later	biochemicaly	by	3C,	a	technique	used	to		identifies	chromatin	
regions	that	are	in	close	spatial	proximity.	Surprisingly,	interactions	were	much	more	
complex	than	just	a	simple	LCR-gene	contact.	First,	a	number	of	interactions	were	
identified	in	cells	before	differentiation	and	expression	of	the	globin	genes,	forming	
a	so	called	chromatin	hub	(CH).	Once	the	genes	are	expressed,	an	additional	set	of	
interactions	form	an	Active	Chromatin	Hub	(ACH)	(Palstra	et	al.,	2003;	Tolhuis	et	al.,	
2002).	Apart	from	these	interactions,	contacts	with	distant	regulatory	elements	were	
also	observed	(Tolhuis	et	al.,	2002)	suggesting	that		several	CHs	are	generated	or	that	
one	CH	contains	additional	sequences	from	other	loci.	The	dynamics	of	active	and	
inactive	genes	is	different;	active	genes	loop	inwards,	while	inactive	genes	loop	out.	
CTCF	has	an	important	role	in	forming	this	structure	since	interactions	are	dependent	
on	CTCF	 in	erythroid	progenitor	cells	but	 there	 is	no	 impact	on	globin	expression	
(Splinter	et	al.,	2006).	The	role	of	CTCF	will	be	described	later	in	this	Chapter.
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1.4	Insulators
A	major	fraction	of	vertebrate	genomes	is	composed	of	repetitive,	silenced	DNA	
that	 exist	 as	 large	 regions	 of	 condensed	 chromatin.	 Chromatin	 is	 compacted	 by	
condensation	processes	that	are	self-propagating	and	can	spread	into	neighboring	
loci	affecting	their	expression	(Ghirlando	et	al.,	2004).	Therefore,	mechanisms	must	
exist	 that	 prevent	 such	 spreading	 into	 neighboring	 gene	 loci.	 Insulators	 are	DNA	
elements	that	were	first	 identified	based	on	their	ability	 to	protect	a	gene	from	the	
outside	influences,	which	might	otherwise	lead	either	to	inappropriate	activation	or	
silencing	of	a	gene	(Kellum	and	Schedl,	1991).	In	addition,	certain	insulator	elements,	
when	placed	between	an	enhancer	and	a	promoter,	inhibit	enhancer-stimulated	gene	
expression.	These	sequences	are	necessary	to	ensure	that	genes	are	not	activated	
in	 the	wrong	place	or	at	 the	wrong	time	by	regulatory	elements	from	other	genes.	
Insulator	elements	have	been	experimentally	identified	based	on	these	two	defining	
characteristics;	barrier	insulators,	which	block	heterochromatization	and	consequent	
silencing	a	gene	and	enhancer	blocking	 (EB)	 insulators	 (Figure	2),	which	prevent	
communication	 between	 discrete	 sequence	 elements	 (typically	 enhancers	 and	
promoters)	when	positioned	between	them	(Wallace	and	Felsenfeld,	2007).
	 Much	 of	 the	 early	 work	 that	 characterized	 insulator	 elements	 was	 done	 in	
Drosophila.	 The	 first	 DNA	 sequences	 to	 be	 described	 to	 have	 the	 	 properties	 of	
an	 insulator	 were	 the	 specialized	 chromatine	 structure	 (scs	 and	 scs’)	 elements.	
These	elements	were	 initially	 identified	as	DNAse	 I	HSS	 	 that	mark	 the	chromatin	
boundaries	of	a	heat	shock	locus	(Udvardy	et	al.,	1985).	Moreover,	it	was	shown	that	
these	 elements	 could	block	 an	 enhancer	 from	activating	 a	promoter	 (Kellum	and	
Schedl,	1992).	Several	DNA	binding	proteins	have	been	shown	to	bind	to	insulator	
sequences:	 Su	 (Hw),	 Zw5,	 BEAF-32,	 GAGA	 factor	 and	 dCTCF	 (Gaszner	 et	 al.,	
1999;	Geyer	and	Corces,	1992;	Hart	et	al.,	1997;	Moon	et	al.,	2005;	Schweinsberg	
et	al.,	2004).	 In	vertebrates	the	only	known	insulator	protein	 is	CTCF	(Wallace	and	
Felsenfeld,	2007).	It	is	unknown	whether	the	vertebrate	CTCF	is	able	to	replace	the	
roles	of	all	the	insulator	proteins	in	Drosophila,	or	other	vertebrate	insulators	are	yet	
to	be	identified.
	 Sequences	 that	 are	 able	 to	 act	 as	 insulators	 were	 identified	 later	 in	 other	
organisms	but	no	significant	similarity	 is	evident	among	these	proteins	(Bell	et	al.,	
2001).	Enhancer-blocking	 insulators	are	best	exemplified	by	 the	gypsy	 element	 in	
Drosophila (Capelson	and	Corces,	2005)	and	the	CTCF-binding	sites	identified	as	
insulators	initially	in	vertebrates	(Chung	et	al.,	1993)	and	later	in	Drosophila (Moon	et	
al.,	2005).	
Although	the	demand	for	insulators	in	genomes	with	larger	distances	between	
genes	seems	 to	be	 less	obvious,	 there	are	well-established	examples	of	 insulator	
mediated	gene	regulation	in	mammals.	The	first	vertebrate	insulator	described	was	
the	HS4	 element	 of	 the	 chicken	β-globin	 locus	which	 showed	enhancer	 blocking	
activity	when	placed	between	a	reporter	gene	containing	the	β-globin	promoter	and	
LCR	(Chung	et	al.,	1993).	The	minimal	core	required	for	insulation	contains	binding	
sites	for	CTCF	and	these	sites	are	necessary	and	sufficient	for	positional	enhancer	
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blocking	activity	(Bell	et	al.,	2001).	The	CTCF	site	 in	cHS4	is	 insufficient	 to	protect	
against	position	effects,	indicating	that	the	enhancer-blocking	activity	of	CTCF	and	
the	boundary	function	of	cHS4	are	separable	(Recillas-Targa	et	al.,	2002).	In	additional	
experiments,	the	upstream	transcription	factor	1	and	2	(USF1/USF2)	were	suggested	
as	candidates	that	control	boundary	activity	of	cHS4.
There	 are	 several	 models	 explaining	 how	 an	 enhancer-blocking	 insulators	
influence	communication	between	enhancers	and	promoters.	The	models	are	not	
mutually	exclusive	and	potentially	any	insulator	could	employ	one	or	a	combination	
of	 mechanisms.	 In	 the	 promoter	 decoy	 model,	 an	 enhancer–blocking	 insulator	
recruits	a	component	of	the	transcriptional	machinery	mimicking	a	promoter	at	the	
molecular	level	(Geyer,	1997).	Consistent	with	this	model,	enhancers	and	insulators	
have	been	observed	to	co-localize	(Yoon	et	al.,	2007)	though	interactions	between	
insulators	and	promoters	have	also	been	observed	(Yoon	et	al.,	2007)	suggesting	
an	 alternative	mechanism.	 The	 physical	 barrier	model	 proposes	 that	 a	molecular	
Figure	2	
Insulators	can	function	as	position	dependent	enhancer-blockers	or	boundary	elements
	
Insulators	 have	 been	 experimentally	 identified	 based	 on	 two	 defining	 characteristics:	 enhancer	
blocking	function	and	boundary	function.
A.	 Enhancer-blocker:	 an	 enhancer	 (E,	 blue	 box)	 can	 activate	 transcription	 (arrow)	 from	 a	
promoter	(P,	red	ellipse)	of	a	cis-linked	gene	(grey	rectangle)	.The	enhancer	activity	is	blocked	when	
an	insulator	element	(I,	yellow	oval)	is	positioned	in	between	the	enhancer	and	promoter.
B.	 Boundary	 element:	 spreading	 of	 nearby	 heterochromatin	 into	 a	 locus	 prevents	 the	
transcriptional	 activation	 by	 an	 enhancer	 of	 a	cis-linked	 gene.	 Insertion	 of	 two	 insulator	 elements	
flanking	the	locus	prevents	the	spread	of	condensed	chromatin.
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signal	coming	from	the	enhancer	such	as	RNA	polII	complex	simply	hits	the	insulator	
complex	 and	 is	 unable	 to	 progress.	 This	model	 can	 explain	 the	 accumulation	 of	
RNA	PolII	at	the	cHS4	insulator	that	 is	inserted	between	the	human	HS2	enhancer	
and	its	target	globin	gene	(Zhao	and	Dean,	2004).	The	argument	for	an	additional	
mechanism	exists,	since	insulators	located	within	introns	can	silence	a	downstream	
enhancer	without	 truncating	 the	gene	product.	 The	 loop	domain	model	proposes	
that	insulator	sites	interact	with	each	other	and/or	with	other	nuclear	structures.	In	the	
Igf2/H19	 locus	in	mice,	functional	 loop	formation	has	been	found	at	the	imprinting	
control	region	(ICR),	which	binds	CTCF	in	an	allele-specific	manner	(Kurukuti	et	al.,	
2006;	Murrell	et	al.,	2004;	Yoon	et	al.,	2007).	Although	these	studies	disagree	on	the	
specific	interactions,	they	agree	that	CTCF–bound	ICR	is	involved	in	loop	formation	
that	is	necessary	for	proper	enhancer-promoter	interactions	with	the	 Igf2	promoter,	
thereby	excluding	other	interactions.
Models	explaining	insulator	boundary	function	have	in	common	that	boundary	
activity	 is	 linked	 to	 a	 disruption	 of	 the	 reaction	 responsible	 for	 heterochromatin	
spreading.	 In	 these	models,	 the	 barriers	 function	 as	 	 chain	 terminators	 by	 either	
modulating	 the	 nucleosomal	 structure	 or	 by	 formation	 of	 looped	 structures	 by	
anchoring	the	chromatin	fiber	(Gaszner	and	Felsenfeld,	2006).	For	example,	the	cHS4	
vertebrate	 insulator	 recruits	 histone	 acetyltransferase	 (HAT)	 and	methytransferase	
which	 leads	 to	histone	modifications	and	eventual	 termination	of	 heterochromatin	
formation	(West	et	al.,	2004).	Although	histone	modification	is	a	necessary	step	for	
insulation	in	cHS4,	it	is	not	sufficient	to	block	heterochromatin	spreading.	Additional	
protein	 binding	 sites	 in	 cHS4	without	 histone	modification	marks	 are	 required	 for	
complete	boundary	activity	(West	et	al.,	2004).
2. the Role of CtCF in long-range interactions
The	complex	 three-dimensional	organization	of	gene	 regulation	 raises	several	
questions.	One	of	 these	 is	which	 factors	are	 involved	 in	nuclear	organization	and	
long-range	interactions.	CTCF,	which	is	thought	to	have	multiple	context	dependent	
functions,	is	one	of	the	potential	candidates	to	mediate	long-range	interactions.
CTCF	(CCCTC	binding	factor)	has	a	very	important	role	in	genetic	and	epigenetic	
maintenance	of	the	genome.	It	was	originally	identified	as	a	transcription	factor	that	
negatively	regulates	the	chicken	c-myc	gene	(Lobanenkov	et	al.,	1990).	Other	studies	
showed	 that	CTCF	 is	 not	 only	 involved	 in	 transcriptional	 silencing	but	 also	 in	 the	
activation	of	c-myc	and	other	genes	(Klenova	et	al.,	1993).	CTCF	can	also	act	as	an	
enhancer-blocking	protein	 (Prioleau	et	al.,	1999;	Recillas-Targa	et	al.,	1999)	and	 it	
can	bind	to	boundary	elements	to	prevent	spreading	of	heterochromatin	(Defossez	
and	Gilson,	2002).	Moreover,	CTCF	binding	sites	have	been	found	at	the	imprinting	
center	of	the	X	chromosome		(Chao	et	al.,	2002)	and	at	the	boundaries	of	domains	
that	 are	escaping	X-inactivation	 (Filippova	et	 al.,	 2005).	How	CTCF	carries	out	 all	
these	 diverse	 functions	 is	 still	 not	 clear.	 Some	 investigators	 have	 suggested	 that	
CTCF	might	function	through	topological	organization	of	the	genome	by	folding	the	
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genome	 into	 loop	domains,	 in	 that	way	 isolating	 the	 genes	 from	 the	 influence	 of	
neighboring	genes	or	regulatory	sequences.	Additionally,	CTCF	could	be	important	
for	 folding	chromatin	 to	bring	distal	 regulatory	elements	closer	 together	 to	 form	a	
chromatin	hub.		
An	important	study	on	the	function	of	CTCF	in	long-range	interactions	was	done	
in	the	mouse	and	human	Igf2/H19	locus	where	it	was	shown	that	this	factor	regulates	
the	imprinting	of	the	both	genes	in	a	methylation	sensitive	manner.	On	the	maternal	
chromosom,	the	Igf2	gene	is	turned	off	and	H19	is	transcribed	while	on	the	paternal	
chromosome	the	situation	is	the	opposite.	
One	of	the	regions	responsible	for	this	expression	pattern	is	the	imprinting	control	
region	(ICR)	that	lies	between	the Igf2	gene	and	the	downstream	enhancers.	The	sites	
in	the	ICR	are	occupied	by	CTCF	on	the	maternally	inherited	allele	while	the	paternal	
copy	is	methylated	preventing	CTCF	binding	(Bell	and	Felsenfeld,	2000;	Hark	et	al.,	
2000;	Kanduri	et	al.,	2000).	Mice	in	which	the	two	alleles	can	be	distinguished	have	
been	used	in	3C	experiments	to	study	the	insulator	effect	on	higher	order	structure	
(Kurukuti	et	al.,	2006;	Murrell	et	al.,	2004).	Contacts	are	detected	between	the	ICR	and	
one	of	the	two	upstream	imprinted	DNA	methylated	regions,	DMR1	and	DMR2.	These	
contacts	differ	on	the	two	alleles	suggesting	allele-specific	interactions	between	the	
enhancer	and	the	Igf2 promoter	(Lopes	et	al.,	2003;	Murrell	et	al.,	2004).	A	different	
model	of	the	 Igf2/H19	system	was	proposed	based	on	a	similar	3C	approach,	but	
with	emphasis	on	 the	 interaction	between	promoters	and	downstream	enhancers.	
In	 the	paternal	 allele,	where	CTCF	does	not	bind	 to	 the	methylated	 ICR,	 the	H19 
downstream	enhancer	interacts	with	the	Igf2	promoter	consequently	expressing	Igf2.	
On	the	maternal	allele,	CTCF	bound	to	ICR	prevents	the H19	downstream	enhancer	
to	activate	Igf2,	which	results	in	activation	of	H19.	Furthermore,	the	chromatin	loop	
between	 the	CTCF-bound	 ICR	and	DMR1	are	maintained	during	mitosis,	whereas	
enhancer-promoter	loops	are	absent	suggesting	a	possible	role	of	CTCF	in	epigenetic	
memory	during	cell	division	(Burke	et	al.,	2005).
How	does	CTCF	mediate	long-range	interactions?	Since	it	forms	dimers	and	even	
oligomers,	it	is	possible	that	CTCF	molecules	bound	to	distal	elements	could	interact	
with	each	other,	thereby	driving	loop	formation	(Yusufzai	et	al.,	2004).	One	interesting	
study,	which	 shows	 that	CTCF	 is	 not	 absolutely	 required	on	both	 interacting	 loci,	
suggested	that	additional	factors	are	involved	in	these	interactions	(Ling	et	al.,	2006).	
Indeed,	 in	 the	case	of	 two	divergently	 transcribed	MHC	class	 II	genes,	HLA-DRB1 
and	HLA-DQA1,	CTCF	requires	at	least	two	additional	factors	to	mediate	long-range	
interactions	(Majumder	et	al.,	2008).
Another	 interesting	 study	 (Lefevre	 et	 al.,	 2008)	 supports	 a	 model	 in	 which	
transcription-dependent	 chromatin	 remodeling	 leads	 to	 physical	 dislodgement	
of	 CTCF	 prior	 to	 gene	 activation.	 CTCF	 form	 an	 insulator	 complex	 bound	 to	 the	
upstream	cis element	of	the	chicken	lysozyme	gene.	Bacterial	lypopolysaccharides	
(LPS)	induce	expression	via	this	element	through	stepwise	recruitment	of	transcription	
factors	followed	by	concomitant	alterations	in	chromatin	structure	within	the	upstream	
cis	 elements	 (Lefevre	 et	 al.,	 2005).	 	 LPS	 stimulation	 triggers	 destabilization	 of	
nucleosomes	and	exposure	of	the	flanking	enhancer	elements,	which	in	turn	allows	
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recruitment	 of	 additional	 factors	 and	 the	 initiation	 of	 non-coding	 RNA	 synthesis.	
Transient	 transcription	 and	 the	 concomitant	 passage	 of	 the	 RNA	 PolII	 complex	
through	this	element	are	correlated	with	H3	phosphorylation		and	repositioning	of	a	
nucleosome	over	the	CTCF	occupancy	site	(Ong	and	Corces,	2008).
2.1	The	Role	of	CTCF	in	the	β-globin	locus
	
The	first	direct	evidence	for	CTCF-mediated	chromatin	looping	was	provided	by	
an	analysis	of	 the β-globin	 locus	(Splinter	et	al.,	2006).	The	entire	mouse	β-globin	
locus	is	embedded	in	a	cluster	of	olfactory	receptor	(OR)	genes	that	are	not	expressed	
in	erythroid	cells	(Bulger	et	al.,	2000).	The	globin	genes	are	positioned	in	the	order	of	
their	developmental	expression	and	all	encode	for	a	β-globin	like	proteins.	Together	
with	α-globin-	 like	 proteins	 and	 heme	 groups	 they	 form	 a	 functional	 hemoglobin	
molecule.	Both	α-	and	β-globin	genes	duplicated	several	times,	subsequently	evolved	
independently	 and	 ended	 up	 on	 different	 chromosomes	 in	 birds	 and	 mammals	
(Hardison,	 1998).	 In	 the	mouse	β-globin	 locus	 is	 situated	on	chromosome	7	and	
contains	four	functional	genes:	εγ, βh1,	βmaj		and		βmin	(from	5’to	3’).	During	primitive	
eryhropoiesis,	yolk	sac	derived	erythroid	cells	express	mostly	εy	and	βh1,	while	the	
expression	of	βmaj	and	βmin	 is	 low.	The	generation	of	definitive	erythroid	cells	starts	
in	fetal	liver	around	day	11	of	embryonic	development	and	is	characterized	by	high	
levels	of	transcription	of	adult	β-globin	genes	(βmaj		and		βmin)	and	inactive,	or	minimal,	
expression	of	embryonic	(εγ,	and	βh1)	genes	(Wawrzyniak	and	Popp,	1987).	Upstream	
of	the	genes	lies	a	cluster	of	erythroid	specific	regulatory	sequences	known	as	the	
LCR,	 a	 dominant	 regulatory	 element	 that	 confers	 position-independent	 and	 copy	
number	dependent	expression	of	linked	transgenes	(Grosveld	et	al.,	1987).	Additional	
Figure	3
Action	 of	 CTCF	 in	 the	 mouse	 Igf2/H19	
locus
On	 the	 maternally	 transmitted	 allele,	
CTCF	binds	to	the	sites	in	the	imprinted	
control	 region	 (ICR)	 and	 prevents	
downstream	 enhancers	 from	 activating	
Igf2	expression.	The	ICR	of	the	paternal	
allele	 is	methylated,	CTCF	doesn’t	bind	
and	the	enhancer	is	no	longer	blocked.
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erythroid-	specific	regulatory	sequences	are	located	upstream	of	the	LCR	(5’HS-84/-
85	and	5’HS-60/-62)	 and	one	downstream	 from	 the	genes	 (3’HS1)	 (Bulger	 et	 al.,	
2003;	Farrell	et	al.,	2000;	Tuan	et	al.,	1985).	The	role	of	different	elements	involved	in	
the	regulation	of	β-globin	gene	expression	and	chromatin	organization	was	defined	
by	deleting	the	different	hypersensitive	(HS)	sites	in	the	locus.	For	example,	deletion	
of	the	whole	β-globin	LCR	in	the	mouse	resulted	in	a	large	decrease	in	β-globin	gene	
expression	 but	 did	 not	 alter	 chromatin	 structure	 (Epner	 et	 al.,	 1998).	 Importantly,	
none	of	the	individual	HS	sites	deletions	affected	the	formation	of	the	remaining	sites,	
implicating	 that	 there	 is	no	dominant	 initiating	site	whose	formation	 is	 required	 for	
formation	of	the	other	HS	sites	(Bender	et	al.,	2000).
CTCF	binding	sites	and	their	relative	positions	are	conserved	between	chicken,	
mouse	and	humans.	In	the	mouse	β-globin	locus	the	CTCF	binding	sites	are	present	
at	 the	 3’HS1,	 in	 the	 LCR	 (5’HS5/cHS4)	 and	 upstream	 of	 the	 locus	 (HS-62.5	 and	
HS-85)	 (Bulger	et	al.,	2003;	Farrell	et	al.,	2002).	Binding	of	CTCF	 to	both	ends	of	
the	locus	led	to	the	idea	that	CTCF	may	serve	as	an	enhancer	blocker	that	prevents	
the	inappropriate	activation	of	surrounding	olfactory	receptor	genes	by	the	β-globin	
LCR	in	erythroid	cells	(Farrell	et	al.,	2002).	Alternetively,	it	may	be	required	to	prevent	
spreading	of	heterochromatin	into	the	β-globin	locus.	Indeed,	it	was	shown	that	CTCF	
is	required	for	the	long-range	interactions	within	the	locus	by	experiments	in	which	
CTCF	was	depleted	(Splinter	et	al.,	2006).	However,	disruption	of	a	CTCF-binding	site	
had	no	effect	on	the	expression	of	the	β-globin	genes	or	an	effect	on	surrounding	
mouse	olfactory	receptor	genes.	The	balance	between	active	and	repressive	histone	
modification	only	changed	locally	at	the	binding	sites	and	not	elsewhere	in	the	locus,	
demonstrating	that	CTCF	does	not	serve	to	insulate	the	β-globin	locus	in	erythroid	
cells	(Splinter	et	al.,	2006).	Expression	of	the	β-globin	genes	was	also	not	changed	in	
the	case	of	deletions	of	other	HS	sites	(Bender	et	al.,	2006).	This	raises	the	question	
how	those	evolutionary	conserved	sites	participate	in	the	tissue-specific	interactions	
with	 the	 LCR	 and	 the	 active	β-globin	 genes.	One	 of	 the	 possible	 explanations	 is	
that	β-globin	gene	expression	benefits	from	the	CTCF-mediated	loops	to	an	extent	
that	is	sufficient	for	evolutionary	selection	but	too	limited	to	be	detected	by	current	
technology	(de	Laat	et	al.,	2008).	Another	explanation	comes	from	the	fact	that	CTCF	
is	a	structural	factor	that	binds	to	many	loci	all	over	the	human	(Kim	et	al.,	2007)	or	
mouse	(Chen	et	al.,	2008)	genome	to	provide	proper		folding	of	the	genome.	It	would	
have	specialized	functions	only	in	imprinted	regions,	where	it	has	been	shown	to	act	
as	an	enhancer	blocker	(Bell	and	Felsenfeld,	2000;	Hark	et	al.,	2000).
.
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Figure	4	
CTCF	binding	in	the	mouse	β-globin	locus
A.	Schematic	 representation	of	 the	mouse	β-globin	 locus	with	 the	position	of	CTCF	binding	sites,	
which	are	indicated	with	red	ovals.	The	β-globin	genes,	aligned	in	the	order	of	their	developmental	
expression,	are	 indicated	by	black	boxes.	Olfactory	 receptor	genes	(OR)	are	 represented	by	white	
boxes	and	flank	the	locus.	DNAse	I	hypersensitive	sites	(HS)	are	indicated	with	arrows.
B.	 The	presentation	 of	 distant	CTCF	binding	 sites	 (red	 ovals)	 that	 occur	 between	 regulatory	DNA	
elements	of	the	β-globin	locus	in	erythroud	progenitor	cells	(HS-62,	5’HS5	and	3’HS1).	Not	all	sites	are	
shown	(HS-85).	Several	proteins	(blue	ovals)	that	bind	to	the	regulatory	elements	are	indicated	but	not	
mentioned	for	simplicity.	The	globin	genes	are	expressed	at	basic	levels	in	these	cells	(Tolhuis,	Palstra	
et	al.	2002;	Palstra,	Tolhuis	et	al.	2003;	Splinter,	Heath	et	al.	2006).	Mutating	the	CTCF	binding	site	at	
3’HS1	destroys	the	interactions	between	it	and	other	CTCF	binding	sites.	At	later	stage	of	erythroid	
development,	additional	contacts	are	made	between	LCR	and	other	regulatory	sites	to	form	the	ACH;	
this	structure	becomes	independent	on	CTCF	binding	(Splinter,	Heath	et	al.	2006)
Palstra,	 R.	 J.,	 B.	 Tolhuis,	 et	 al.	 (2003).	 “The	 beta-globin	 nuclear	 compartment	 in	 development	 and	 erythroid	
differentiation.”	Nat	Genet	35(2):	190-4.
Splinter,	E.,	H.	Heath,	et	al.	(2006).	“CTCF	mediates	long-range	chromatin	looping	and	local	histone	modification	
in	the	beta-globin	locus.”	Genes	Dev	20(17):	2349-54.
Tolhuis,	B.,	R.	J.	Palstra,	et	al.	(2002).	“Looping	and	interaction	between	hypersensitive	sites	 in	the	active	beta-
globin	locus.”	Mol	Cell	10(6):	1453-65.
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2.2	Identification	of	CTCF-binding	sites	in	the	genome
	The	CTCF	protein,	originally	identified	as	a	transcriptional	repressor,	has	been	
associated	with	different	functions	such	as	transcriptional	activator,	enhancer-blocker,	
boundary	 definer	 and	 genome	 organizer.	 It	 binds	 to	 DNA	 in	 a	 sequence-specific	
manner,	with	11-zinc-finger	domains.	
A	 first	 attempt	 to	 map	 CTCF	 binding	 sites	 in	 a	 genome-wide	 fashion	 was	
performed	using	ChIP-on-Chip	in	fetal	liver	cells	(Mukhopadhyay	et	al.,	2004).	In	this	
procedure,	 chromatin	 is	 cross-linked,	 sonicated	 and	 protein-DNA	 complexes	 are	
purified	by	immunoprecipitation.		Following	de-crosslinking,	the	associated	proteins	
are	degraded,	and	the	isolated	DNA	is	labelled	and	hybridized	to	microarrays	that	
cover	 mouse	 genome.	 The	 analysis	 of	 microarrays	 can	 determine	 the	 genomic	
binding	location	of	protein	of	interest.	However,	only	a	subset	of	CTCF	binding	sites	
was	identified	in	this	study	due	to	technical	limitations.								
More	recent	genome-wide	approaches	allowed	much	better	characterization	of	
the	distribution	of	CTCF	binding	sites	 (Barski	et	al.,	2007;	Kim	et	al.,	2007;	Xie	et	
al.,	2007).	It	was	found	that	CTCF	binds	throughout	the	genome	at	conserved	sites,	
implying	that	these	sites	are	functional	(Wallace	and	Felsenfeld,	2007).	Identified	sites	
correlate	strongly	with	regions	containing	genes,	suggesting	that	CTCF’s	primary	role	
in	the	genome	is	to	regulate	gene	expression.	The	domains	depleted	of	CTCF	sites	
tend	to	include	clusters	of	related	gene	families	and	genes	that	are	transcriptionally	
co-regulated;	CTCF	sites	 flank	many	of	 these	 regions.	Domains	 that	are	enriched	
in	CTCF	binding	sites	often	have	multiple	alternative	promoters	 (Kim	et	al.,	2007).	
These	observations	are	consistent	with	a	role	of	CTCF	as	an	enhancer	blocker.
3. Cohesin:
Another	interesting	protein	complex,	that	has	several	diverse	function,	is	Cohesin.	
It	is	involved	in	many	cellular	processe	which	will	be	discussed	bellow.	The	Cohesin	
is	best	known	for	 its	role	in	sister	chromatid	cohesion.	The	genomes	of	eukaryotic	
organisms	are	organized	in	chromosomes,	which	are	individual	large	DNA	molecules	
folded	into	complex	structures.	Before	cell	division,	the	DNA	replication	machinery	
faithfully	copies	each	of	these	DNA	molecules	and	a	physical	linkage	is	established	
between	 the	 two	 sister	DNA	molecules	 (or	 sister	 chromatids).	 This	 physical	 DNA	
connection	is	known	as	sister-chromatid	cohesion.	This	pair-wise	organization	allows	
the	cell	to	distribute	chromatids	during	cell	division	so	the	daughter	cells	receive	a	full	
complement	of	chromosomes.	The	communication	between	two	sister	chromatids	
has	two	components:	the	DNA	catenation	arising	from	the	replication	process	itself	
and	a	multiprotein	complex	holding	sister	helices	together,	known	as	Cohesin.		This	
complex	is	deposited	on	chromatin	during	the	G1	phase	and	establishes	cohesion	
concomitant	with	DNA	replication.	The	physical	linkage	between	the	sister	chromatids	
is	maintained	in	G2	and	is	dissolved	only	during	mitosis.	 In	yeast,	this	occurs	in	a	
single	step	at	the	onset	of	anaphase.	It	requires	cleavage,	by	the	enzyme	separase,	of	
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Scc1/Rad21,	one	of	the	subunits	of	the	Cohesin	complex.	In	Metazoa,	most	Cohesin	
dissociates	 from	chromatin	during	prophase,	 in	 a	process	 regulated	by	Aurora	B	
and	 Polo	 kinase,	 whereas	 a	 small	 population,	 located	 preferentially	 at	 pericentric	
heterochromatin,	 remains	 on	 the	 condensed	 chromosomes	 until	 anaphase.	 This	
mitotic	 Cohesin	 is	 essential	 to	 prevent	 the	 precocious	 separation	 of	 the	 sister	
chromatids,	and	is	removed	from	chromatin	by	separase	cleavage	upon	activation	
of	 the	APC/C	(Anaphase	Promoting	Complex	or	Cyclosome)	(Losada	and	Hirano,	
2005;	Nasmyth	and	Haering,	2005).
	 	Biochemical	studies	 in	yeast	and	high	 resolution	 imaging	of	purified	human	
Cohesin	complexes	suggest	 that	Cohesin	forms	a	tripartite	ring.	Cohesin	contains	
four	core	subunits:	SMC1	and	SMC3,	members	of	the	SMC	(Structural	Maintenance	
of	Chromosomes)	protein	family,	and	two	non-SMC	subunits	Scc1/Rad21	and	Scc3/
SA	(Nasmyth	and	Haering,	2005).	The	SMC1	and	SMC3	subunits	of	Cohesin	both	
form	rod-shape	molecules	that	heterodimerize	by	means	of		‘hinge’	domains	situated	
at	 the	 ends	of	 30-nm-long	 intramolecular	 antiparallel	 coiled-coiles	 (Haering	et	 al.,	
2002)(Figure	5).	ATPase	‘heads’,	at	the	other	ends,	are	connected	by	the	Scc1/kleisin	
subunit	of	Cohesin	thereby	forming	a	tripartite	ring	with	a	35nm	diameter	(Gruber	et	
al.,	2003;	Haering	et	al.,	2002).	Although	it	has	been	proposed	that	Cohesin	forms	a	
ring	that	embraces	the	sister	DNA	molecules,	other	models	are	possible	(Nasmyth	
and	Haering,	2005).	The	ring-like	structure	has	led	to	the	proposal	that	Cohesin	holds	
sister	 chromatids	 together	 by	 embracing	 the	 two	DNA	duplexes	within	 its	 coiled-
coil	arms,	trapping	sister	DNAs	inside	its	ring	(Gruber	et	al.,	2003).	This	topological	
model	 for	Cohesin	 interaction	with	DNA	 is	 further	 supported	 by	 experiments	with	
circular	DNA	molecules	in	yeast	(Ivanov	and	Nasmyth,	2005)	explaining	how	cleavage	
of	Scc1/Rad21	by	separase	at	the	onset	of		anaphase	opens	the	ring	and	thereby	
triggers	 sister	 chromatid	 separation	 (Uhlmann	 et	 al.,	 1999).	 An	 alternative	model	
suggests	that	two	Cohesin	complexes	interact	directly	with	DNA	and	with	each	other	
to	hold	two	DNA	molecules	together.	 It	has	also	been	proposed	that	one	Cohesin	
ring	encircling	one	sister	chromatid	may	interact	with	proteins	(other	than	Cohesins)	
present	on	the	other	sister	chromatid	(Chang	et	al.,	2005).		In	a	variation	of	the	latter	
model,	Cohesin	rings	embracing	a	single	chromatid	could	interact	with	each	other	
either	directly	or	with	the	participation	of	accessory	factors	to	establish	cohesion.
In	normal	cells,	Cohesin	can	connect	sister	chromatids	only	 in	S	phase,	even	
though	 newly	 synthesized	 Cohesin	 complexes	 can	 associate	 with	 DNA	 in	 the	
subsequent	G2	phase	(Uhlmann	and	Nasmyth,	1998).	Until	recently,	it	was	generally	
assumed	that	sister–chromatid	cohesion	can	only	be	generated	at	replication	forks	
where	DNA	is	synthesized.	The	finding	that	cohesion	can	also	occur	in	G2	phase	if	
DNA	 is	damaged	challenged	 this	opinion	 (Strom	et	al.,	2007;	Strom	and	Sjogren,	
2005).	 In	 this	 process,	 if	 DNA	 is	 damaged	 by	 double-strand	 breaks,	 Cohesin	 is	
loaded	de novo	 to	 the	damaged	DNA	 forming	physical	 connections	between	 the	
sister	 chromatids	 (Strom	 et	 al.,	 2004).	 However,	 repair	 of	 damaged	 DNA	 also	
depends	on	DNA	synthesis,	so	it	remains	possible	that	establishment	of	cohesion	
after	DNA	damage	is	also	mechanistically	coupled	to	DNA	synthesis,	since	those	two	
processes	are	linked	during	S	phase.
27							Introduction
3.1	Cohesin	in	gene	regulation
Early	 evidence	 that	 the	 sister	 chromatid	 cohesion	 apparatus	 plays	 a	 role	 in	
gene	expression	arose	from	studies	on	gene	silencing	in	yeast	and	on	long-range	
gene	 activation	 in	Drosophila	 (Donze	 et	 al.,	 1999;	Rollins	 et	 al.,	 1999).	 The	 yeast	
data	indicated	that	Cohesin	helps	establish	the	boundaries	that	define	the	silenced	
chromatin	domains,	while	Drosophila	 studies	 showed	 that	Nipped-B	 (Delangin)	 is	
required	for	long-range	activation.	The	function	of	Delangin	will	be	explained	in	details	
further	in	this	chapter.
Cohesin	and	yeast	gene	silencing
In	S.cerevisiae,	 the	 silent	 loci	 are	 surrounded	 by	 boundary	 elements	 that	 are	
able	 to	 block	 the	 spread	 of	 the	 silent	 chromatin	 established	 by	 chromatin-bound	
SIR	 (silent	 information	 regulator)	 protein	 complexes.	 Deletion	 of	 the	 boundaries,	
that	surround	silent-mating-type	loci,	leads	to	spreading	of	SIR	complexes	into	the	
neighboring	 regions	 (Donze	et	al.,	1999).	A	genetic	screen	of	 the	 factors	 that	are	
able	to	establish	this	type	of	boundary	revealed	that	some	mutations	of	Smc1	cause	
loss	of	boundary	function	(Donze	et	al.,	1999).	Supporting	this	idea,	the	Scc1/Rad21	
Cohesin	 subunit	 binds	 to	 boundary	 elements	 of	 the	 silent-mating-type	 locus,	 as	
well	as	to	the	locus	itself.	This	is	consistent	with	the	idea	that	Cohesin	functions	in	
controlling	the	spread	of	silencing	complexes	(Chang	et	al.,	2005;	Glynn	et	al.,	2004;	
Figure	5
Hypothetical	 models	 of	 Cohesin-mediated	
cohesion
a	Subunit	composition	of	the	Cohesin	complex	and	
arrangement	of	the	subunits	in	the	Cohesin	ring
b	 –	 e	 Models	 proposed	 to	 explain	 how	 Cohesin	
interacts	with	DNA
b	 Cohesin	 molecule	 entraps	 the	 two	 sister	
chromatids
c	the	two	Cohesin	rings	interact	with	each	other	and	
bind	each	to	a	chromatid
d	 Cohesin	 ring	 embracing	 a	 single	 chromatid	
interacts	with	proteins	(red	ovals)	on	 the	opposite	
chromatid
e	Cohesin	ring	embracing	each	a	single	chromatid	
interacts	 with	 each	 other.	 The	 intermolecular	
interactions	 are	 stabilized	 by	 additional	 factors	
(light	grey	ovals).
Notice	that	only	in	model	c	Cohesin	binds	directly	
to	DNA	molecule
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Laloraya	et	al.,	2000).	Cohesin	also	binds	to	non-transcribed	region	in	the	ribosomal	
RNA	repeat	and	to	subtelomeric	repeats.	Binding	of	Cohesin	to	these	sites	requires	
SIR	 proteins,	 indicating	 that	 Cohesin	 binding	 to	 this	 loci	 dependent	 on	 silencing	
(Chang	et	al.,	2005;	Kobayashi	et	al.,	2004).	The	presence	of	Cohesin	in	rDNA	and	
subtelomeric	 repeats	 raises	 the	possibility	 that	Cohesin	might	also	be	 involved	 in	
inhibition	of	spreading	of	silencing	complexes	at	those	locations.	Loss	of	cohesion	
is	essential	to	establish	silencing	loci,	while	loss	of	Scc1	causes	premature	silencing	
(Lau	et	al.,	2002).	More	recent	studies	show	that	silencing	has	a	reciprocal	effect	on	
Cohesin	binding	and	cohesion	(Chang	et	al.,	2005).	
	 Genome-wide	mapping	 of	 Cohesin	 binding	 sites	 in	 yeast	 revealed	 a	 strong	
correlation	 of	 Cohesin	 binding	 to	 non-transcribed	 spacer	 regions	 between	
convergent	 transcription	 units	 (Glynn	 et	 al.,	 2004;	 Lengronne	 et	 al.,	 2006).	 This	
location	of	Cohesin	might	be	a	consequence	of	RNA	polymerase	being	involved	in	
“pushing”	Cohesin	from	its	initial	locations.	It	should	be	noted	that	this	idea	has	not	
been	shown	experimentally	and	hence	that	it	is	currently	unknown	how	Cohesin	re-
localizes	and	whether	it	requires	factors	other	than	the	transcriptional	machinery	for	
this	“maneuver”.
																
Cohesin	in	long-range	gene	activation	in	Drosophila
A	genetic	screen	identified	Nipped-B	gene,	the	homologue	of	Scc2	in	yeast	and	
Delangin	 in	humans,	as	a	mediator	of	a	 long	range	enhancer-promoter	 interaction	
(Rollins	et	al.,	1999).	This	finding	initially	suggested	that	Cohesin	itself	might	facilitate	
activation	by	stabilizing	interactions	between	distant	enhancers	and	promoters	in	a	
way	similar	to	sister	chromatid	cohesion	(Dorsett,	1999;	Hagstrom	and	Meyer,	2003).	
However	 this	mechanism	appears	 unlikely	 after	 it	was	 shown	 that	 reduced	 levels	
of	Cohesin	subunits	 increased	cut	expression,	opposite	 to	 the	effect	of	Nipped-B	
mutations	(Dorsett	et	al.,	2005;	Rollins	et	al.,	2004).	This	opposite	effect	of	Cohesin	
and	Nipped-B	on	cut	gene	expression	suggests	certain	possibilities.	It	is	possible	that	
Cohesin	acts	as	an	insulator	that	blocks	enhancer-promoter	communication,	similar	
to	the	manner	in	which	Cohesin	blocks	spreading	of	silencing	protein	complexes	in	
yeast.	In	this	case	Nipped-B,	in	addition	to	loading	Cohesin	onto	chromosomes,	may	
also	remove	or	help	the	re-localization	of	Cohesin	to	permit	gene	activation.	Reduced	
levels	of	Nipped-B	would	slow	the	rate	of	Cohesin	mobilization	and	have	an	indirect	
effect	on	gene	transcription	through	Cohesin	(Dorsett,	1999;	Dorsett,	2007;	Gause	
et	al.,	2001).
One	could	argue	that	sister	chromatid	cohesion	per se inhibits	gene	activation.	In	
such	a	model	Cohesin	would	block	communication	of	the	enhancers	and	promoters	
of	the	sister	chromatids	thereby	reducing	the	ability	of	the	enhancer	and	promoter	
on	 each	 sister	 chromatid	 to	 come	 together.	However	 it	 appears	 unlikely	 to	 act	 in	
this	way	 since	 a	 reduced	 level	 of	Pds5,	 the	 factor	 required	 for	 cohesion,	 but	 not	
Cohesin	binding,	does	not	change	gene	expression	(Dorsett	et	al.,	2005).	Another	
possibility	is	that	Cohesin	inhibits	gene	activation	by	interacting	with	Nipped-B	and	
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preventing	it	 from	performing	another	(unknown)	function.	Current	evidence	favors	
the	Cohesin	 insulator	model	over	 the	 idea	of	an	 interaction	between	Cohesin	and	
Nipped-B	(Dorsett,	2007).	There	is	more	evidence	that	the	effect	of	Nipped-B	on	gene	
expression	involves	its	role	in	regulating	the	binding	of	Cohesin	to	chromosomes.	The	
mutation	in	pds5	that	reduces	Cohesin-binding	increases	cut	expression.	A	null	pds5	
mutation,	which	causes	loss	of	sister	chromatid	cohesion,	but	not	Cohesin	binding,	
does	not	increase	gene	activation		(Dorsett	et	al.,	2005).
3.2	Genomic	mapping	of	Cohesin
The	 genomic	 location	 of	 Cohesin	 has	 been	 demonstrated	 by	 chromatin-
immunoprecipitation	 followed	 by	 hybridization	 to	 DNA	 microarray	 (Chip-on-chip)	
studies	in	different	species	(Glynn	et	al.,	2004;	Misulovin	et	al.,	2008;	Parelho	et	al.,	
2008;	Wendt	et	al.,	2008).	In	S.cerevisiae,	Cohesin	binds	approximately	every	11kb	
correlating	with	AT	content	and	with	a	clear	preference	for	intergenic	regions	between	
convergent	 transcription	 units	 (Glynn	 et	 al.,	 2004).	 Centromeric	 regions	 are	 also	
enriched	for	Cohesin.	Chip-on-chip	mapping	showed	Cohesin	subunits	to	be	present	
at	the	inactive	genes.	This	suggests	that	in	yeast	Cohesin	is	re-localized	in	response	
to	transcription:	after	activation	of	gene	transcription	Cohesin	is	redistributed	around	
the	genes	(Bausch	et	al.,	2007;	Glynn	et	al.,	2004;	Wendt	et	al.,	2008).	Once	a	gene	
becomes	inactive,	Cohesin	returns	to	its	previous	location	(Bausch	et	al.,	2007).	The	
dynamics	nature	of	Cohesin	association	with	chromatin	suggests	that	Cohesin	might	
be	involved	in	organizing	local	chromatin	structure.
Chip-on-Chip	results	from	Drosophila	cell	lines	show	a	different	binding	pattern	
of	Cohesin	compared	to	yeast,	having	a	clear	preference	for	active	genes.	Its	binding	
sites	are	found	mostly	in	active	transcriptional	units,	but	also	in	untranscribed	regions	
(Misulovin	et	al.,	2008).	The	binding	sites	of	SA	(Scc3)	are	enriched	in	5’	untranslated	
regions	 (5’UTRs)	 and	 in	 intronic	 regions.	 The	 prevalence	 of	 Cohesin	 subunits	 at	
5’UTRs	suggests	that	there	is	correlation	between	Cohesin	binding	and	the	presence	
of	a	poised	PolII	at	 the	5’end	of	a	subset	of	genes.	Thus	Cohesin	may	function	 in	
the	 regulation	of	gene	 transcription	by	aiding	 the	 loading	of	 the	RNA	transcription	
machinery.	In	Drosophila,	there	is	a	negative	correlation	between	Cohesin	binding	and	
histone	H3K27	trimethylation,	a	marker	of	transcriptionally	repressed	chromatin.	This	
further	suggests	that	heterochromatin	either	inhibits	Cohesin	binding	or	that	Cohesin	
acts	as	a	barrier	to	heterochromatic	spreading	(Misulovin	et	al.,	2008).	Although	yeast	
and	Drosophila	showed	differences	in	Cohesin	binding	patterns,	they	both	show	that	
Cohesin	is	able	to	relocate	in	response	to	a	different	state	of	transcription	within	a	
region.	Additionally,	while	Cohesin	 is	present	 in	non-coding	regions	of	 transcribed	
genes	 in	 Drosophila,	 it	 has	 reduced	 binding	 over	 coding	 regions,	 similar	 to	 the	
situation	 in	yeast.	The	mechanism	of	how	Cohesin	 responds	 to	different	states	of	
transcription	has	not	been	determined	(McNairn	and	Gerton,	2008).
It	 is	not	clear	why	 the	distribution	of	Cohesin	binding	sites	differs	so	much	 in	
yeast	and	Drosophila.	It	could	be	that	is	not	particularly	important	for	sister	chromatid	
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cohesion	 where	 Cohesin	 binds,	 as	 long	 as	 the	 spacing	 along	 the	 DNA	 fiber	 is	
sufficiently	dense	to	maintain	sister	chromatid	cohesion.	Such	a	loose	constraint	may	
have	created	opportunities	during	evolution	to	re-use	the	unique	molecular	properties	
of	Cohesin	for	other	regulatory	functions.	For	example	insulator	activity	of	Cohesin	
has	not	only	been	observed	in	mammals	but	has	also	been	suggested	for	yeast	and	
Drosophila	(Dorsett,	2007;	Peric-Hupkes	and	van	Steensel,	2008).
3.3	CTCF	and		Cohesin	cooperation
Recently,	 four	 groups	mapped	 Cohesin-binding	 sites	 in	mammalian	 genome	
and	found	a	substantial	overlap	with	CTCF	binding	sites	(Parelho	et	al.,	2008;	Rubio	
et	al.,	2008;	Stedman	et	al.,	2008;	Wendt	et	al.,	2008).	Using	Chip-on-Chip,	Wendt	
et	al.	determined	the	binding	of	the	Cohesin	subunit	Rad21	and	CTCF	through	most	
of	the	non-repetitive	human	genome	in	HeLa	cells	(Wendt	et	al.,	2008).	They	found	
nearly	14,000	sites,	similar	to	the	number	of	CTCF	binding	sites	detected	in	previous	
studies	(Kim	et	al.,	2007).	The	high	degree	of	co-localization	of	CTCF	and	Cohesin	
binding	sites	suggests	that	CTCF	and	Cohesin	influence	each	others	binding.	Indeed,	
it	appears	that	CTCF	influences	the	positioning	of	Cohesin,	but	not	overall	binding.	
In	CTCF-depleted	cells	Cohesin	was	still	bound	to	the	chromatin	but	in	most	cases	
not	to	the	shared	CTCF	sites.	Wendt	et	al.	also	showed	that	CTCF-depleted	cells	do	
not	show	an	effect	on	sister	chromatid	cohesion	 indicating	 that	 the	positioning	of	
Cohesin	by	CTCF	is	not	required	for	cohesion	(Wendt	et	al.,	2008).
The	effect	of	Cohesin	on	CTCF	binding	is	less	clear	and	may	vary	from	site	to	
site.	The	knockdown	of	the	Rad21,	Cohesin	subunit,	had	no	(Parelho	et	al.,	2008)	or	a	
moderate	(Wendt	et	al.,	2008)	effect	on	CTCF	binding.	It	has	also	been	suggested	that	
Cohesin	may	increase	the	accessibility	of	some	sites	to	CTCF	by	affecting	chromatin	
structure,	 or	 by	 increasing	 the	binding	affinity	 through	CTCF-Cohesin	 cooperative	
binding	(Gause	et	al.,	2008).
The	 co-localisation	 of	 CTCF	 and	 Cohesin	 raises	 the	 question	 what	 is	 the	
functional	 significance	 of	 shared	 sites,	 with	 respect	 to	 gene	 expression.	 Several	
functional	analyses	have	demonstrated	that	the	Cohesin	complex	plays	an	important	
role	in	gene	regulation	by	CTCF.	Using	reporter	gene	assays,	Wendt	et	al	show	that	
depletion	of	the	Rad21	Cohesin	subunit	partially	reduces	the	activity	of	the	chicken	
β-globin	 insulator	 (Wendt	 et	 al.,	 2008).	 In	 a	 further	 analysis	 they	 investigated	 the	
effect	of	depletion	either	Rad21	or	CTCF	on	H19	transcript	levels	at	the	endogenous	
H19/Igf2	 locus.	The	transcript	levels	of	H19	where	decreased	while	 Igf2	transcripts	
were	 increased,	mimicking	what	 occurs	when	 the	 insulator	 is	 inactivated	by	DNA	
methylation	on	the	paternal	chromosome	during	imprinting.	The	finding	that	Cohesin	
accumulates	 at	CTCF-binding	 sites	 suggests	 the	 exciting	 possibility	 that	Cohesin	
stabilizes	CTCF-mediated	long-range	interactions.	It	is	possible	that	a	portion	of	the	
available	Cohesin	 is	 diverted	 from	a	 role	 in	 sister	 chromatid	 cohesion	 to	 support	
long-range	interactions.
Although	 the	 data	 above	 strongly	 suggest	 a	 role	 in	 long-range	 interaction,	 it	
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is	 important	 to	determine	how	and	where	Cohesin	subunits	organize	higher-order	
chromatin	structures.	To	allow	a	better	description	of	Cohesin	 in	 this	process,	 it	 is	
necessary	to	perform	3C	long	range	interaction	experiments	on	cells	that	lack	CTCF	
and/or	Cohesin.
3.4	The	Cohesin	accessory	factors
The	association	of	Cohesin	with	chromatin	requires	the	SMC	proteins	to	have	a	
functional	hinge	domain	and	ATPase	activity,	and	it	requires	the	activity	of	the	Scc2/
Scc4	(Delangin)	loading	complex	(Ciosk	et	al.,	2000;	Gruber	et	al.,	2006;	Weitzer	et	
al.,	2003).	Metazoan	Delangin	is	a	large	chromatin-associated	protein	that	contains	
multiple	 HEAT	 repeats,	 which	 are	 related	 to	 Armadillo-like	 repeats	 that	 mediate	
protein-protein	 interactions	 (Neuwald	 and	 Hirano,	 2000).	 In	 addition	 to	 the	 HEAT	
repeats,	the	N-terminus	of	Metazoan	Delangin	contains	a	Heterochromatin	Protein	1	
(HP1)	binding	domain	that	was	shown	to	interact	with	HP1α.	This	interaction	raises	
the	 possibility	 that	 Delangin	 is	 involved	 in	 the	 establishment	 and	maintenance	 of	
Figure	6
Hypothetical	model	of	how	Cohesin	complexes	cooperate	with	CTCF
The	model	is	based	on	data	obtained	largely	with	G2/M	cells.
The	 Figure	 proposes	 that	 the	 CTCF-Cohesin	 complexes	might	 establish	 and	 stabilize	 long-range	
interactions.	 The	 proposal	 that	 these	 interactions	 involve	 CTCF-CTCF	 interactions	 is	 entirely	
hypothetical.	
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heterochromatin	domains	(Lechner	et	al.,	2005).
The	recently	identified	metazoan	Scc4,	a	binding	partner	of	Delangin,	appears	to	
have	an	important	role	in	neuronal	development.	Depletion	of	Scc4	(or	Mau-2	in	C. 
elegans)	causes	severe	Premature	Sister	Chromatid	Separation	and	impaired	loading	
of	Cohesin	in	human	cells	(Seitan	et	al.,	2006;	Watrin	et	al.,	2006).	The	identification	of	
Mau-2	as	Scc4	was	among	the	first	indications	that	Cohesin,	and	Cohesin	associated	
proteins,	may	have	an	additional	role	related	to	neuronal	development.
Chromosome	cohesion	is	established	during	S-phase	and	in	response	to	DNA	
damage	in	G2-phase.	In	both	cases,	Cohesion	is	dependent	on	upon	the	activity	of	
the	Eco1	protein	(Ball	and	Yokomori,	2008;	Ben-Shahar	et	al.,	2008).	 In vitro,	yeast	
Eco1	and	human	homologues	are	capable	of	autoacetylation.	Recently,	Eco1	and	
human	paralogues	were	demonstrated	to	specifically	acetylate	the	Smc3	protein.	This	
event	is	essential	for	the	establishment	of	cohesion	(Zhang	et	al.,	2008).	Depletion	or	
a	mutation	in	the	Eco1	gene	can	result	in	the	loss	of	chromosome	cohesion	and	in	
premature	sister	chromatid	separation	(Hou	and	Zou,	2005).
	Once,	cohesion	has	been	established	 in	S-phase	by	the	Cohesin	complex,	 it	
has	to	be	maintained	to	function	properly.	Several	proteins	are	important	for	on	the	
Cohesin	complex	and	Cohesin-mediated	cohesion.	One	of	them	is	Pds5,	an	essential	
gene	in	budding	yeast	(Hartman	et	al.,	2000).	The	deletion	of	one	of	the	Pds5	genes	
in	mouse	 is	embryonic	 lethal,	due	 to	developmental	defects,	which	 indicates	 that	
Pds5	has	an	important	role	in	the	process	of	cohesion.
4. Delangin 
Drosophila	 Nipped-B (Delangin	 in	 mammals)	 is	 an	 essential	 gene	 that	 was	
identified	in	a	genetic	screen	for	mutants	interfering	with	long-range	gene	activation	
of	the	cut	and	Ultrabithorax	(Ubx)	homeobox	genes	by	enhancers	positioned	some	
80	and	50	kbp	away	 from	 the	gene	promoters	 (Rollins	et	 al.,	 2004;	Rollins	et	 al.,	
1999).	Nipped-B	facilitates	the	activation	of	the	cut	gene	by	the	distant	wing-margin	
enhancer.		Mutations	that	result	in	reduced	Nipped-B	levels	result	in	a	lower	expression	
of	cut	gene.	In	contrast	to	other	cut	activators,	mutations	in	Nipped-B	have	a	much	
more	striking	effect	when	cut	 activation	 is	hindered	by	a	gypsy	 insulator	 insertion	
rather	than	by	loss	of	 important	components	of	the	enhancer	sequence	(Rollins	et	
al.,	1999).	Subsequent	work	revealed	that,	as	expected,	Nipped-B	is	also	required	for	
sister	chromatid	cohesion	(Rollins	et	al.,	2004)	and	it	was	shown	that	Delangin	and	
its	orthologues	are	required	for	Cohesin	to	bind	to	chromosomes	(Arumugam	et	al.,	
2003;	Ciosk	et	al.,	2000;	Gillespie	and	Hirano,	2004;	Seitan	et	al.,	2006).	
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Protein	motifs	and	sequence	conservation
Delangin	is	expressed	in	two	isoforms	of	2804	and	2697	amino	acids.	Delangin	
isoforms	 have	 very	 few	 features	 that	 provide	 clues	 to	 their	 function.	 The	 amino-
terminal	region	contains	several	potential	nuclear	localization	sequences.The	tandem	
repeats	of	an	undecapeptide	sequence	are	conserved	in	the	amino-terminal	region	
in	mammals,	chick	and	Xenopus.	The	Carboxyl-terminal	region	has	a	cluster	of	HEAT	
repeats:	 protein-protein	 interaction	 motifs	 that	 have	 been	 reported	 in	 conserved	
position	 in	Delangin	homologues,	 including	Drosophila Nipped-B,	Saccharomyces 
cerevisiae Scc2,	Schizosaccharomyces pombe Mis4 and	Coprinus cinereus Rad9.	
4.1	Chromosomal	and	DNA	repair	functions	of	Cohesin	and	Delangin		 	 	
	 orthologues	
DSB	 (DNA	 double-strand	 break)	 repair	 is	 an	 important	 component	 of	 the	
machinery	that	maintains	the	integrity	of	the	genome	after	DNA	damage.	Mistakes	
in	this	process	lead	to	genomic	instability,	for	example.	chromosomal	translocations	
or	aneuploidy.	The	cell	responds	to	DSBs	in	several	ways,	one	of	which	is	through	
the	homologous	recombination	(HR)	repair	pathway.	In	this	process,	an	intact	sister	
chromatid	serves	as	a	template	for	the	repair	that	occurs	in	S/G2	phase,	following	
DNA	replication	(West,	2003).
Studies	 in	S.cerevisie	 and	 chicken	 cells	 gave	 the	 first	 evidence	of	 the	 role	 of	
Cohesin	in	postreplicative	DNA	repair	(Sjogren	and	Nasmyth,	2001;	Sonoda	et	al.,	
2001).		Immunostaining	analysis	of	laser-induced	damage	in	human	cells	and	Chip	
(Chromatin	 immunoprecipitation)	 analysis	 of	 the	 HO-endonuclease-induced	 DSB	
site	 in	 yeast	 revealed	 that	Cohesin	 specifically	 accumulates	 at	 the	damage	 sites,	
suggesting	a	specific	function	of	Cohesin	in	DNA	repair	(Kim	et	al.,	2002;	Strom	et	al.,	
2004).	Cohesin	accumulation	at	the	damage	site	requires	Scc2-Scc4,	indicating	that	
the	loading	mechanism	is	similar	to	that	for	genome-wide	Cohesin	binding	following	
mitosis	(Strom	et	al.,	2004;	Unal	et	al.,	2004).
C. cinereus Rad 9 
C.elegans Pqn-85 
S.pombe Mis 4 
S.cerevisie Scc2 
Drosophila Nipped-B 
Xenopus XScc2 
Mouse Delangin 
H.sapiens NIPBL 
Delangin	orthologues	in	different	species
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In	both	types	of	cells,	human	and	yeast	in	in	vitro	studies,	Cohesin	recruitment	to	
the	damage	site	is	dependent	on	the	Mre11-Rad50	complex.	This	complex	is	one	of	
the	first	factors	to	recognize	and	to	accumulate	at	DNA	ends	(Kim	et	al.,	2002;	Strom	et	
al.,	2004).	Cohesin	clustering	in	the	area	surrounding	the	damage	site	coincides	with	
and	requires	H2A	phosphorylation	(γH2A)	in	yeast.	It	is	still	unclear	whether	Cohesin	
binds	directly	or	indirectly	to	phosphorylated	H2A	(Ball	and	Yokomori,	2008).
Since	Cohesin	loading	at	the	damaged	sites	appears	to	correlate	with	the	presence	
of	sister	chromatids,	it	is	speculated	that	Cohesin	establishes	local	sister	chromatid	
cohesion	at	the	damaged	sites	to	facilitate	HR	repair	by	promoting	homologues	pairing	
of	 damaged	and	 intact	 sister	 chromatids.	One	elegant	 experiment	 in	S.cerevisiae 
showed	that	Cohesin	is	indeed	needed	at	the	damaged	site	in	G2	to	promote	sister	
chromatid	cohesion.	In	this	experiment	it	was	shown	that	Cohesin	is	newly	recruited	
in	 the	G2	phase	by	 inactivating	 a	 temperature	 sensitive	mutant	Cohesin	 involved	
in	genome-wide	sister	chromatid	cohesion	and	complementing	it	with	an	inducible	
temperature-resistant	Cohesin	(Strom	et	al.,	2007).
			In	yeast,	in	the	absence	of	any	damage,	newly	expressed	Cohesin	accumulates	
at	its	normal	binding	sites	in		G2	phase,	but	is	unable	to	establish	sister	chromatid	
cohesion	(Lengronne	et	al.,	2006;	Strom	et	al.,	2004).	In	contrast,	Cohesin	at	damaged	
sites	 can	 establish	 sister	 chromatid	 cohesion.	 This	 fact	 suggests	 that	 function	 of	
Cohesin,	of	keeping	sister	chromatids	 together,	 is	 reactivated	 in	 response	 to	DNA	
damage	(Strom	et	al.,	2004).	
How	DSB	in	G2/M	induces	sister	chromatid	cohesion	at	the	lesions	and	on	the	
Cohesin-associated	regions	(CARs)	is	still	not	understood.	In	the	absence	of	DNA	
damage,	Cohesin	 is	 loaded	at	CARs	but	cannot	mediate	cohesion	 (Lengronne	et	
al.,	2006).	Upon	DSBs,	the	DNA	damage	response	pathway	induces	DSB-proximal	
Cohesin	loading	(Unal	et	al.,	2004).	It	has	been	suggested	that	DSBs	are	cohesive	
through	 the	action	of	 factors	 that	have	different	action	 in	other	phases	of	 the	cell	
cycle.	They	are	activated	by	DNA	damage	only	 in	G2/M.	 In	undamaged	cells,	 the	
same	factor	or	factors	are	active	only	during	S	phase	therefore	Cohesin	loaded	at	
CARs	in	G2/M	generates	cohesion	(Unal	et	al.,	2007).
The	reactivation	of	Cohesin	is	not	limited	to	damaged	sites	but	occurs	genome-
wide	when	there	is	Cohesin	that	is	synthesized	but	not	incorporated.	A	limited	number	
of	 DSBs	 on	 one	 chromosome	 is	 sufficient	 to	 induce	de novo	 cohesion	 on	 other	
chromosomes	i.e.	Cohesin	complexes	could	establish	cohesion	on	both	damaged	
and	 undamaged	 chromosomes	 during	G2	 phase.	 This	 implies	 that	 the	 presence	
of	DNA	double-strand	breaks	somehow	reactivates	the	molecular	machinery	that	is	
normally	responsible	for	cohesion	only	during	S	phase	(Strom	et	al.,	2007;	Unal	et	
al.,	2007).	
									Inactivation	of	Cohesin	subunits	or	Scc2/Scc4	results	in	a	reduced	efficiency	of	
post-replicative	DSB	in	G2	phase	of	the	cell	cycle.	The	local	enrichment	of	Cohesin	at	
a	damaged	site	depends	on	the	Scc2/Scc4	complex	(Strom	et	al.,	2007).	Additionally,	
a	homologue	of	Delangin,	Pqn-85,	was	identified	in	genome	wide	screens	for	genes	
required	for	resistance	to	ionizing	radiation	in	C.elegans	(van	Haaften	et	al.,	2006).	
Other	interesting	evidence	of	the	importance	of	Delangin	for	DNA	repair	comes	
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from	 humans,	 where	 cells	 derived	 from	 Cornelia	 de	 Lange	 patients,	 who	 have	
a	mutation	 in	Delangin	 gene,	 have	 a	 reduced	 capacity	 to	 tolerate	DNA	damage.	
Exposure	 of	CdLS	 fibroblasts	 and	B-lymphoblastoid	 cells	 to	 the	damaging	 agent	
mitomycin	C	(MMC)	leads	to	increased	number	of	chromosomal	aberrations.	After	
X-ray	 exposure,	 the	 cells	 with	 increased	 chromosomal	 aberrations	were	 detected	
only	if	they	were	irradiated	in	G2	phase	when	the	repair	of	the	double	strand	breaks	
is	dependent	on	sister	chromatid	cohesion	(Vrouwe	et	al.,	2007).	
4.2	Cornelia	de	Lange	syndrome	
	 Cornelia	 de	 Lange	 syndrome	 (CdLS;	 OMIM	 122470)	 is	 a	 rare	 multisystem	
developmental	disorder	with	characteristic	facial	dysmorphia,	growth	and	cognitive	
retardation,	malformations	of	the	upper	limbs	and	a	variety	of	abnormalities	affecting	
a	wide	 range	 of	 tissues	 and	 organs.	 It	 is	 estimated	 to	 occur	 at	 a	 frequency	 of	 1	
per	10,000	to	30,000	births	(Jackson	et	al.,	1993).	The	deficits	begin	prenatally	and	
continue	after	birth.	A	remarkable	feature	is	the	diversity	of	developmental	defects,	
and	thus,	CdLS	may	provide	clues	regarding	the	mechanisms	of	other	developmental	
disorders	 that	display	subsets	of	 these	 features.	There	 is	marked	heterogeneity	 in	
the	 phenotype.	 Individuals	 who	 show	 profound	 growth	 and	 neuro-developmental	
delay,	 sometimes	 accompanied	 by	 severe	 limb	 defect,	 have	 been	 described	 as	
exhibiting	classical	CdLS;	in	mildly	affected	individuals,	the	growth	retardation	and	
developmental	delay	are	less	severe.	Affected	individuals	are	typically	identified	as	
sporadic	cases,	but	several	reports	have	documented	families	with	multiple	affected	
members	(Russell	et	al.,	2001).	In	some	multicase	pedigrees	there	is	strong	evidence	
for	 autosomal	 dominant	 inheritance:	 in	 others,	 germinal	mosaicism	 (mosaicsm	 in	
which	an	 individual	has	a	subset	of	germline	cells	 carrying	a	mutation	 that	 is	not	
found	in	other	germline	cells)	(Strachan,	2005).
Although	 genetic	 data	 and	 samples	 were	 accumulated	 over	 several	 years,	
mapping	 of	 the	 gene(s)	 responsible	 for	 CdLS	 proved	 challenging	 because	 it	 is	
genetically	dominant,	and	the	vast	majority	of	cases	are	spontaneous.	There	are	rare	
examples	of	a	parent	having	more	than	one	CdLS	child	that	is	most	likely	caused	by	
germline	mosaicism,	and	a	few	cases	in	which	a	mildly	affected	patient	passed	on	
the	disorder	to	their	offspring.	The	first	CdLS	gene	was	mapped	by	linkage	exclusion	
analysis	and	a	de novo	balanced	translocation	affecting	the	5p13.1	region	(Krantz	
et	 al.,	 2004;	 Tonkin	 et	 al.,	 2004).	 Subsequent	 analysis	 revealed	mutations	 in	 the	
Delangin	(NIPBL)		gene	in	15p13.1	in	many	of	the	patients,	and	then	several	studies	
have	identified	variety	a	of	Delangin	mutations	in	CdLS	patients	(Bhuiyan	et	al.,	2006;	
Borck	et	al.,	2004),(Gillis	et	al.,	2004;	Krantz	et	al.,	2004),(Tonkin	et	al.,	2004).
Delangin	 mutations	 have	 been	 identified	 in	 about	 half	 of	 the	 CdLS	 patients.	
Recently,	 two	mutations	 in	 the	Smc1L1	 gene	 (Xp11.21)	 were	 identified	 in	 certain	
relatively	mild	cases	of	CdLS	that	lacked	a	Delangin	mutation	(Musio	et	al.,	2006).	
Smc1L1,	which	encodes	 the	Smc1	Cohesin	 subunit,	 is	X-linked,	 and	 the	affected	
individuals	are	male.	This	indicates	that	the	mutations	are	unlikely	to	be	strong	loss-
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of-function	 alleles,	 which	would	 likely	 to	 be	 lethal.	 The	Smc1L1	 gene	 escapes	 X-
inactivation	and	of	the	3	female	carriers	that	passed	on	Smc1L1,	one	displayed	very	
mild	characteristic	consistent	with	CdLS.	It	is	currently	unknown	how	many	cases	are	
caused	by	Smc1L1	mutations	(Dorsett,	2007).
It	remains	possible	that	mutations	in	other	genes	encoding	components	of	the	
sister	chromatid	cohesion	apparatus	could	cause	CdLS.	However,	none	of	the	other	
potential	candidate	genes,	such	as	 the	human	Mau-2	 (KIAA0892)	or	Pds5	genes,	
are	 located	 in	 the	 five	 candidate	 regions	 identified	 by	 linkage	 exclusion	 (Dorsett,	
2007).	 It	 is	also	likely	that	some	CdLS-causing	mutations	occur	 in	non-transcribed	
regulatory	regions	of	Delangin	gene,	or	have	been	missed	because	the	large	gene	
size	 and	 complex	 splicing	 patterns	 currently	 preclude	 sequencing	 of	 the	 entire	
Delangin	transcription	unit.	Improvements	in	screening	for	Delangin		mutations,	and	
large	scale	screening	of	patients	for	Smc1L1	mutations	will	 resolve	some	of	 these	
questions	in	the	near	future	(Dorsett,	2007).	
The	 known	Delangin	 mutations	 indicate	 that	 reduced	 levels	 or	 activity	 of	 the	
encoded	Delangin	protein	cause	CdLS.	Many	Delangin	mutations	predict	a	protein	
truncation,	 although	 it	 is	 currently	 unknown	 whether	 or	 not	 the	 encoded	 mutant	
proteins	are	expressed.	A	deletion	removing	the	Delangin	region	was	seen	in	a	severe	
case	 of	 CdLS,	 supporting	 the	 idea	 that	 loss-of–function	 mutations	 cause	 CdLS.	
Many	of	 the	 less	severe	cases	of	CdLS	are	associated	with	mutations	 that	cause	
amino	acids	substitutions,	although	there	are	exceptions	to	the	general	correlation	of	
milder	CdLS	cases	with	missense	mutations	and	more	severe	forms	with	truncations	
(Bhuiyan	et	al.,	2006;	Gillis	et	al.,	2004).	Many	polymorphisms	are	found	in	unaffected	
parents,	and	in	addition	to	numerous	other	genetic	differences	between	individuals,	
these	polymorphisms	could	contribute	to	the	phenotypic	variability	of	the	syndrome	
(Dorsett,	2007).
An	 intriguing	 finding	 from	molecular	 analysis	 of	Delangin	 mutations	 in	 CdLS	
patients	 is	 that	 a	 central	 conserved	 arginine	 residue	 (R2298)	 in	 one	 of	 the	HEAT	
repeats	 has	 been	 altered	 by	missense	mutations	 in	multiple	 independent	 cases,	
suggesting	that	it	is	a	critical	residue.	Another	important	finding	is	that	with	only	a	few	
exceptions,	the	Delangin	missense	mutations	associated	with	CdLS	affect	residues	
conserved	 in	 Drosophila Nipped-B.	 Thus,	 it	 appears	 likely	 that	 determination	 of	
the	molecular	 function	of	Nipped-B	 in	Drosophila	 and	other	model	organisms	will	
illuminate	the	molecular	etiology	of	CdLS	(Dorsett,	2007).
Evidence	 from	 Drosophila	 favors	 the	 idea	 that	 the	 developmental	 disorders	
in	 CdLS	 are	 caused	 by	 altered	 expression	 of	 genes	 that	 control	 development.	
Although	the	effects	on	sister	chromatid	cohesion	are	seen	in	homozygous	Nipped-
B	mutants,	 no	 effects	 on	 cohesion	 are	 observed	 in	 heterozygous	mutants,	which	
shows	measurable	effects	on	gene	expression.	Even	partial	reduction	of	Nipped-B	
by	RNAi	sufficient	to	cause	lethality	had	no	detectable	effect	on	cohesion	(Rollins	et	
al.,	2004).
If	 the	cohesion	insulator	mechanism,	proposed	to	explain	the	opposite	effects	
on	Nipped-B	and	Cohesin	on	gene	expression	in	Drosophila is	correct,	one	would	
predict	that	several	genes	that	control	development	will	be	affected	in	CdLS.	Cohesin	
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likely	binds	every	20	kb	or	so,	and	many	mammalian	genes	rely	on	distant	control	
elements	 for	 appropriate	 temporal	 and	 spatial	 expression.	 Many	 of	 those	 could	
explain	some	of	the	developmental	deficits	in	CdLS	(Dorsett,	2007).
The	Drosophila	 data	 also	 suggest	 that	 the	Smc1L1	 is	 associated	with	milder	
forms	of	CdLS	 likely	cause	alterations	 in	gene	expression.	A	null	allele	of	Smc1L1	
in	Drosophila	 dominantly	 increases	cut	 gene	expression	 (Dorsett	 et	 al.,	 2005),	 as	
does	RNAi	knockdown	of		the	Stromalin	and	Rad21	Cohesin	subunit	(Rollins	et	al.,	
2004).	These	effects	are	opposite	to	those	of	Nipped-B	mutations,	and	thus	it	might	
be	 surprising	 at	 first	 that	 human	Smc1L1	mutations	 cause	 similar	 developmental	
problems	as	Delangin	mutations.	Multiple	explanations	resolve	this	apparent	paradox.	
The	CdLS	patients	with	Smc1L1	mutations	display	relatively	mild	symptoms,	and	it	
is	possible	that	over-expression	or	inappropriate	expression	of	certain	genes	could	
have	 similar,	 but	 not	 identical,	 effects	 on	 development	 as	 their	 under	 expression	
(Dorsett,	2007).
An	 intriguing	 possibility	 is	 that	 the	 identified	 Smc1L1	 mutations	 are	 not	 null	
alleles,	but	slow	down	Cohesin	binding	dynamics	as	is	proposed	above	in	the	case	of	
reduced	Delangin	levels.	One	of	the	Smc1L1	mutations	alters	a	conserved	residue	at	
the	junction	of	the	N-terminal	helix	and	the	hinge	domain	that	dimerizes	with	the	Smc3	
hinge.	It	has	been	shown	for	a	prokaryotic	SMC	protein	that	the	hinge	is	critical	for	
DNA	binding	dynamics,	and	that	hinge-DNA	interactions	stimulate	the	ATPase	activity	
of	the	head	domain	(Hirano	and	Hirano,	2002;	Hirano	and	Hirano,	2006).	The	ATPase	
activity,	along	with	Scc2/Nipped-B/Delangin,	is	essential	for	the	binding	of	Cohesin	to	
chromosomes	(Arumugam	et	al.,	2003).	The	stimulation	of	the	head	ATPase	activity	
by	the	hinge	domain	may	involve	direct	interactions,	as	atomic	force	microscopy	has	
revealed	hinge-head	contacts	in	fission	yeast	Smc1-Smc3	heterodimers	(Sakai	et	al.,	
2003).	These	contacts	could	be	affected	by	the	changes	in	the	flexibility	of	the	coiled-
coil	domain.	Thus,	it	remains	possible	that	Smc1L1	mutations	could	slow	the	kinetics	
of	 Cohesin	 binding	 and	 unloading,	 and	 thereby	 alter	 gene	 expression	 in	manner	
similar	to	that	proposed	for	Delangin loss-of–function	mutations.	Another	possibility	
is	that	a	subset	of	the	CdLS	deficits,	including	those	found	in	patients	with	Smc1L1	
mutations,	reflect	changes	in	sister	chromatid	cohesion,	as	opposed	to	changes	in	
gene	expression.	Using	 immortalized	cell	 lines,	one	study	 revealed	mild	cohesion	
defects	in	40	%	of	CdLS	patients	(Kaur	et	al.,	2005).	The	procedures	used	to	prepare	
metaphase	spreads	enhance	chromatid	separation,	so	it	is	unclear	if	such	cohesion	
defects	occur	in vivo,	or	the	analysis	reveals	a	subtle	defect	that	has	little	role	in	the	
etiology	of	CdLS.
The	current	challenge	is	to	determine	the	relative	contribution	of	changes	in	gene	
expression	and	sister	chromatid	cohesion	in	CdLS,	and	to	identify	the	critical	target	
genes	responsible	for	the	known	developmental	effects.	This	will	be	aided	by	studies	
on	the	molecular	mechanisms	by	which	Nipped-B and	Cohesin	subunit	mutations	
affect	gene	expression,	cohesion	and	development	in	Drosophila,	but	a	mammalian	
model	 is	 essential	 to	 identify	 target	genes	 relevant	 to	 specific	CdLS	birth	defects	
(Dorsett,	2007).
38 Chapter	1
5. Role of Ldb1 in long-range gene activation
Existing	evidence	indicates	that	most	transcriptional	activator	proteins	recruit	the	
basal	 transcriptional	machinery	 and	 increases	 its	 binding	 to	 a	promoter	 (Ptashne	
and	Gann,	1997).	Often,	an	activator	binds	to	a	sequence	located	many	kilobases	
away	from	the	promoters	it	activates.	In	these	cases,	the	local	concentration	of	the	
activator	 relative	 to	 the	 promoter	 it	 activates	 is	 not	 higher	 than	 its	 concentration	
relative	 to	 many	 other	 promoters	 (Rippe,	 2001).	 This	 suggests	 that	 mechanisms	
other	than	diffusion-driven	chromatin	looping	support	long-range	activation.	Indeed,	
several	sequences	that	facilitate	specific	long-range	interactions	have	been	identified	
in	Drosophila,	mostly	 in	 the	Antennapedia	and	Bithorax	homeotic	gene	complexes	
(Calhoun	and	Levine,	2003;	Hopmann	et	al.,	1995;	Qian	et	al.,	1992;	Ronshaugen	
and	Levine,	2004;	Zhou	and	Levine,	1999).	Their	 function	is	to	support	 long-range	
activation	in	many	genes	(Dorsett,	1999).	One	reason	for	this	 idea	is	that	 insulator	
sequences,	 such	 as	 the	 one	 in	 the	 Drosophila gypsy	 transposon,	 block	 diverse	
enhancers	in	many	genes.	The	location	of	insulators	is	important	since	they	are	able	
to	block	enhancers	only	when	positioned	between	an	enhancer	and	a	promoter.	 It	
has	been	postulated	for	the	Drosophila gypsy	insulator	that	they	interfere	with	general	
factors	that	function	between	many	enhancers	and	promoters	to	facilitate	enhancer-
promoter	communication	(Dorsett,	1999).
For	the	identification	of	general	facilitators	of	enhancer-promoter	communication,	
genetic	screens	were	performed	to	isolate	of	factors	that	support	activation	of	the	cut 
gene	by	a	wing	margin-specific	enhancer	located	85	kbp	upstream	of	the	promoter	
(Morcillo	et	al.,	1997;	Morcillo	et	al.,	1996)	.	The	region	between	this	enhancer	and	
the	promoter	contains	many	enhancers	 that	activate	cut	 in	specific	 tissues	during	
embryogenesis	and	larval	development	(Jack	and	DeLotto,	1995).	In	addition	to	tissue-
specific	activators	 that	bind	to	 the	wing	margin	enhancer,	 these	screens	 identified	
two	proteins,	Chip	(Ldb1	in	mammals)	and	Nipped-B	(Delangin	in	Mammals),	that	
are	expressed	in	virtually	all	cells,	and	facilitate	the	expression	of	diverse	genes.	Chip	
(Ldb1)	interacts	with	many	DNA-binding	proteins,	and	was	suggested	to	support	the	
cooperative	binding	of	proteins	to	enhancers	and	to	the	sites	between	enhancers	and	
promoters	(Gause	et	al.,	2001;	Morcillo	et	al.,	1997;	Torigoi	et	al.,	2000).	The	linking	
model	 for	 long-range	enhancer-promoter	 interactions	was	proposed	to	explain	the	
properties	 of	Drosophila Chip	protein	 (Dorsett,	 1999;	Gause	 et	 al.,	 2001).	 Recent	
experiments	 have	 shown	 that	 Ldb1,	 the	mouse	 homologue	 of	 Chip,	 forms	 large	
complexes	with	transcriptional	factors	(Meier	et	al.,	2006)	that	bind	specific	sites	in	
the	genome	indicating	that	Ldb1	complexes	more	likely	play	role	in	looping.
	Many	proteins,	both	ubiquitously	expressed	and	erythroid	specific	are	known	
to	be	involved	in	β-globin	regulation	and	chromatin	looping.	Most	of	these	factors,	
often	present	in	protein	complexes,	bind	to	the	promoters	of	the	globin	genes	and	
to	the	HS	sites	in	the	β-globin	locus.	It	was	shown	that	cis-regulatory	elements	and	
their	distant	 target	genes	come	 in	close	proximity	during	gene	activation	with	 the	
exclusion	of	intervening	chromatin	(Palstra	et	al.,	2003;	Splinter	et	al.,	2006;	Tolhuis	
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et	al.,	2002).	The	erythroid	activators	EKLF,	GATA-1	and	FOG-1	are	required	for	close	
interactions	(Drissen	et	al.,	2004;	Vakoc	et	al.,	2005).	
The	widely	expressed	nuclear	protein	Ldb1	(CLIM2,	NLI)	is	the	human	homologue	
of	Drosophila	Chip	protein	which	was	identified	in	a	genetic	screen	for	factors	involved	
in	long-range	activation	of	the	cut	gene	(Morcillo	et	al.,	1997;	Morcillo	et	al.,	1996).	The	
null	phenotype	of	the	murine	Chip	homologue	Ldb1	exhibits	pleiotropic	effects	during	
mouse	development,	including	failure	of	erythroid	differentiation	(Mukhopadhyay	et	
al.,	2003).	
Earlier	work	showed	that	Ldb1	participates	 in	a	DNA-binding	complex	 formed	
in	 murine	 erythroid	 cell	 extracts	 with	 the	 hematopoietic	 factors	 GATA-1,	 LMO-2,	
TAL-1	and	E2A	(Wadman	et	al.,	1997).	Ldb1	functions	locally	as	a	positive	regulator	
of	late	erythroid	gene	expression	through	the	promoters	of	the	Eklf, c-kit, P4.2	and	
glycophorin A	genes	(Anderson	et	al.,	1998;	Lahlil	et	al.,	2004;	Lecuyer	et	al.,	2002).	
Ldb1,	together	with	Rb,	Eto2	and	BRG1	proteins	can	also	play	a	repressive	role	in	
gene	expression	(Goardon	et	al.,	2006;	Vitelli	et	al.,	2000).	Ldb1	is	also	a	member	of	
a	complex	that	assembles	at	the	sites	upstream	of	the	α-globin	gene	at	a	particular	
stage	of	development	(Anguita	et	al.,	2004).	The	same	complex	binds	to	the	LCR	and	
β-globin	promoter	in	murine	erythroleukemic	(MEL)	cells	(Brand	et	al.,	2004).
In	recent	studies,	it	was	shown	that	the	Ldb1/GATA-1/TAL-1/LMO2	complex	binds	
in	vivo	to	the	human	β-globin	LCR	which	is	located	upstream	of	the	globin	genes	and	
is	 required	 for	 their	 high-level	 expression	 in	 erythroid	 cells	 (Stamatoyannopoulos,	
2005).	 In	 these	cells,	both	Ldb-1	and	GATA-1	were	 reported	 to	be	present	at	 the	
promoter	of	the	βmaj		gene	and	HS1-HS4	of	the	LCR	in	mouse	fetal	liver	and	MEL	cells	
and	at	HS1-HS4	in	human	K562	cells.
The	truncation	of	Ldb1	reduces	the	expression	of	the	ε-gene	on	a	minichromosome	
containing	HS2	in	K562	cells,	while	a	knockdown	of	Ldb1	leads	to	a	decreased	βmaj	
expression	in	differentiated	MEL	cells.	Furthermore,	if	there	is	a	reduced	level	of	Ldb1,	
the	interaction	between	HS2	and	the	promoter	of	the	βmaj	is	reduced	to	background	
levels.	This	suggest	 that	Ldb1	 is	either	directly	or	 indirectly	 involved	 in	 long-range	
chromatin	interactions	at	the	β-globin	locus	(Song	et	al.,	2007).	Since	Ldb1	is	not	a	
DNA-binding	protein,	but	interacts	with	many	factors	that	are	involved	in	the	regulation	
of	erythroid	genes,	it	is	more	likely	that	this	is	an	indirect	effect	where	an	assembly	of	
complexes	on	the	locus	is	not	appropriate.	It	would	be	interesting	to	understand	how	
the	depletion	of	Ldb1	affects	binding	of	individual	partners	from	the	complex.
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INTRODUCTION
Erythrocytes are derived from the haematopoietic stem cell (HSC)
(Durand and Dzierzak, 2005). From approximately E8.5 to
E10.5 in the mouse, definitive HSCs are derived from the
aorta–gonado–mesonephros region (AGM) (Medvinsky and
Dzierzak, 1996; Yoder et al., 1997; de Bruijn et al., 2000; Cumano
et al., 2001). Recently the placenta has been identified as a further
source of adult HSCs (Gekas et al., 2005; Ottersbach and Dzierzak,
2005). At E11 the mouse fetal liver becomes the main organ of
haematopoiesis, later replaced by the bone marrow.
HSC differentiation involves coordinated changes in
transcription, often by functionally conserved genes such as
Gata2, Tal1, Lmo2, Gata1 and Runx1/Aml1 (Cantor and Orkin,
2001).
Often the binding sites for transcription factor complexes are
located at great distance from the genes that they control. In the
human and mouse �-globin locus, the interacting binding sites and
genes are spread over a distance of 100 kb. A three-dimensional
structure resulting from long-range interactions, the Active
Chromatin Hub (ACH), has recently been demonstrated (Tolhuis et
al., 2002; Palstra et al., 2003; Patrinos et al., 2004). We anticipate
that (novel) classes of proteins will mediate such 3D interactions of
distal regulatory elements. An example of such a protein is
Chip/Ldb1 (Morcillo et al., 1997), a protein that can interact with
the insulator protein Su(Hw) (Torigoi et al., 2000). Initially isolated
in a screen for proteins that bind LIM domains (Agulnick et al.,
1996), orthologues of Ldb1 have now been identified in a range of
other species. Ldb1 is a ubiquitously expressed nuclear protein that
does not bind DNA but appears to participate in transcriptional
control by acting as a co-factor for other proteins. It is part of a
protein complex in murine erythroid cells composed of the
haematopoietic transcription factors Lmo2, Tal1, Gata1 and E2A
(Tcfe2a – Mouse Genome Informatics) (Wadman et al., 1997)
binding to a GATA-E box motif. This complex binds to the locus
control region and �-globin promoter of murine erythroleukemic
(MEL, C88) cells (Brand et al., 2004), to the erythroid specific
glycophorin A (Gypa) promoter (Lahlil et al., 2004), and to
multiple sites in the �-globin locus during erythroid differentiation
(Anguita et al., 2004).
Consistent with its interaction with a broad range of transcription
factors involved in development, the Ldb1 knockout mouse dies
between E9.5 and E10.5 from a series of developmental defects,
including absence of haematopoieisis (Mukhopadhyay et al., 2003)
(A.H., unpublished). The latter partly resembles the knockout
phenotypes of the haematopoietic transcription factors Lmo2 and
Tal1 (Warren et al., 1994; Robb et al., 1995; Shivdasani et al.,
1995).
In order to understand the role of Ldb1 in erythroid transcriptional
interactions, we performed a biochemical screen to identify its
binding partners. Using in vivo biotinylation (de Boer et al., 2003;
Rodriguez et al., 2005) we describe a number of novel partners. We
show that Ldb1 forms complexes that change composition during
C88 cell differentiation, and that these complexes are bound to the
target genes in vivo. We show that Ldb1 and its binding partners are
co-expressed at early stages of development of the murine
haematopoietic system, and that the novel erythroid binding partners
are required for development of the definitive but not the primitive
haematopoetic system of zebrafish embryos.
MATERIALS AND METHODS
Ldb1 cDNA and bio-Ldb1 construct cloning
Ldb1 cDNA was cloned from D14.5 fetal liver RNA (Trizol, Life
Technologies) by RT-PCR (SuperScriptII Reverse transcriptase, Invitrogen;
Pfu Polymerase, Promega) into the EcoRI site of pBluescript (pBS)
(construct AH-3).
ATG-less Ldb1 cDNA was amplified and cloned between the BamHI and
NotI sites of pBS. The bio-tag was cloned directly in front of the ATG-less
cDNA. Tagged cDNA was isolated as a XhoI–NotI fragment and cloned into
the SalI and NotI sites of pEV-Neo (de Boer et al., 2003) to give construct
pEV-Neo-bio-Ldb1.
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MEL cell transfection and culture
C88 cells were cultured and induced for differentiation with DMSO as
previously described (Antoniou, 1991). C88BirA cells (Rodriguez et al.,
2005) were transfected by electroporation with ScaI-linearised pEV-Neo-
bioLdb1, cultured in 96-well plates containing medium with 1 �g/ml
puromycin and 0.8 mg/ml neomycin to select single clones (de Boer et al.,
2003; Rodriguez et al., 2005).
Nuclear extract preparation
Small-scale nuclear extract preparation of C88 cell cultures (30-50 ml) and
nuclear extracts of larger cultures (5.5-9 L) were prepared as described by
de Boer et al. (de Boer et al., 2003).
Strepatavidin pulldown and mass spectrometry
Strepatavidin-coated Dynabeads M-280 (Dynal) were blocked for 1 hour
with chicken serum albumin/PBS (200 ng/�l). The salt and detergent
concentrations of nuclear extract samples of 5-6 mg from induced
C88BirA/bio-Ldb1 cells or 15 mg from noninduced C88BirA/bio-
Ldb1 cells were adjusted to 200 mM KCl and 0.3% NP40 with 10 mM
KCl buffer (10 mM KCl, 10 mM HEPES-KOH, 1.5 mM MgCl2, 25%
glycerol, 0.75% NP40, 2 mM PMSF) prior to overnight incubation with
blocked beads at 4°C. The beads were washed for 5 minutes six times in
washing solution (150/200 mM KCl, 10 mM HEPES-KOH pH 7.9, 1.5
mM MgCl2, 0.2 mM EDTA, 0.3% NP40, 0.2 mM PMSF) at room
temperature. Pulled down proteins were processed and analysed by
mass spectrometry (LC-MSMS, MS) as described (Rodriguez et al.,
2005).
Immunoprecipitations and western blot analysis
Immunoprecipitations and western blot analysis were performed as
previously described (Rodriguez et al., 2005). Bio-Ldb1 was detected using
a 1/10,000 dilution of Streptavidin-Horseraddish Peroxidase (HRP)
conjugate (NEN).
Antibodies
Monoclonal rat antibodies against Mtgr1 and Lyl1 were produced by Absea.
The antibody against E2-2 was obtained from Abcam (ab2233), and all
others were from Santa Cruz Biotechnology: �-Ldb1 (sc-11198), �-Lmo2
(sc-10499), �-Lmo4 (sc-11121, sc-22833), �-Eto-2 (sc-9741), �-Runx1 (sc-
8563), �-Cdk9 (sc-484), �-HEB (sc-357), �-E2A (sc-349), �-Gata1-N6 (sc-
265), �-HDAC1 (sc-7872), �-NMP 238 (sc-15259). The antibody against
NMP 238 was used as a loading control for the IP experiments, because it
showed no change after induction.
Chromatin immunoprecipitations
Fixation, lysis of cells and sonication of chromatin were performed
as previously described (Rodriguez et al., 2005). Primers for real-
time PCR were as described (Rodriguez et al., 2005). Primers
for the Gata1 hypersensitive site (HS) and negative control sequences
were:
Gata1 HS-3.5 Reverse primer: 5�-CCGGGTTGAAGCGTCTTCT-3�
Gata1 HS-3.5 Forward primer: 5�-TCAGGGAAGGATCCAAGGAA-3�
Gata1 Negrev: 5�-TGCCGCTTGCCTTTGTAAG-3�
Gata1 Negfor: 5�-CACTAGCAGCTGGGTGGGTTA-3�
Zebrafish maintenance and morpholino injections
Wild-type zebrafish were kept and staged according to Westerfield
(Westerfield, 1993). ATG morpholinos (MO) (Gene-Tools) and
corresponding mismatch MOs were derived from the genebank cDNA of
ldb1 (NM_131313, 5�-GCCCACGTCTCGGTCCAGCATGGTG-3�), tcf4
(NM_131259, 5�-AGCTGCGGCATTTTTCCCGAGGAGC-3�), cdk9
(BC055634, 5�-CGACGCCATCGTAGTATTTGGACAT-3�, control
mismatch MO 5�-CGAgGaCATCGTAcTATTTaGAgAT-3�), lmo4
(NM_177984, 5�-AGCTTTCCACACGACTGTTCACCAT-3�, control
mismatch MO 5�-AGgTTTgCACACcACTGTTgACgAT-3�), mtgr1
(XM_695328 5�-CTCTTAAAAGCGTGAAAGACCGCAT-3�, control
mismatch MO 5�-CTgTTAAAAcCGTcAAAGAgCGgAT-3�), eto-2
(EST AF164710 5�-AACATGACGGTTGGAACTCTGGTT-3�, control
mismatch MO 5�-AAgATcACGGTTcGAACTgTGcTT-3�).
All MOs were dissolved in water to a concentration of 1 mM and injected
at three doses (0.1 nl, 0.5 nl and 1.2 nl) into zebrafish embryos at the two- to
eight-cell stage. As an injection control, rhodamin-dextrane or phenol red
were added to a concentration of 10% vol/vol before use.
Whole mount in situ hybridisation
Digoxigenin-UTP (Roche) labelled antisense and sense RNA probes
against the zebrafish orthologues of hemoglobin beta embryonic-1 (�E1)
(Quinkertz et al., 1999) and runx1 (M. Gering) were synthesized from
linearised plasmids using T3 and T7 RNA polymerases. In situ
hybridisation was performed as described previously (Jowett and Yan,
1996). To remove pigmentation, embryos older than 32 hours
postfertilisation (hpf) were treated with 5% H2O2/PBS for 2-3 hours prior
to in situ hybridisation.
Probes were detected by incubation with alkaline phosphatase coupled
anti-Digoxigenin antibody (Roche) and colour reaction with Fast Red
(Roche) for �E1 and BM Purple (Roche) for runx1.
Immunohistochemistry
E9.5 FVB mouse embryos were fixed in 2% paraformaldehyde/PBS for 2
hours at room temperature. After overnight equilibration in 20%
Sucrose/PBS at 4°C, embryos were orientated and quick frozen in Tissue
Tek (Sakura Finetek).
Immunohistochemistry was essentially carried out as previously
described (de Bruijn et al., 2002). All animal experiments were carried out
according to the Dutch Welfare of Animals Act.
RESULTS
Generation of bio-Ldb1 cells
In order to identify Ldb1 interacting partners, C88BirA MEL cells
expressing the Escherichia coli BirA protein-biotin ligase (de Boer
et al., 2003) were stably transfected with pEV-Neo-bio-Ldb1
(Fig. 1A).
A total of 16 C88BIR/bioLdb1 clones were isolated and induced
to differentiate with DMSO. Nuclear extracts were tested for
presence of the fusion protein using an �-Ldb1 antibody and
streptavidin-HRP (Fig. 1B). Clone #3F4 was chosen because it
expresses low levels of bio-Ldb1 (Fig. 1C) in the uninduced state.
This allowed us to compare Ldb1 complexes before and after
terminal differentiation.
Identification of Ldb1 interaction partners
Nuclear extracts prepared from noninduced and induced #3F4 cells
and untransfected C88 cells were incubated with streptavidin-coated
paramagnetic beads, and separated by polyacrylamide gel
electrophoresis (PAGE) (de Boer et al., 2003; Rodriguez et al., 2005)
(Fig. 1D). Proteins were trypsin digested, eluted and analysed by
mass spectrometry (LC-MSMS). Table 1 shows the pulled down
proteins when washed with 150 mM and 200 mM KCl. The pattern
of background proteins was similar to that observed for Gata1 (de
Boer et al., 2003; Rodriguez et al., 2005) and other transcription
factors (H. Braun, J. Demmers and J. Philipsen, personal
communication).
The screen was validated by the fact that known Ldb1 partners
(Lmo2, Tal1, Gata1 and E2A) (Wadman et al., 1997) were readily
identified. We also found three proteins of the Ssdp family, members
of which interact with Ldb1 in HeLa cells and in Drososphila (Chen
et al., 2002; van Meyel et al., 2003; Nishioka et al., 2005). These
Ssdp interactions were not analysed further. In addition, a number
of novel (potential) interaction partners of different functional
classes were found, including transcription (co-)factors, cell-cycle
proteins, chromatin remodelling and DNA repair proteins. Some of
the previously identified binding partners of Ldb1 (Tal1, E2A), the
basic helix-loop-helix (bHLH) proteins HEB (Tcf12 – Mouse
Genome Informatics), E2-2 (Tcf4 – Mouse Genome Informatics),
RESEARCH ARTICLE Development 133 (24)
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Lyl1 and the novel interacting protein Eto-2 (Cbfa2t3h – Mouse
Genome Informatics) were detected in all three analyses. Eto-2, an
orthologue of the D. melanogaster gene nervy, was the most
abundant protein in two of the three LC-MSMS outputs. Mtgr1
(Cbfa2t2 – Mouse Genome Informatics), another member of the
ETO protein family, was also identified by MS analysis of
noninduced and induced cell extracts. The known partner Lmo2 was
present in extracts from noninduced and induced cells (Fig. 2),
whereas Lmo4, Gata1 and Runx1 were present in the MS analyses
of induced cells only, although it should be noted that Gata1 may
have been absent due to the fact that only very few Gata1 peptides
are detectable in our MS analyses (Rodriguez et al., 2005). In
contrast to the proteins mentioned above, the cell-cycle protein Cdk9
was only found in nuclear extracts of noninduced cells. Proteins of
different chromatin remodelling complexes were also identified only
in induced cell extracts, for example Hdac1 (see Fig. S1B in the
supplementary material), but these have as yet not been investigated
in detail.
Western blots of equal amounts of nuclear extracts of noninduced
and induced C88 cells showed that the levels of all binding partners
except for the newly identified interacting proteins Eto-2, Cdk9 and
Lmo4, did not change significantly (Fig. 2, input lanes) in normal
untransfected cells and bio-Ldb1 cells. Levels of Lmo4 and Cdk9
increased with induction, whereas there was considerably less Eto-
2 in induced extracts (Fig. 2A, input Lmo4, Cdk9 and Eto-2 panels).
Interestingly, the much less abundant 55 kD isoform of Cdk9 (Shore
et al., 2003) is upregulated with induction, while the 41 kD isoform
of Cdk9 decreases in untransfected MEL cells, and is present at the
same levels in noninduced and induced bio-Ldb1 extracts (Fig. 2,
input Cdk9 panels); this phenomenon is also seen in differentiating
macrophages (Liu and Herrmann, 2005).
Identification of different complexes
To confirm the interactions found in the MS analysis,
immunoprecipitations of equal amounts of nuclear extracts from
induced and noninduced C88 cells (Fig. 2) were performed with an
�-Ldb1 antibody. Immunoprecipitations carried out on normal C88
cells and bio-Ldb1 transfected cells showed essentially the same
results. The �-Ldb1 antibody depleted the extracts of noninduced
cells almost completely of Ldb1 (Fig. 2A,B). Lmo2, Tal1, the two
E2A isoforms E12 and E47, HEB and Gata1, precipitated equally
with Ldb1 before and after induction (not shown). The only
difference we observed between the bio-Ldb1 transfected cells and
untransfected cells was a small change in the ratio of expression of
E12 and E47 (Fig. 2A,B, E2A panels). Consistent with its lower
level in induced cell extracts, less Eto-2 precipitated with Ldb1 from
induced cell extracts compared with that of noninduced cells (Fig.
2A,B, Eto-2 panels). Mtgr1, the other identified Eto-family member,
was also enriched to a lesser extent in induced cells (Fig. 2A,B,
Mtgr1 panels). As expected, more Lmo4 precipitated with Ldb1 in
induced cells compared with noninduced cells (Fig. 2A,B, Lmo4
panels), whereas the amount of coprecipitated Lmo2 did not change
(not shown). These results suggest that the newly identified partner
Lmo4 may play a more important role at later stages of erythroid
differentiation. Most notably, the two isoforms of Cdk9
immunoprecipitated with Ldb1 only in noninduced cells (Fig. 2A,B,
Cdk9 panels). As Cdk9 is involved in cell-cycle progression
(Bettencourt-Dias et al., 2004), its interaction with Ldb1 in
noninduced, proliferating C88 cells only, may link the complex
containing Ldb1 and Cdk9 to the maintenance of the proliferative
state. Although their level is unchanged, there was less
coprecipitation of E2-2 and Lyl1 with either �-Ldb1 (Fig. 2A,B) or
�-Eto-2 (not shown) in induced cells.
4915RESEARCH ARTICLELdb1 complexes and haematopoiesis
Fig. 1. Ldb1 biotinylation and streptavidin pulldown. (A) Schematic representation of bio-Ldb1. The 23 amino acid sequence recognised by
BirA and a triple haemagglutinin tag are fused in tandem to the amino-terminal end of the ATG-less Ldb-cDNA. (B) Expression of Ldb1 and bio-
Ldb1 in nuclear extracts of induced C88BirA/bio-Ldb1, C88-/BirA and C88–/– cells. Eight of 16 transfectants are shown. Three clones (lanes 3-5) did
not express bio-Ldb1, lane 9 not loaded. Clone #3F4 was chosen for further experiments. Lanes on the right are C88-/BirA and C88–/– controls.
(C) Ldb1 and bio-Ldb1 expression in equal amounts (see Coomassie stained gel) of nuclear extracts of noninduced (–) and induced (+) #3F4 cells.
Expression of endogenous Ldb1 is reduced in induced cells. (D) PAGE of proteins bound to bio-Ldb1. Pulldowns of noninduced and induced cell
extracts washed at lower stringency conditions are shown. PD, pulled down proteins; NE, untreated nuclear extract.
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In order to gain a better understanding of some of the Ldb1-
containing complexes, and to determine whether Ldb1 binding
partners bind to Ldb1 in the absence of Eto-2 and vice versa, we
performed sequential immunoprecipitation experiments. We first
depleted nuclear extracts of either Ldb1 or Eto-2 with their
respective antibodies, and then incubated the supernatants with �-
Eto-2 and �-Ldb1 respectively (Fig. 3 and see Fig. 1A in the
supplementary material). Immunoprecipitations were then
analysed for Ldb1 interacting proteins identified and validated in
the single immunoprecipitation experiments (Fig. 3). It should be
noted that we have not set out to characterise all the possible
complexes that may be formed by every single Ldb1 interacting
partner identified in the MS analysis, a task which is outside the
scope of this paper.
As noted above, the �-Ldb1 antibody (almost) completely
depletes Ldb1 protein from the extract (Figs 2, 3, Ldb1 panels). A
precipitation with �-Eto-2 antibody brings down high amounts of
Ldb1, indicating that a high proportion of complexes contains both
Ldb1 and Eto-2. However, �-Eto-2 did not deplete the extract of
Ldb1 protein, as more Ldb1 protein is precipitated with �-Ldb1
from the �-Eto-2 treated supernatant (Fig. 3, Ldb1 panels).
Conversely, precipitation of Ldb1 with �-Ldb1 antibody brings
down large amounts of Eto-2 (Figs 2, 3, Eto-2 panels) but does not
deplete Eto-2 completely from the extract, as there is more Eto-2 left
in the supernatant (Fig. 3, Eto-2 panel). Thus, there are probably at
least three complexes, one containing both Eto-2 and Ldb1, one that
contains Ldb1 but not Eto-2, and one that contains Eto-2 but not
Ldb1 (Fig. 3B).
To investigate the binding behaviour of Cdk9, the only protein that
does not interact with Ldb1 upon induction of differentiation, we
tested the sequential immunoprecipitations for its presence. �-Ldb1
antibody precipitated Cdk9 with a substantial amount left in the
supernatant, which was not precipitable by �-Eto-2 antibody (Fig.
3, Cdk9 panel). In reverse, incubation of nuclear extracts with �-Eto-
2 antibody also precipitated Cdk9 only partially, the remainder also
not being bound to Ldb1 (Fig. 3, Cdk9 panel). We suggest that Cdk9
requires both Ldb1 and Eto-2 for its interaction with either of the two
proteins. E2-2 and Lyl1 exhibited similar interaction behaviour (Fig.
3), with the exception that Lyl1 is also bound to Ldb1 alone (Fig.
3B).
To test whether the Ldb1-Lmo2 interaction requires Eto-2, we
first depleted Eto-2 followed by Ldb1 immunoprecipitation and
testing for Lmo2 (Fig. 3, Lmo2 panels). �-Eto-2 brought down only
some Lmo2. As all of Lmo2 is in complex with Ldb1 (Fig. 3), we
conclude that there is a complex containing Lmo2-Ldb1-Eto-2, and
that the remaining Lmo2 left in the supernatant after Eto-2 depletion
is bound to Ldb1, but not Eto-2. Lmo4 behaves similarly but shows
an important quantitative difference. There is little Lmo4 before
differentiation, but this increases several fold after induction of
differentiation (Fig. 2).
The two isoforms of E2A show a different binding behaviour. Both
the larger E47 and smaller E12 isoforms are precipitated equally by
Ldb1, albeit incompletely. The remaining E47, but not E12, is bound
by Eto-2 (Fig. 3 and see Fig. S1A in the supplementary material; E2A
panels). Conversely, �-Eto-2 completely depletes the extracts of the
E47 isoform but binds only some E12 (Fig. 3, E2A panel). Some of
this remaining E12 is precipitable by Ldb1. Taking into account the
Ldb-1/E2A data from above, this indicates the presence of a complex
containing Ldb1/Eto-2/E47/E12, two further complexes composed
of at least Eto-2/E47 or Ldb1/E12, and ‘free’ E12 that can participate
in other complex formation.
Mtgr1 was the second member of the Eto family identified in our
MS analysis. �-Ldb1 antibody precipitates some Mtgr1, but not
all, with a substantial amount left in the supernatant that is all
precipitated with an �-Eto-2 antibody (Fig. 3, Mtgr1 panel and see
Fig. S1A in the supplementary material). Precipitation with �-Eto-
2 antibody, however, completely depletes Mtgr1 from the nuclear
extracts, indicating that all Mtgr1 is complexed with Eto-2 (Fig. 3
and see Fig. S1A in the supplementary material; Mtgr1 panels). We
conclude that there are at least two complexes containing Mtgr1: one
complex containing Mtgr1/Eto-2/Ldb1, and that the Mtgr1/Ldb1
interaction requires Eto-2; a further complex containing Mtgr1/Eto-
2, but not Ldb1.
Tal1 also forms several complexes, which contain either Ldb1
and/or Eto-2. �-Ldb1 antibody precipitates most, but not all Tal1
from the nuclear extract, part of the remaining Tal1 is pulled down
with Eto-2 (Fig. 3, Tal1 panel). Testing first with �-Eto-2 shows that
Eto-2 brings down some but not all Tal1; some is precipitable with
an �-Ldb1 antibody (Fig. 3, Tal1 panel). This indicates that there are
at least four Tal1-containing complexes: Eto-2/Tal1/Ldb1,
Ldb1/Tal1, Eto-2/Tal1 and ‘free’ Tal1.
HEB also forms complexes that contain either Ldb1 and/or Eto-
2. Both �-Ldb1 and �-Eto-2 precipitate large amounts of HEB
indicating that HEB forms complexes with Ldb1 or Eto-2, and
probably a complex containing all three of these proteins. A second
precipitation with either �-Eto-2 or �-Ldb1 precipitates more HEB,
although small amounts remain in the supernatant after this second
RESEARCH ARTICLE Development 133 (24)
Table 1. Proteins identified by LC-MSMS in bio-Ldb1 pulldown
experiments
Non-induced Induced 1 Induced 2
Proteins pulled down C88/BirA LS LS HS
Transcription factors
LIM only proteins
Lmo2 – + – +
Lmo4 – – + +
Zinc finger proteins
Gata1 – – + +
Basic helix-loop-helix
Tal1 – + + +
E2A – + + +
Lyl1 – + + +
HEB – + + +
E2-2 – + + +
ETO-family
Eto-2 – + + +
Mtgr1 – + - +
Runt domain
Runx1 – – + +
Ssdp
Ssdp2 – + + +
Ssdp3 – + + +
RIKENcDNA1210001E11 – + + +
(Ssdp4)
Cell-cycle proteins/kinase
Cdk9 – + – –
The lower amount of identified proteins and their corresponding peptides in the
lower stringency pulldown experiment of induced cells (induced 1) is due to the
lower amount of input for the LC-MSMS analysis.
LS, low stringency; HS, high stringency.
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immunoprecipitation (Fig. 3, HEB panel). Therefore, HEB forms at
least three complexes: HEB/Ldb1, HEB/Eto-2 and ‘free’ HEB.
When an �-HEB immunoprecipitation is carried out, it does
precipitate all the partners, including Lyl1, Cdk9 and E2-2,
suggesting that it is part of a large Ldb1/Eto-2 complex (Fig. 3B), or
perhaps a smaller one containing Ldb1 and Eto-2.
Finally, Gata1, a transcription factor known to participate in a
multitude of complexes (Rodriguez et al., 2005), also forms separate
complexes with either Eto-2 or Ldb1. Treatment of extracts with �-
Ldb1 antibody brings down a small part of Gata1. Further
precipitation with �-Eto-2 provides evidence of an Eto-2-Gata1
interaction separate from Ldb1 (Fig. 3, Gata1 panel, and see Fig.
S1A in the supplementary material). In reverse, �-Eto-2 antibody
indeed precipitates part of Gata1. Very little Gata1 is then
precipitable with an �-Ldb1 antibody, indicating that possibly most
of the Eto-2/Gata1 complex also contains Ldb1 (Fig. 3, Gata1
panel). We conclude that Gata1 forms at least four complexes:
Gata1/Ldb1, Gata1/Eto-2, Gata1/Ldb1/Eto-2 and ‘free’ Gata1,
which is known to participate in other complexes.
Single immunoprecipitations using antibodies for the Ldb1
interacting proteins confirmed all the pairwise interactions described
above (not shown).
Although it is difficult to distinguish the complexes from each
other, the data strongly suggest that there are several subcomplexes
formed by Ldb1 and its interaction partners that can form larger,
functional complexes (possibly via the homodimerisation of Ldb1).
We can distinguish two large subcomplexes with either Ldb1 or Eto-
2 and one large complex containing both Ldb1 and Eto-2 (Fig. 3B
and Fig. 7). Upon differentiation, association with Cdk9 is lost and
the level of Eto-2 is substantially decreased, whereas the amount
of Lmo4 is increased several fold. The reduction in association
between Ldb1 and Eto-2 is also reflected in the reduced
coimmunoprecipitation of E2-2 and Lyl1 with �-Ldb1 and �-Eto-2
in induced cells. In addition, these complexes appear to interact with
Runx1, but we have as yet not been able to characterise this
interaction due to the poor quality of the available antibody.
Chromatin immunoprecipitations
To confirm that Eto-2 and Ldb1 are bound to chromatin at specific
regulatory sites, we carried out chromatin immunoprecipitations
using a number of erythroid genes: Gata1,Gypa,Myb,Myc and Eklf
(Klf1 – Mouse Genome Informatics), for which the binding of Gata1
complexes is known (Rodriguez et al., 2005). Among the Gata1
gene regulatory regions, the HS-3.5 is known to bind the
4917RESEARCH ARTICLELdb1 complexes and haematopoiesis
Fig. 2. Analysis of Ldb1 interacting protein complexes. Protein levels of Eto-2, Cdk9 and Lmo4 change with induction of C88 cell
differentiation. Western blot analysis of noninduced (Unind.) and induced (Ind.) C88 cells containing bio-Ldb1 (A) or untransfected C88 cell nuclear
extracts (B). Input lanes indicate levels of tested proteins in untreated nuclear extracts diluted to the same concentration as in the
immunoprecipitation experiments. Proteins immunoprecipitating with Ldb1 (IP lane) and supernatant (Sup) are shown and labelled accordingly. The
isoforms of bio-Ldb1, Cdk9 and E2A, are indicated.
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Gata1/Tal1/Ldb1 complex, whereas the DNaseI hypersensitive site
in the gene (Gata1 IE) does not (Guyot et al., 2004). The GATA-E
box sites in the Gypa and Eklf promoters are also known targets of
Gata1/Ldb1 (Lahlil et al., 2004; Rodriguez et al., 2005). In contrast,
the Myb and Myc genes bind a Gata1/Gfi1b complex (Rodriguez et
al., 2005). In all cases we find an enrichment for Gata1 (as expected)
when compared with non GATA site negative control fragments (not
shown) (Rodriguez et al., 2005). In contrast, Eto-2 and Ldb1 were
bound to Gata1, Eklf andGypa (Fig. 4), but not to Myc andMyb (not
shown). The ratio of Eto-2/Ldb1 binding to the three elements,
decreases during differentiation in C88 cells (Fig. 4) in accordance
with the fact that there is less Ldb1/Eto-2 complex (see Fig. 2).
Gata1, glycophorin A and Eklf proteins are expressed late in
erythroid differentiation [the –3.5 HS of the Gata1 gene also
regulates Gata1 expression in megakaryocytic cells (McDevitt et
al., 1997; Onodera et al., 1997)], whereas Myc and Myb are
RESEARCH ARTICLE Development 133 (24)
Fig. 3. Sequential immunoprecipitations to investigate Ldb1- and Eto-2-containing complexes. (A) Nuclear extracts of noninduced normal
C88 cells were first depleted of either Ldb1 or Eto-2 with their respective antibodies. The supernatants were then incubated with �-Eto-2 or �-
Ldb1, respectively. The second supernatant was also loaded to determine which proteins do not interact with either Eto-2 or Ldb1. IgG lanes are
control immunoprecipitations carried out with a nonspecific, isotype-matched antibody. (B) Scheme of interacting factors from IP experiments in A
(see also Fig. S1A in the supplementary material). Each new line represents the analysis of an additional three transcription factors.
Fig. 4. ChIP of Ldb1 and Eto-2. (Top) The boxes
indicate the localisation of the upstream HS in the
Eklf, Gata1 and Gypa promoters that contain
Gata-1/Tal1 binding sites and negative controls not
containing such sites. Bar graphs show the relative
enrichment of sequences immunoprecipitated by
Eto-2 (red), Ldb1 (yellow) and the IgG control
(blue) in noninduced (middle row) and induced
(bottom row) C88 cells. All values were normalised
to a GAPDH control. 
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downregulated. The decrease of Eto-2 levels in late erythroid
cells suggests that Eto-2 adds a repressive function to the
Gata1/Tal1/Ldb1 complex to keep late erythroid genes off early
during differentiation. In contrast, Eto-2 is not essential for Gfi1b
repressed genes such as Myb and Myc expressed at early stages
(Rodriguez et al., 2005).
Eto-2, Cdk9 and Lmo4 are required for definitive
haematopoiesis in a zebrafish model system
Ldb1 and its constitutive binding partners Lmo2 and Tal1 are
essential for embryonic blood formation (Warren et al., 1994; Robb
et al., 1995; Shivdasani, 1995). We next asked whether the newly
identified Ldb1 interacting partners E2A, Cdk9, Eto-2, Lmo4 and
Mtgr1 are required for haematopoietic development. As the genetic
regulation of embryonic and definitive haematopoiesis is highly
conserved between zebrafish and mammals, we tested the role of
these proteins by MO-mediated inhibition of mRNA translation in
zebrafish embryos (Nasevicius and Ekker, 2000). In zebrafish,
primitive erythrocytes expressing embryonic haemoglobin derive
from the intra-embryonic intermediate cell mass (ICM) and start
circulating at 24 hpf. Shortly thereafter, with development of the
definitive haematopoietic system, a ventrally located flk1-positive
subpopulation of the dorsal aorta precursors starts to express runx1.
runx1 is also expressed in primitive erythrocytes, the olfactory
epithelium, Rohon-Beard neurons (Kalev-Zylinska et al., 2002) and
the anterior paraxial mesoderm.
ATG-MOs and mutated MOs targeted against the zebrafish
orthologues of Cdk9, Eto-2, Lmo4,Mtgr1 and Ldb1were injected at
three increasing doses into one- to eight-cell stage embryos. To test
the effects of these MOs on the embryonic and definitive
haematopoeitic system, we analysed embryos after onset of blood
circulation by in situ hybridisation with probes against embryonic
�E1 and runx1, respectively (Fig. 5).
Ldb1-MO-injected embryos displayed variable phenotypes at all
doses, including deformation of the body axis, dysmorphic somites,
abnormal tail morphology, haematopoietic defects resembling that of
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Fig. 5. Analysis of zebrafish embryos after MO injections. The developmental stage of each embryo is in the bottom left corner; the targeted
gene is indicated in the top left corner. All pictures were taken at the same magnification. (A) Noninjected wild-type (wt) control embryos stained
for �E1- (zE1b-globin, left column) and runx1-mRNAs (right column). The ICM, dorsal aorta (DA), primitive erythrocytes (Pr.Ery.), anterior paraxial
mesoderm (APM) and olfactory epithelium (OE) are indicated. The �E1signal is red, runx1 signal is blue. Treated embryos were injected with 1 pmol
eto-2-MO (32 hpf), 1 pmol cdk9-MO (28 hpf),1 pmol lmo4-MO (30 hpf), or with 0.5 pmol of the control tcf4-MO (30 hpf). (B) The reduction of
runx1 expression in the dorsal aorta region resulting from injection with the MOs directed against eto-2 (n=23/27), cdk9 (n=33/56) and lmo4
(n=36/54) was still observable after 2 days. Embryos injected with the mtgr1-MO were analysed at 38 hpf and showed only a slight effect on the
definitive haematopoietic system. All embryos shown were injected with 1 pmol of the corresponding MO.
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the mouse (A.H., unpublished) and necrosis in the brain (not shown).
The severity of defects increased with increasing dose of injected
Ldb1-MO. As a negative control, we used mutated ATG-MOs and an
MO targeted against tcf4, the zebrafish orthologue of Tcf7/2. The
latter is not expressed in haematopoietic tissues and, when deleted,
has a specific effect in the intestinal epithelium of the mouse (Korinek
et al., 1998). As expected, no effects of the mutated ATG-MOs (not
shown) or tcf4-MO on the haematopoietic system were observed in
the injected zebrafish at any dose. Embryos injected with the highest
dose of tcf4-MO displayed some tail abnormalities.
The cdk9-MO had no effect on �E1 expression or expression of
runx1 in the primitive erythrocytes located in the posterior ICM, the
olfactory epithelium and the anterior paraxial mesoderm. However,
they had a severe effect on definitive erythropoiesis. A 0.5-pmol
dose of cdk9-MO showed a clear reduction of runx1 signal in the
dorsal aorta region (n=10/18), which decreased further in embryos
injected with 1 pmol (n=8/10). Surprisingly the effect appears to be
specific to the haematopoietic system, although Cdk9 is expressed
in many tissues (Bagella et al., 1998).
Embryos injected with the eto-2-MOs had a similar phenotype.
The reduction of runx1 expression in embryos injected with 0.5
pmol (n=13/16) and 1 pmol of eto-2-MO (n=5/7) was more severe
compared with the cdk9-MO: runx1 in the dorsal aorta was either
almost or completely abolished. Embryonic �E1 expression was
normal in all eto-2-MO-injected embryos; however, some primitive
erythrocytes in the caudal region were located laterally to the
midline as opposed to their location in wild-type embryos. This is
similar to the effect observed when sonic hedgehog signalling is
inhibited (Gering and Patient, 2005), suggesting that eto-2 may play
a role in the response to extracellullar signals. Injection of 1-2 pmol
of the mtgr1-MO did not affect embryonic haematopoiesis. Some
reduction of runx1 expression in dorsal aorta precursor cells was
observed at 38 hpf (n=5/25; Fig. 5B).
Embryos treated with the lmo4-MO were comparable to
knockdowns of cdk9 and eto-2. Expression of embryonic �E1 was
normal, whereas reduced levels of runx1 were observed in the dorsal
aorta region at 0.5 pmol MO (n=8/13) and decreased further with
lmo4-MO injected at 1 pmol. In addition, some of the treated
embryos appeared to have brain or neural tube abnormalities, which
are the cause of perinatal death of the corresponding knockout
mouse (Hahm et al., 2004; Tse et al., 2004; Lee et al., 2005). These
mice showed no defects in the haematopoietic system, although only
half of the homozygous Lmo4 null mutants were born. The other half
died around E9 of gestation, possibly due to a haematopoietic
phenotype. The effects of the eto-2-, cdk9- and lmo4-MOs on the
definitive haematopoietic system were still observable after 2 days
(Fig. 5B) with normally circulating embryonic blood cells. At this
stage of development the reduction in body size of the embryos
injected with the eto-2-, cdk9-, lmo4- and mtgr1-MOs also became
more apparent (Fig. 5B).
We conclude that the newly identified Ldb1 interaction partners
eto-2, cdk9 and lmo4 are essential for definitive erythropoiesis in
zebrafish, whereas mtgr1 plays a less critical role. The fact that
embryonic haematopoieis is intact shows that the expression of tal1
and gata1 is not affected by knockdown of eto-2, cdk9 and lmo4. The
dorsal aorta is normally formed in such treated embryos, indicating
that the eto-2, cdk9 and lmo4 are not required for vasculogenesis. It
is noteworthy in this context that Eto-2 in zebrafish (this paper) and
most of its constitutive binding partners, namely HEB and E47 in
mouse (Zhuang et al., 1996) and Mtgr1 in mouse (Amann et al.,
2005) and zebrafish (this paper), are not required for embryonic
haematopoiesis.
Ldb1 interacting partners are expressed in the
same cells in the para-aortic splanchnopleura of
the early mouse embryo.
The results obtained for the novel Ldb1 interaction partners in the
zebrafish suggest that they would be expressed in the early mouse
embryo at stages prior to the ‘birth’ of the definitive haematopoietic
stem cells in the AGM (Durand and Dzierzak, 2005). We therefore
performed immunohistochemistry and immunofluorescence on E9.5
embryo sections (Fig. 6). Immunohistochemical analysis with �-
Ldb1, �-E2A, �-Lmo2, �-Gata1, �-Eto-2 and �-Cdk9 showed that
all are expressed in the para-aortic splanchnopleura (P-Sp), the
region destined to contribute to the AGM (Fig. 6A,B).
To further determine the expression pattern of the interacting
proteins and to confirm that cells within the P-Sp co-express these
proteins, we performed in situ immunofluorescence experiments on
the cryosections. We found that cells positive for Gata1 expression
also expressed Eto-2, Ldb1 and Runx1 (Fig. 6C). Cells expressing
Ldb1 were also positive for Runx1, E2A and Lmo2 (not shown).
Although we cannot analyse all of the proteins due to antibody
incompatibilities, the observation that Gata1 and Eto-2, Gata1 and
Ldb1, and Ldb1 and Runx1 are co-expressed in the pre-AGM cells
of the P-Sp suggests that they form a complex that may be essential
for the induction of the definitive haematopoietic system. The fact
that Eto-2 is predominantly cytoplasmic at that time (Fig. 6C,
column 3, panels Eto-2 and merge) suggests that it may respond to
extracellullar signals at the prehaematopoietic stage. At later stages
(fetal liver), it is abundant in the nucleus but its cytoplasmic
expression is very weak. (see Fig. S2 in the supplementary material).
DISCUSSION
Ldb1 forms dynamic complexes during erythroid
differentiation
By using a systems biology approach we identified all known and
many new binding partners of Ldb1 and determined their
importance for haematopoietic development. The important
implication of this work is that the analysis of proteins co-expressed
and interacting with each other in a late mature cell type are already
implicated at the earliest stages of, in this case, blood development.
The Ldb1 proteome has a number of interesting interactions: (1)
with Eto-2 (and Mtgr1); (2) with a large number of different bHLH
proteins; (3) with Cdk9; and (4) with the Ssdp proteins, although this
latter interaction was not analysed further. Recently we have shown
that Gata1 forms at least five clearly identifiable protein complexes
(Rodriguez et al., 2005). We did not observe such distinct complexes
for Ldb1. Clearly, Ldb1 forms a core complex with the known
partners Gata1, Tal1, Lmo2 and E2A, and the newly identified
partner Eto-2 (Fig. 6). Eto-2 also forms complexes with E2A and
Tal1 without Ldb1. In the sequential immunoprecipitations we can
distinguish between the preferential binding partners of Eto-2 and
Ldb1, and deduce the existence of a higher order complex the
formation of which is favoured in proliferating cells. At the same
time it is difficult to separate groups of interacting proteins from
each other by immunoprecipitations, especially if a protein interacts
with others in different combinations. Hence, we are in the process
of purifying the different complexes. With induction, levels of Eto-
2 decrease and formation of the large complex is lower (Fig. 7).
Cdk9, which has been linked to cell-cycle progression (Bettencourt-
Dias et al., 2004), would no longer be part of the complex. This may
explain why the cells stop proliferating upon differentiation. At the
same time, the levels of Lmo4 increase, possibly replacing
Lmo2/Eto-2 and leading to an activation of transcription of genes
expressed after terminal differentiation.
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Noteworthy is the presence of a large number of DNA binding
proteins within the complex, particularly the presence of at least five
bHLH proteins and the zinc finger transcription factor Gata1. It is
possible that such a complex may very well be involved in the
establishment and/or facilitation of long-range interactions,
processes in which Ldb1 has been implicated (Morcillo et al., 1997).
Specifically, in Drosophila melanogaster, Chip was identified in a
screen for factors involved in the long-range gene activation of the
cut gene. Chip was proposed to bridge the Pannier (GATA) and
Achaete/Scute (bHLH) complexes causing the intervening DNA to
loop out bringing DNA control elements into close proximity
(Ramain et al., 2000). The erythroid Ldb1-Lmo2-Tal1-E2A-Gata1
complex may have a similar role. It was recently shown that the
complex binds to multiple sites in the �-globin locus (Anguita et al.,
2004). We envisage that these complexes also interact and promote
long-range interactions in other gene loci, for example in the �-
globin locus ACH (Tolhuis et al., 2002).
The Eto family members Eto-2 and Mtgr1 are thought to be
repressors by binding the NCor/Sin3A/HDAC1 (Gelmetti et al.,
1998; Lutterbach et al., 1998; Wang et al., 1998) complex. Eto-2
was the most abundant protein in the MS analysis, suggesting it
is a direct (and crucial) binding partner of Ldb1 (confirmed by
immunoprecipitations). We also observed that Eto-2 and its
family member Mtgr1 interact with each other. Moreover Eto-2
appears to be the bridging factor for Ldb1 to interact with Mtgr1
(Fig. 3, and see Fig. S1A in the supplementary material). Eto
proteins and the D. melanogaster orthologue nervy have four
highly conserved protein interaction domains (Davis et al., 1999;
4921RESEARCH ARTICLELdb1 complexes and haematopoiesis
Fig. 6. Ldb1 interacting partners are expressed in the P-Sp. (A) Haematoxylin stained 10 �m transversal cryosection of a E9.5 FvB embryo. The
area of the P-Sp is indicated by the box. (B) High magnification (�1000) of the areas such as shown in (A). Expression of Cdk9, E2A, Ldb1, Lmo2
and Gata1 was detected with specific antibodies and visualised with DAB. IgG panel shows the background staining with an unspecific IgG
antibody. (C) Immunofluorescence analysis of E9.5 embryos with �-Eto-2, �-Ldb1, �-Runx1 and �-Gata1 antibodies. Specific staining is seen for
both Eto-2 (green) and Gata1 (red) antibodies (second column), compared with the IgG control (first column). (Third column) Enlargement of the
section shown in the second column. Merge is a superposition of images of the Eto-2 and Gata1 detection; cells that express both Eto-2 and Gata1
appear as yellow. The overlay of Gata1 and DAPI staining shows exclusive nuclear localisation of Gata1, whereas Eto-2 is seen in the nucleus and
cytoplasm. (Fourth column) Ldb1- (green) and Gata1- (red) expressing cells are located in the dorsal aorta region; most of the cells positive for Ldb1
are also positive for Gata1 (Ldb1 is also expressed in other cell types). A similar pattern is shown for Gata1- (red) and Runx1- (green) expressing cells
in E9.5 embryos (sixth column). (Fifth and seventh columns) High magnification of the same sections reveals more detail. DA, dorsal aorta; NT,
neural tube.
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Davis et al., 2003). The DNA binding of the Eto-2 complexes we
describe probably occurs through its bHLH binding partners
and/or Gata1.
Interestingly, with induction Eto-2 and the Eto-2/Ldb1 complex
decrease, while the level of Lmo4 increases. Thus, the level of the
large Ldb1-Eto-2 complex drops to be replaced by one with
Lmo4. Complementary results were obtained by other groups
through characterisation of Tal1 complexes (Schuh et al., 2005;
Goardon et al., 2006). As indicated by the chromatin
immunoprecipitation experiments, the repressive role of
Eto-2 may very well explain how late erythroid genes become
activated. An alternative or complementary explanation may
be post-translational protein modifications of the Eto-2
complex members, a possibility that cannot be excluded at
present.
A good candidate to carry out modifications and change
specific interactions is Cdk9. This CDC2 orthologue precipitated
differentially with Ldb1 in proliferating and differentiating
C88 cells. The invariance of the main isoform independent of
the cell-cycle stage has been reported (Garriga et al., 2003). Cdk9
is thought to have two functions: regulating RNA polymerase II
by phosphorylating its C-terminal domain (Marshall et al., 1996;
Zhu et al., 1997); and regulating the cell cycle. A ‘knockdown’ of
the D. melanogaster orthologue of Cdk9 causes an arrest at the
G1 to S transition (Bettencourt-Dias et al., 2004), congruent
with the in vitro data that the human CDK9 orthologue
phosphorylates Rb (Graña et al., 1994). Interestingly, Gata1 has
been found to interact with Rb in vitro (Whyatt et al., 1997).
We detect an interaction between Cdk9 and Ldb1 only in
noninduced, proliferating C88 cells, suggesting Ldb1 and its
partners might be involved in transcriptional control of the cell
cycle through the dual function of Cdk9. Putative target genes
could be E2F family members expressed in haematopoietic cells.
Cdk9 also interacts with BRG1 and STAT3 to activate
transcription of the cell-cycle inhibitor p21waf1 (Giraud et al.,
2004), suggesting that Cdk9 has different functions in the cell
cycle depending on its partners. In this context it is interesting that
we detect Eto-2 protein in the cytoplasm of haematopoietic stem
cell precursors (Fig. 6) and of developing neurons (N.M.,
unpublished). Eto-2 may respond to extracellular signals by
translocating from the cytoplasm into the nucleus, while it is
downregulated in terminally differentiating cells. This suggests
that Eto-2 plays a key role in the development of the definitive
HSCs, and is required for the subsequent phases of expansion of
the different lineages. It then needs to be downregulated to allow
the activation of late genes such as Eklf for terminal
differentiation.
Late erythroid differentiation complexes and
early haematopoiesis
It is remarkable that the analysis of interacting proteomes of Gata1
(Rodriguez et al., 2005) and Ldb1 (this paper) in late erythroid cells
has resulted in the identification of a number of proteins essential for
early haematopoiesis (as found in the zebrafish experiments), in
particular Lmo4, Cdk9 and Eto-2.
Lmo4 expression in mice has been detected at E9 from the caudal
region of the dorsal and lateral paraxial mesoderm up to the direct
vicinity of the dorsal aorta, suggesting that Lmo4 could play a role
in HSC formation (Kenny et al., 1999). Lmo4 is also upregulated in
late T cell differentiation (Kenny et al., 1999) similar to that
observed in C88 cells. In Xenopus, Xlmo4 and Gata-2 act
synergistically in ventral mesoderm formation. However, an
Xlmo4-MO did not prevent ventral mesoderm formation (de la
Calle-Mustienes et al., 2003). In zebrafish, lmo4 is expressed at
gastrulation but not during ventral mesoderm formation (Lane et
al., 2002). In accordance with this, we found embryonic
haematopoiesis in lmo4-MO-treated zebrafish embryos to be
normal. We show the expression of lmo4 at later stages to be
important for the formation of definitive HSCs in zebrafish.
Whether the same phenotype is observed in mice remains to be
determined.
MO-mediated repression of eto-2 had the most drastic phenotype
in zebrafish – absence of runx1 expression in embryonic
erythrocytes and lack of definitive haematopoiesis, suggesting it is
essential for runx1 expression at that stage. Cdk9-MO-treated
embryos lacked definitive cells. However in embryonic blood cells
runx1 expression was detected, suggesting Cdk9 does not regulate
runx1 directly.
The fact that these factors are already co-expressed in the same
cells in the murine P-Sp before the generation of the definitive HSCs
in the AGM (de Bruijn et al., 2000) suggests that they are also
essential for definitive haematopoiesis in the mouse. Eto-2 and Cdk9
may be more important in this process than Gata1, because loss of
Gata1 is not deleterious to these very early stages (with cytoplasmic
Eto-2). This in turn suggests that Tal1, Ldb1 and Lmo2 are dominant
at this stage. Because all of the Ldb1-bound Gata1 is complexed
with Eto-2, we postulate that when Eto-2 translocates from the
cytoplasm to the nucleus, the balance of interactions is changed
causing the transition to a more proliferative Gata1-driven phase
followed by terminal differentiation.
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Fig. 7. Model of Ldb1 complexes in uninduced MEL cells. The horizontal arrows indicate that the balance of interaction is towards the large
complex in proliferating noninduced cells. Upon the induction of differentiation and termination of proliferation the level of Eto-2 drops whereas
the level of Lmo4 rises, hence the equilibrium would shift towards the smaller complexes. The presence of several DNA binding proteins in a single
complex may explain the role of Ldb1 as a facilitator of long-range interactions.
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Supplementary material for this article is available at
http://dev.biologists.org/cgi/content/full/133/24/4913/DC1
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AbStRACt 
Delangin	(NIPBL	in	humans,	Nipped-B	in	Drosophila,	Scc2	in	yeast)	is	a	protein	
involved	in	the	loading	of	Cohesin	onto	chromatin	and	hence	thought	to	be	important	
for	sister	chromatid	cohesion.	Mutations	in	Delangin	and	the	Cohesin	complex	are	
associated	with	 the	developmental	disorder	Cornelia	de	Lange	Syndrome	 (CdLS)	
in	 humans.	 It	 is	 a	 rare	 dominantly	 inherited	 multisystem	 disorder	 affecting	 both	
physical	 and	mental	 development.	 Heterozygous	mutations	 in	 the	Delangin	 gene	
were	 found	 in	 about	 half	 of	 CdLS	 cases.	 To	 understand	 the	 role	 of	 Delangin	 in	
mammals,	 we	 generated	mice	 lacking	Delangin.	Homozygous	mutants	 are	 lethal	
early	in	development.	Heterozygous	mice	are	born	exhibiting	the	characteristics	of	
CdLS	 that	 is	 heterogeneous	 and	 not	 fully	 penetrant.	 Affected	mice	 have	 severely	
reduced	body	size	and	abnormalities	in	many	organs	and	show	abnormal	behavior.	
This	suggests	that	a	reduced	level	of	Delangin	can	cause	chromatin	defects	very	early	
in	development.	We	did	not,	however,	detect	cohesion	defects	in vitro experiments.	
These	 results	 suggest	 that	 Delangin	 have	 important	 functions	 in	 chromosomal	
dynamics	and	gene	regulation.	In	addition,	we	think	that	our	mouse	model	can	be	
a	valuable	model	 for	understanding	the	molecular	mechanism	behind	Cornelia	de	
Lange	Syndrome.
IntRODuCtIOn:
Cell	 proliferation	 depends	 on	 genome	 duplication	 and	 segregation	 of	 sister	
chromatids	to	opposite	poles	of	the	cell	prior	to	division.	Cohesin	is	a	protein	complex	
that	keeps	sister	chromatids	 together	 from	 the	 time	of	 replication	 in	S	phase	until	
their	separation	at	the	onset	of	anaphase,	a	process	that	is	essential	for	the	correct	
segregation	of	chromosomes	during	mitosis.	The	Cohesin	proteins	are	evolutionarily	
conserved	 across	 species	 (Hirano,	 2006;	Nasmyth	 and	Haering,	 2005).	 The	 core	
complex	consists	of	SMC1	and	SMC3,	members	of	the	SMC	(Structural	Maintenance	
of	 Chromosomes)	 protein	 family,	 and	 two	 non-SMC	 subunits	 SCC1/Rad21	 and	
SCC3/SA	(Nasmyth	and	Haering,	2005).	Together,	these	proteins	form	a	large	ring-
shaped	structure	of	about	30-40	nm	in	diameter	that	encircles	DNA.	Several	models	
have	been	suggested	for	the	mechanism	by	which	Cohesin	rings	may	hold	the	two	
sister	chromatids	together	but	 the	precise	topology	 is	still	unclear	(Losada,	2007).	
Cohesin	is	required	but	not	sufficient	for	sister	chromatid	cohesion.	The	association	
of	 Cohesin	 with	 chromatin	 requires	 the	 SMC	 proteins	 to	 have	 a	 functional	 hinge	
domain,	ATPse	activity	 and	 the	activity	 of	SCC2/SCC4	 loading	complex	 (Ciosk	et	
al.,	2000;	Gruber	et	al.,	2006;	Weitzer	et	al.,	2003).	Cohesin	activity	is	regulated	by	
its	regulatory	factors	SCC2,	SCC4,	PDS5	and	ECO1	(Hartman	et	al.,	2000;	Nasmyth	
and	Haering,	2005).	In	addition	to	sister	chromatid	cohesion,	Cohesin	is	important	
for	meiosis,	DNA	repair,	gene	expression	and	regulation	of	developmental	processes	
(Dorsett,	2007;	Hirano	and	Hirano,	2006;	Nasmyth	and	Haering,	2005;	Revenkova	
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and	Jessberger,	2006).
Early	evidence	that	the	sister	chromatid	cohesion	apparatus	plays	a	role	in	gene	
regulation	arose	 from	studies	on	gene	silencing	 in	yeast	and	on	 long-range	gene	
activation	 in	Drosophila	 (Donze	 et	 al.,	 1999;	 Rollins	 et	 al.,	 1999).	 In	more	 recent	
studies	it	was	shown	that	Cohesin	has	a	role	in	neuronal	development	in	Drosophila 
(Pauli	et	al.,	2008;	Schuldiner	et	al.,	2008).	Loss	of	Cohesin	binding	in	dividing	cells	
resulted	 in	 Precocious	 Sister-Chromatid	 Separation	 (PSCS)	 while	 in	 non-dividing	
cells	it	resulted	in	defects	in	axonal	pruning	(Pauli	et	al.,	2008).	In	vertebrates,	early	
studies	that	 identified	Cohesin	as	a	factor	 in	 the	regulation	of	 the	particular	genes	
focused	on	the	expression	of	runx	genes	in	zebrafish.	The	combination	of	a	genetic	
screen	and	morpholino	experiments	 revealed	 that	Rad21	and	SMC3	are	essential	
for	 proper	 runx1	 expression	 (Horsfield	 et	 al.,	 2007).	 Genome-wide	 chromatin	
immunoprecipitation	experiments	in	human	and	mouse	cells	subsequently	showed	
that	Cohesin	accumulates	at	sides	bound	by	CTCF,	a	sequence	specific	DNA-binding	
protein	that	has	been	implicated	as	a	transcriptional	regulator,	insulator	and	organizer	
of	higher-order	chromatin	structure	(Parelho	et	al.,	2008;	Stedman	et	al.,	2008;	Wendt	
et	al.,	2008).	
					The	deletion	of	the	Pds5b	gene,	a	regulatory	component	of	Cohesin,	in	mouse,	
is	 embryonic	 lethal,	 with	 apparent	 developmental	 defects,	 indicating	 that	 	 Pds5	
is	 important	 for	 the	 role	of	Cohesin	 in	development	 (Zhang	et	al.,	2007).	However	
there	was	no	cohesion	defect	in	PDS5B-/-	cells	which	suggest	that	PDS5B	and	the	
Cohesin	complex	have	important	other	functions	beyond	their	role	in	chromosomal	
dynamics.
The	loading	of	Cohesin	onto	chromatin	requires	the	activity	of	the	SCC2/SCC4	
complex	(Ciosk	et	al.,	2000;	Watrin	et	al.,	2006).	Consistent	with	its	essential	function	
in	 regulating	sister	chromatid	cohesion,	Delangin	has	been	well	conserved	during	
evolution.	 Its	 orthologues,	 including	 Mis4 (S.pombe)	 and	 Rad9	 (C.cinereus),	 are	
known	to	be	involved	in	various	aspects	of	chromosome	function	and	double-strand	
DNA	repair	(Kaur	et	al.,	2005;	Michaelis	et	al.,	1997;	Rollins	et	al.,	2004;	Seitz	et	al.,	
1996;	Sjogren	and	Nasmyth,	2001;	Strom	et	al.,	2004;	Tomonaga	et	al.,	2000;	Toyoda	
et	al.,	2002;	Unal	et	al.,	2004).	
Physical	 linkage	 of	 sister	 chromatids	 by	 the	 cohesin	 complex	 is	 essential	 for	
correct	chromosome	segregation	but	is	also	vital	for	DNA	double-strand	break	(DSB)	
repair	by	homologous	recombination		(HR)	during	the	S-	and	G2	phase	of	the	cell	
cycle	(Sjogren	and	Nasmyth,	2001).	The	inactivation	of	Cohesin	subunits	or	SCC2/
SCC4	results	in	a	reduced	efficiency	of	post-replicative	DSB	in	the	G2	phase	of	the	
cell	cycle.	The	local	enrichment	of	cohesin	at	damaged	sites	depends	on	the		SCC2/
SCC4	complex	(Strom	et	al.,	2007).	Additionally,	a	homologue	of	the	Delangin, Pqn-
85,	was	identified	in	genome	wide	screen		for	genes	required	for	resistance	to	ionizing	
radiation	in	C.elegans	(van	Haaften	et	al.,	2006).	Furthermore,	there	is	a	evidence	for	
the	importance	of	Delangin	in	DNA	repair	in	humans,	where	cells	with	a	mutation	in	
Delangin	gene	derived	from	Cornelia	de	Lange	patients,	have	reduced	capacity	to	
tolerate	DNA	damage	(Vrouwe	et	al.,	2007).
Delangin	 (NIPBL,	 Nipped-B,	 SCC2)	 is	 a	 large	 chromatin	 associated	 protein	
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that	contains	multiple	HEAT	repeats	which	mediate	protein-protein	interactions.	The	
Delangin	gene	is	predicted	to	code	for	two	different	isoforms	of	2804	and	2697	amino	
acids,	termed	Delangin-A	and	Delangin-B,	respectively.	The	human	Delangins	share	
a	high	degree	of	homology	with	Drosophila	Nipped-B	and	Scc2	from		S.cerevisiae.	
The	N-terminus	of	the	metazoan	Delangin	contains	a	Heterochromatin	Protein1	
(HP1)	binding	domain	that	has	been	shown	to	interact	with	HP1α	protein	(Lechner	et	
al.,	2005).	Mammalian	HP1α	heterochromatin	proteins	have	been	shown	to	bind	to	
Delangin	through	an	interaction	motif	located	in	a	poorly	conserved	terminal	region	
of	 the	protein	 (Lechner	 et	 al.,	 2005;	 Thiru	 et	 al.,	 2004).	 This	 interaction	 raises	 the	
possibility	that	Scc2	has	a	direct	involvement	in	the	establishment	and	maintenance	
of	heterochromatic	domains	(Lechner	et	al.,	2005).	Delangin	homologue	in	Drosophila	
(Nipped-B)	is	an	essential	gene	that	was	identified	in	a	genetic	screen	for	mutants	
interfering	with	long-range	gene	activation	of	the	cut	and	Ultrabithorax (Ubx)	homeobox	
genes	by	enhancers	positioned	some	80	and	50	kbp	away	from	the	gene	promoters	
(Rollins	et	al.,	2004;	Rollins	et	al.,	1999).	Nipped-B	facilitates	activation	of	the	cut	gene	
by	the	distant	wing-margin	enhancer	and	mutations	that	result	in	reduced	Nipped-B	
levels	result	in	a	lower	expression	of	cut.	In	contrast	to	other	cut	activators,	mutations	
in	Nipped-B	have	a	much	more	striking	effect	when	cut	activation	is	hindered	by	a	
gypsy	insulator	insertion	rather	than	by	loss	of	important	components	of	the	enhancer	
sequence	(Rollins	et	al.,	1999).	Subsequent	work	revealed	that,	as	expected,	Nipped-
B	is	also	required	for	sister	chromatid	cohesion	(Rollins	et	al.,	2004).	The	co-operation	
with	Cohesin	subunits	 in	 regulating	sister	chromatid	cohesion	does	not	extend	 to	
gene	 regulation.	Nipped-B	 and	Cohesin	 subunits	 have	 an	 opposite	 effect	 on	 the	
cut gene	in	Drosophila:	Cohesin	inhibits	long-range	activation	of	the		cut	gene	while	
Nipped-B	activates	it	(Rollins	et	al.,	2004).
Heterozygous	mutations	in	the	Delangin	gene	were	found	in	about	half	of	Cornelia	
de	Lange	syndrom	patients	 (Bhuiyan	et	al.,	2006;	Gillis	et	al.,	2004;	Krantz	et	al.,	
2004;	Tonkin	et	al.,	2004).	In	other	cases,	mutations	in	the	X-linked	SMC1A	and	SMC3	
genes	were	responsible	for	the	same	syndrome	(Borck	et	al.,	2007;	Deardorff	et	al.,	
2007;	Musio	et	al.,	2006).	Cornelia	de	Lange	syndrome	(CdLS,	also	called	Brachmann	
de	Lange	syndrome;	OMIM	122470)	is	characterized	by	pre-	and	postnatal	growth	
retardation,	 microcephaly,	 severe	 mental	 retardation	 with	 speech	 delay,	 feeding	
problems,	 major	 malformations	 including	 limb	 defects	 and	 characteristic	 facial	
features	(Jackson	et	al.,	1993).	There	is	a	profound	heterogeneity	of	the	phenotype	
in	the	patients.	Individuals	who	show	growth	and	neuro-developmental	delay	exhibit	
classical	CdLS	features.	In	mildly	affected	patients	developmental	delay	and	growth	
retardation	 are	 less	 severe	 (Ireland	 et	 al.,	 1993;	 Jackson	 et	 al.,	 1993).	 Affected	
individuals	 are	 typically	 identified	 as	 sporadic	 cases	 though	 several	 reports	 have	
documented	families	with	multiple	affected	members	(Russell	et	al.,	2001).
Here	 we	 describe	 phenotypic	 defects	 resulting	 from	 a	 homozygous	 or	
heterozygous	deletion	of	Delangin	in	mice,	resulting	in	a	lethal	embryonic	defect	or	a	
classical	CdLS	phenotype	respectively.	
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ReSuLtS:
Generation of Delangin-deficient mice
The	role	of	Delangin	was	examined	in	mice	carrying	a	targeted	allele	shown	in	
Figure	 1.	 Using	 homologous	 recombination	 in	 ES	 cells,	 a	GFP-neo	 cassette	was	
inserted	in	exon	10	(out	of	47)	560	bp	downstream	of	the	ATG	at	a	unique	EcoRV	
site.	The	targeting	of	the	construct	was	carried	out	before	the	most	of	the	exons	were	
characterized	at	the	5’end	of	the	gene.	Since	N-terminus	of	the	Delangin	gene	is	not	
conserved	among	 the	species	a	disruption	at	exon	10	 is	highly	unlikely	 to	yield	a	
functional	protein.	Homologous	integration	of	the	construct	in	the	genome	results	in	
the	production	of	GFP-protein	from	the	endogenous	promoter.	Three	heterozygous	
independent	 ES	 cell	 clones	 (Delangin	 KO	 ES104/171;	 Delangin	 KO	 ES104B2;	
Delangin	KO	ES104B23)	were	injected	into	C57BL/6	blastocysts	to	produce	chimeric	
mice	that	transmitted	the	targeted	allele	through	the	germline.	Southern	blot	(Figure	
1B)	shows	one	positive	clone.	Chimeric	mice	were	then	crossed	with	CAG-Cre	(Sakai	
and	Miyazaki,	1997)		mice	and	the	neomycin	gene	was	deleted	from	the	genome.	
Deletion	of	the	neomycin	resistance	gene	is	essential	since	the	promoter	 included	
in	the	selection	cassette	may	influence	neighboring	genes.	The	male	chimeras	were	
crossed	with	FVB	females	to	generate	mice	that	are	heterozygous	for	the	targeted	
allele.	 No	 differences	 between	 3	 independent	 mouse	 lines	 were	 detected.	 This	
indicates	that	the	resulting	mouse	mutants	are	indeed	the	outcome	of	the	Delangin 
genetic	modification.	When	heterozygous	mice	were	crossed,	no	viable	homozygous	
embryos	were	born.
	To	characterize	the	timing	of	embryonic	lethality	caused	by	homozygous	deletion	
of	Delangin,	timed	pregnancies	between	Delangin	heterozygous	mice	were	set	up.	
Heterozygous	mice	exhibit	difficulties	 in	breeding	making	 it	 very	difficult	 to	obtain	
homozygous	 null	 mice.	 However	 no	 viable	 homozygous	 embryos	 were	 detected	
during	 embryonic	 development	 at	 different	 time	 points	 starting	 from	 6.5	 E	 days	
(25	embryos	were	analyzed)	concluding	 that	 the	homozygous	deletion	 is	an	early	
embryonic	lethal	event.		To	generate	heterozygous	mice	for	analysis	we	used	crosses	
between	 heterozygous	 males	 and	 FVB	 females.	 Heterozygous	 mice	 are	 born	 in	
accordance	to	the	Mendelian	ratio.
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Delangin deficiency results in size reduction of the embryos and 
aberrant postnatal growth
The	 WT	 (Wild	 type)	 embryos	 were	 indistinguishable	 from	 mutant	 once	 until	
embryonic	day	16.	From	day	E16.5	the	mutants	began	to	show	signs	of	progressive	
growth	retardation.	Newborn	Delangin-deficient	mice	are	drastically	smaller	from	WT	
littermates	with	up	 to	50%	reduction	 in	body	weight	 (Figure	2A).	 In	Figure	2B,	 the	
weight	difference	within	a	litter	is	followed	during	11	weeks.	The	growth	curves	show	a	
similar	ratio	of	weight	gain	between	the	two	groups	but	the	mutants	do	not	draw	level	
with	WT	littermates	resulting	 in	substantial	weight	differences.	Surviving	 littermates	
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Figure	1	
Targeting	construct	and	analysis	of	a	targeted	ES	clone
(A)	Scheme	of	a	portion	of	the	mouse	Delangin	gene	and	the	targeting	construct
(Top)	The	genomic	region	before	 targeting	around	exon	10	 is	shown	with	 the	position	of	a	unique	
EcoRV	site	where	the	neo-cassette	is	inserted	and	the	positions	of	HindIII	and	SacI	restriction	sites	
used	to	identify	legitimate	recombination	events.
(Middle)	The	 targeting	construct	 (in	 the	5’	 to	3’	direction)	consisting	of	neomycin	 resistance	gene	
flanked	by	 lox	P	 sites	 linked	 (black	 ellipses)	 to	 a	GFP	 reporter	 gene	and	NEO-polyA	under	PMC	
(mutated	polyoma	enhancer).
(Bottom)	 The	 genomic	 arrangement	 after	 targeting	with	 the	 positions	 of	 the	 restriction	 fragments	
and	the	position	of	 the	probe	used	for	Southern	hybridization	(red	bar).	The	SacI	 fragment	 in	wild	
type	allele	is	10.1Kb,	and	after	targeting	a	novel	SacI	fragment	of	7.3Kb	is	generated	because	of	the	
insertion	of	the	neo-cassette.
	(B)	Analysis	of	WT	and	1	positive	clone	by	Southern	hybridization.	Note	the	expected	recombinants	
bands	after SacI	restriction	cuts	and	hybridization	with	the	probe	depicted	in	red.
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achieve,	on	average,	only	2/3	of	the	body	weight	of	WT	(Figure	2C).	This	observation	
is	in	consistent	with	the	most	commonly	observed	clinical	feature	of	CdLS	patients.	
i.	e.	small	body	size.	
Figure	2
	The	size	reduction	of	the	newborns	
and	aberrant	postnatal	growth	 in	
Delangin-	deficient	mice
(A)	 Newborn	 Delangin	
heterozygous	 mice	 are	 smaller	
from	 WT	 littermates	 with	 up	 to	
50%	reduction	in	body	weight.
(B)	 The	weight	 difference	of	 one	
litter	 followed	 during	 11	 weeks	
showing	 a	 substantial	 difference	
but	similar	ratio	of	weight	gain.	
(C)	 The	 weight	 distribution	 of	
Delangin-deficient	 mice	 and	 WT	
(2	months	old).	Note	a	significant	
difference	 between	 two	 groups	
for	either	males	or	females.	
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High lethality and a complex, heterogeneous and not fully penetrant 
phenotype in Delangin-deficient mice
The	heterozygous	Delangin	mice	are	born	exhibiting	a	phenotype	that	is	complex,	
heterogeneous	and	not	fully	penetrant.	They	display	profound	variations	from	normal	
morphology	that	is	indistinguishable	from	WT,	to	severe	body	weight	reductions	and	
complex	developmental	abnormalities.	 In	humans,	a	similar	variation	 in	phenotype	
occurs,	for	example,	the	same	mutation	occurring	in	different	patients	was	associated	
with	substantially	different	degrees	in	pathology.	Conversely,	patients	with	the	same	
pathology	will	in	many	cases	have	different	mutations	within	Delangin	gene	(Tonkin	
et	al.,	2004).	The	lethality	rate	is	very	high	in	the	post-natal	period.	The	majority	of	the	
affected	mice	die	around	week	4	usually	from	heart	failure	and	breathing	difficulties.	
Since	Delangin	is	ubiquitously	expressed	in	mouse	tissues	during	development,	
the	alteration	in	Delangin	function	could	potentially	have	a	significant	impact	on	every	
tissue	in	the	embryo.	Various	tissues	were	examined	and	severe	abnormalities	in	the	
heart,	lungs,	stomach,	thymus,	bone	marrow,	kidney	and	the	endocrine	system	were	
detected.	
Heart	and	lung	abnormalities	
Since	 Delangin-deficient	 mice	 suffer	 from	 respiratory	 distress	 and	 perinatal	
lethality,	we	examined	cardiac	malformation	in	affected	animals.	In	many	cases,	we	
could	detect	severely	dilated	cardiomyopathy	that	is	not	seen	in	the	control	animals	
(Figure	 3	 A	 and	 B).	 The	 diameter	 of	 the	 myocytes	 is	 less	 than	 normal	 in	 many	
instances.	Fibrosis	is	also	detected	in	the	heart	muscle	(Figure	3	C	and	D).	These	
abnormalities	 can	cause	 the	 respiratory	distress	and	contribute	 to	early	postnatal	
lethality.		Patients	with	CdLS	often	have	congenital	heart	defects.
Young	 Delangin-deficient	 mice	 developed	 respiratory	 insufficiency	 whereas	
littermate	 controls	 were	 asymptomatic.	 Histopathology	 analysis	 of	 lung	 sections	
revealed	bronchopneumonia	with	lung	emphysema	that	is	not	detected	in	the	controls	
(data	not	shown).	In	addition	to	this	pathology	of	the	lungs	of	older	mice	had	atrophic,	
or	disrupted	alveolar	walls	(Figure	G	and	K).	The	size	of	the	alveoli	and	alveolar	sacs	
were	drastically	different	when	compared	to	the	control	animals	resulting	in	dilation.
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Stomach and Thymus
The	liver,	small	intestine,	cecum	and	colon	tissues	of	Delangin-deficient	mice	were	
histologically	similar	to	those	in	controls	animals	apart	from	some	sporadic	cases.	
However,	the	stomach	had	the	most	striking	defects	which	were	consistent	among	
mutants.	 The	overall	mucosa	height	 is	drastically	 decreased	 in	Delangin-deficient	
mice	(Figure	4A	and	B)	and	they	had	an	irregular	arrangement	and	reduction	of	the	
gastric	gland	layer	that	showed	a	decrease	in	the	number	of	glands,	especially	fundic	
gastric	glands.	This	ultimately	leads	to	atrophy	of	the	gastric	mucosa.	In	addition,	the	
thickness	of	the	muscularis	mucosa	and	muscularis	externa	was	decreased	(Figure	
4A,	4B,	4C	and	4D).
The	 thymic	architecture	 in	Delangin-deficient	mice	 is	also	disturbed	 (Figure	E	
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Figure	3	
Heart	 and	 lung	 abnormalities	 in	
Delangin-	deficient	mice
(A-D)	Heart	abnormalities
(A-B)	 Severe	 cardiomyopathy	 in	
Delangin-deficient	mice	(B)	that	is	not	
seen	in	WT	(Wild	Type)	animals	(A).
(C-D)	 Fibrosis	 and	 hyperatrophic	
heart	 muscle	 in	 Delangin-deficient	
mice	(D)	Note	the	reduced	diameter	
of	the	myocytes	in	Delangin-deficient	
mice	compared	to	normal	(C).	WT	wild	
type;	M	mutant,	Delangin-	deficient
PM	papillary	muscle;	LVW	left	ventricle	
wall;	L	lumen
*atrophic	heart	muscle	f	fibrosis
(E-K)	Lung	abnormalities
(E-K)	The	lungs	of	Delangin-deficient	
mice	 are	 atrophic	 with	 disrupted	
alveolar	walls	(F	and	K)	compared	to	
WT	(E	and	G).
WT	 wild	 type;	 M	 mutant,	 Delangin-	
deficient
B	 bronchus;	 AP	 arteria	 pulmonaris;	
b	 bronchiole;	 as	 alveolar	 sac;	 AV	
alveoli
*disrupted	alveolar	wall
**atrophic	alveolar	wall
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and	F).	Histological	analysis	of	thymi	of	young	mice	revealed	progressive	changes	
that	 result	 in	poorly	defined	cortical	 and	medular	 structures.	 The	 thymic	cortex	of	
Delangin-deficient	mice	is	atrophic	and	depleted	of	T	lymphocytes	resulting	in	a	loss	
of	corticomedullary	distinction.
Delangin-deficient	mice	do	not	display	 limb	or	digit	 truncations,	or	 loss	of	any	
other	bone	elements	features	that	can	be	observed	 in	a	subset	of	 individuals	with	
CdLS.	 Upon	 staining	 the	 skeletons	 of	 young	 and	 adult	 animals	 with	 Alcian	 Blue	
and	Alizarin	red,	there	were	not	obvious	delays	in	ossification	in	Delangin-deficient	
animals.	Also,	no	apparent		lesions	were	found	in	the	brain	in	any	of	the	Delangin-
deficient	animals.
Chromosomal analysis show normal sister chromatid separation in 
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Stomach	 and	 Thymus	
abnormalities
(A-D)	Stomach	abnormalities
The	 overall	 mucosa	 height	
is	 drastically	 decreased	 in	
Delangin-deficient	 mice	 (B	 and	
D)	 compared	 to	 WT	 (A	 and	
C).	 Note	 the	 difference	 in	 the	
thickness	of	muscularis	mucosa	
(MM)	 and	 muscularis	 externa	
(ME).
WT	 wild	 type;	 M	 mutant,	
Delangin-	deficient
FGG	fundic	gastric	glands
CG		cardiac	glands
MM		Muscularis	mucosa
ME	Muscularis	externa
(E-F)	Thymus	abnormalities	
The	 thymic	 architecture	 is	
disturbed	 with	 poorly	 defined	
cortical	and	medullar	structures	
(F)	 that	 are	 distinctive	 in	 WT	
(Wild	type)	thymi	(E).
M	medulla	
C	cortex
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Delangin-deficient mice
The	 yeast	 homologues	 of	 Delangin (Scc2)	 is	 important	 for	 sister	 chromatid	
cohesion.	 The	 evidence	 that	 absence	 of	 Delangin	 results	 in	 a	 similar	 cohesion	
abnormality	in	Drosophila	(Rollins	et	al.,	2004),	and	in	some	cases	in	CdLS	patients	
(Kaur	et	al.,	2005),	prompted	us	to	evaluate	Delangin’s	role	in	sister	chromatid	cohesion	
in	our	mouse	model.	Metaphase	spreads	from	undifferentiated	ES	clones	as	well	as	
mouse	embryonic	fibroblasts	(MEFs)	and	B-	and	T	cells	were	scored	for	prematurely	
separated	1,	2	or	3	chromosomes	 (PSCS1,	PSCS2	and	PSCS3)	as	shown	 in	 the	
Figure	5A	and	B.	Western	blot	analysis	shows	that	the	cells	are	haploinsufficient	for	
Delangin	protein	and	100	metaphase	spreads	from	each	group	was	evaluated	and	
compared	to	WT	controls.	There	were	no	cases	where	more	than	3	chromosomes	were	
separated	prematurely.	Comparison	of	metaphase	spreads	from	Delangin-deficient	
cells	with	controls	led	as	to	conclusion	that	Delangin-deficient	cells	did	not	show	a	
significant	increase	in	PSCS.	Other	types	of	chromosomal	aberrations	such	as	breaks	
or	fragmentation	were	not	analyzed	but	an	enhanced	aneuploidy	in	mutant	groups	
was	also	not	seen.	 In	accordance	with	this	 finding,	mice	carrying	a	mutated	allele	
do	not	develop	cancer	suggesting	that	there	is	no	obvious	chromosome	instability	
in	these	mice.	We	therefore	conclude	that	the	phenotype	observed	in	mutant	mice	is	
not	caused	by	a	function	of	Delangin	maintaining	chromosome	stability	since	the	cell	
cycle	and	proper	chromosome	segregation	were	not	effected.
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Delangin heterozygous eS cells are sensitive to γ-radiation and 
slightly sensitive to uV light
The	Delangin	homologues	SCC2	in	yeast,	and	Pqn-85	in	C. elegans,	have	been	
shown	 to	 be	 required	 for	 resistance	 to	 double-stranded	DNA	breakage	 and	 cells	
from	CdLS	patients	have	a	reduced	capacity	to	tolerate	DNA	damage	(Vrouwe	et	al.,	
2007).	We	therefore	investigated	the	sensitivity	of	heterozygous	Delangin	cells	to	the	
DNA-damaging	agents:	γ-radiation	and	UV	light.
Cell	 survival	 of	 the	 Delangin-deficient	 ES	 cells	 after	 exposure	 to	 damaging	
agents	was	 tested.	Cells	were	 exposed	 to	 the	 increased	dosage	 of	UV	 light	 and	
γ-radiation.	The	sensitivity	 to	damage	was	determined	by	measuring	 their	colony-
forming	ability.	Exposure	of	Delangin-deficient	ES	cells	 to	 increasing	doses	of	UV	
radiation	did	not	result	in	an	increase	in	radiation	sensitivity.		Delangin-deficient	ES	
are	slightly	sensitive	to	UV-light	only	at	higher	doses	of	6	and	9J	when	compared	to	
WT	cells	and	the	UV	sensitive	Xpa-/-	ES	positive	control	cells,	which	are	deficient	in	
nucleotide	excision	repair	(Figure	6A).	However	Delangin-deficient	ES	cells	a	2	to	3	
Figure	5	
Chromosomal	analysis	of	Premature	Sister	Chromatid	Separation	(PSCS)	in	Delangin-deficient	mice
(A)	Metaphase	spreads	from	2	ES	clones	(ESB2	and	ESB23),	MEFs	(B2	clone),	T-cells	(B2	clone)	and	
B-cells	(B2	clone)	were	scored	for	prematurely	separated	1,	2	or	3	chromosomes	(PSCS1,	PSCS2	and	
PSCS3)	and	compared	to	relevant	WT(Wild	Type)	controls.
(B)	The	example	of	PSCS2	(prematurely	separated	chromosomes	are	encircled)	and	Western	Blot	
showing	reduction	in	the	Delangin	protein	level.
79Chapter	3
fold	increased	sensitivity	to	γ-radiation	(both	B2	and	B23	clones,	Figure	6B).	The	Rad	
54	repair	protein	deficient	cells	were	used	as	a	positive	control	(Essers	et	al.,	1997).	
In	the	Rad54	deficient	cells,	both	copies	of	the	gene	are	inactivated	while	in	Delangin	
deficient	clones	there	 is	still	one	WT	allele.	This	makes	the	sensitivity	of	Delangin-
deficient	cells	even	more	striking.
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Figure	6		
	Effect	of	UV-light	and	ionizing	radiation	on	survival	of	Delangin-	deficient	ES	cells
Clonogenic	survival	of	ES	cells:	WT	(Wild	Type),	Delangin-deficient	clones	(B2	clone	and	B23	clone),	
Xpa-/-	and	Rad54	-/-	treated	with:
(A)	UV-light
(B)	Ionizing	radiation
After	treatment	with	increasing	doses	of	DNA-damaging	agents,	cells	were	grown	for	7	days,	fixed,	
stained	and	colonies	were	counted.	The	ability	to	form	colonies	is	plotted	as	a	function	of	increasing	
dose	of	DNA	damage.	Error	bars	represent	standard	error	of	the	mean	(SEM).	Genotypes	of	analyzed	
cell	lines	are	indicated.
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MAteRIAL AnD MetHODS
Generation of Delangin heterozygous mice
Delangin-deficient	 mice	 were	 generated	 by	 homologous	 recombination	 and	
genotypes	were	determined	by	Southern	and	PCR-analysis.	A	neomycine	resistance	
gene	flanked	by	LoxP	sites	linked	to	a	GFP	reporter	gene	was	introduced	into	10th	
exon	of	 the	murine	Delangin	gene.	The	Delangin	recombination	vector,	 flanked	by	
two	homologous	sequences	of	2.2kb	on	 the	5’	end	and	2.3kb	on	 the	3’end,	was	
constructed	in	pBluescript	SK+.	The	targeting	vector	was	linearized	with	HindIII	sites	
and	 transfected	 by	 electroporation	 into	 to	 IB10	 cells.	 Homologous	 recombinants	
were	screened	by	Southern	blot	hybridization	using	genomic	DNA	that	was	digested	
with	SacI	 restriction	 enzyme	 giving	 two	 different	 fragments:	 10.1	 kb	 for	WT	 allele	
and	7.3kb	 for	 targeted	allele.	The	probe	 is	situated	at	 the	3’	end	of	 the	construct.	
Three	 targeted	ES	clones	with	 the	correct	 karyotype	were	 injected	 into	blastocyst	
Male	 chimeras	 were	 crossed	 with	 FvB	 females	 for	 generation	 of	 mice	 that	 were	
heterozygous	for	delangin.	The	screening	of	offspring	was	done	with	Southern	blot	
analysis	using	the	same	probe	for	generation	of	ES	targeted	clones.	 	For	deletion	
of	PMC-Neo	cassette,	heterozygous	Delangin	mice	were	bred	with	CAG-Cre	mice	
that	 express	 the	Cre	 recombinase	 under	 the	 control	 of	 the	 cytomegalovirus	 early	
enhancer	chicken	β-hybrid	(CAG)	promoter	(Sakai	and	Miyazaki,	1997).	
In	order	to	determine	the	genotype	following	primers	were	used	for	PCR	reaction	
designed	to	amplify	GFP	fragment	in	targeted	allele:
F	5’:	TTTTCTGCAGGTGAGCAAGGGCGAGGAGCTG	3’	and
R	5’:	TTTTCCCGGGTTACTTGTACAGCTCGTCCATG	3’
Isolation of the embryos
Timed	pregnancies	were	obtained	by	crossing	heterozygous	Delangin	mice.	The	
plugged	females	were	sacrificed	at	a	specific	time	points	using	the	day	of	plugging	
as	0.5E.	Embryos	were	isolated	and	genotyped	by	PCR.
Cells and cell culture
Mouse	ES	cells	used	were	wt	(IB10)	and	Delangin	heterozygous	ES	cells.	The	
cells	were	cultured	on	gelatinized	dishes	in	a	1:1	mixture	of	DMEM	and	BRL	(Buffalo	
Rat	Liver)	conditioned	medium,	supplemented	with	10%	fetal	calf	serum,	0.1M	non-
essential	 amino	 acids,	 100U/ml	 penicillin/streptomycin,	 50	 μM	β-mercaptoethanol	
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and	500	U/ml	leukemia	inhibitory	factor.
Delangin	heterozygous	and	Wild	type	MEFs	were	prepared	from	embryonic	day	
13.5	(E13.5).	Single	torsos	were	minced,	and	cells	dispersed	by	rotation	for	1	hr	in	
0.1%	trypsin-EDTA	solution	at	37°C.	Cells	were	washed	once	in	phosphate-buffered	
saline	(PBS),	taken	up	in	Dulbecco’s	modified	Eagle’s	medium	(DMEM)	containing	
10%	fetal	calf	serum	(FCS).	The	explants	that	were	observed	to	grow	out	from	the	
tissue	pieces	were	passaged	until	the	dish	is	full	and	then	frozen.
B-	and	T-	cells	were	derived	from	mouse	peripheral	blood	from	WT	and	Delangin-
deficient	 littermates.	 Blood	 was	 first	 lysed	 in	 Gey’s	 lysis	 solution	 for	 	 removal	 of	
erythrocytes	and	 then	cultured	 for	 7	days	 in	 IMDM	medium	supplemented	with	4	
mM	glutamine,	 10%	Fetal	Calf	Serum,	5	10-5	M	β-mercaptoethanol	 and	penicillin/
streptomycin	.
B-cells	were	stimulated	with	LPS	(5μg/ml	final	concentration)	for	5	days	without	
splitting.	After	splitting	no	LPS	was	added,	cells	were	counted,	lysed	and	spotted	on	
the	slides	for	metaphase	preparation.	T-cells	were	cultured	in	complete	IMDM	medium	
on	anti-CD3	and	CD-28	coated	plates	 for	 3	days.	After	one	day	culturing	without	
stimulation,	they	were	split	and	cultured	with	IL-2	(5μg/ml	final	concentration).
Metaphase spreads
Metaphase	spreads	of	ES	and	MEFs	were	prepared	by	adding	Colcemid	(Gibco	
Karyomax,	10μg/ml)	to	the	single	cell	suspension	in	a	final	concentration	of	0.04	μg	
ml-1	for	30	min	at	37°C.	After	hypotonic	treatment	(0.075	M	KCl)	for	10	min,	the	pellet	
was	fixed	in	Carnoy’s	Fix	(3:1	methanol/acetic	acid).	Cells	were	then	dropped	onto	
Superfrost	Plus	glass	slides,	air-dried	and	kept	at	-20°C.
For	 B-cells,	 2	 μl/ml	 of	 Colcemid	 (Gibco	Karyomax,	 10μg/ml)	 was	 added	 one	
day	before	ending	incubation,	followed	by	5	μl/ml	for	1hour	at	37°C.	After	hypotonic	
treatment	(0.075M	KCl)	for	10	min.,	the	pellet	was	fixed	in	Carnoy’s	Fix	(3:1	methanol/
acetic	acid).	The	cells	were	dropped	onto	moist,	chilled	Superfrost	Plus	glass	slides.	
DNA	was	counterstained	with	100ng/ml	of	DAPI	and	mounted	in	Vectashield.	
Colony survival curves
The	sensitivity	 of	ES	cells	 to	 increasing	doses	of	DNA-damaging	agents	was	
determined	 by	 measuring	 their	 colony-forming	 ability.	 The	 cells	 were	 trypsinized,	
counted	and	plated	onto	gelatinized	6	cm	dishes.	After	16	hours,	cells	were	irradiated	
with	a	single	dose	in	the	range	0-12	Gy	using	a	137Cs	source	or	UV	(0-8J).	Cells	were	
grown	for	6	days,	fixed,	stained	and	colonies	were	counted.	All	the	experiments	were	
done	in	triplicate.
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Histopathology analysis
The	mice	were	euthanized	with	O2	and	CO2	and	the	body	weights	were	measured.	
The	perfusion	was	done	with	10%	formalin	in	PBS.	They	are	post-fixed	with	the	same	
solution	 for	 48hours	 at	 4oC.	 The	 necropsy	 is	 completed	 the	 organs	 weight	 were	
measured.	 The	organs	were	embedded	 in	paraffin	 and	were	 serially	 sectioned	at	
6μm	thickness,	stained	with	Hematoxylin	and	Eosin	and	examined	microscopically.
DISCuSSIOn
In	 eukaryotic	 cells,	 replicated	 DNA	 molecules	 remain	 physically	 connected	
from	 the	moment	 of	 synthesis	 in	 S-phase	 until	 their	 separation	during	 anaphase.	
The	Cohesin	 complexes	 are	 essential	 for	 the	proper	 separation	of	 the	duplicated	
genome.	Cohesin	function	is	also	important	in	other	biological	processes,	like	DNA	
repair	and	transcriptional	regulation.	In	each,	Cohesin	is	required	but	not	sufficient	
for	proper	function.	It	is	therefore	important	to	understand	the	roles	of	the	additional	
factors	that	are	necessary	for	proper	Cohesin	function.	
Mutations	 in	 different	 Cohesin	 proteins	 (Delangin,	 SMC1A	 and	 SMC3)	 have	
been	found	in	the	patients	with	the	Cornelia	de	Lange	Syndrome	causing	a	broad	
spectrum	of		prenatal	and	postnatal	abnormalities	(Krantz	et	al.,	2004;	Musio	et	al.,	
2006;	Tonkin	et	al.,	2004).	The	complexity	of	the	phenotype	in	CdLS	patients	suggests	
the	 involvement	of	Cohesin	and	Delangin	 in	early	developmental	processes	either	
through	 chromosomal	 dynamics	 or	 through	 alternative	 functions	 in	DNA	damage	
repair	or	 transcriptional	regulation.	 It	 is	very	well	possible	that	a	combination	of	all	
these	processes	is	involved	in	the	observed	phenotypes.	
In	this	work,	we	have	generated	Delangin-deficient	mice	that	manifest	a	spectrum	
of	 developmental	 abnormalities,	 similar	 to	 those	 seen	 in	CdLS	patients.	 In	CdLS,	
mutations	 in	 the	Delangin	 gene,	 even	 in	 a	 presence	 of	 a	 wild-copy	 of	 the	 gene,	
triggers	a	haploinsuffiency	in	the	Cohesin	pathway.	Mutations	in	the	Cohesin	pathway	
cause	 severe	 developmental	 defects	 in	 different	model	 systems.	 For	 example,	 in	
Drosophila,	mutations	in	Cohesin	trigger	a	decrease	in	the	levels	of	the	ecdysone	B	
receptor	that	effects	neuronal	development	(Schuldiner	et	al.,	2008).	
The	phenotype	of	 the	affected	(heterozygous)	mice	resembles	to	some	of	 the	
abnormalities	 seen	 in	 human	 patients.	 The	 most	 evident	 are	 pre-	 and	 postnatal	
growth	retardation,	heart	abnormalities,	gastro-intestinal	problems	and	hearing	loss.	
The	abnormal	skeletal	patterning,	a	common	defect	occurring	 in	severely	affected	
human	patients,	was	not	seen	in	Delangin-deficient	mice.	
One	of	the	possibilities	that	may	explain	the	lack	of	a	defect	in	skeletal	patterning	
in	Delangin-deficient	mice	is	that	in	some	patients	mutations	cause	the	production	
of	 a	 truncated	 protein	 that	 displays	 a	 dominant-negative	 effect	 on	 the	 WT	 allele	
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resulting	in	a	more	severe	phenotype.	It	can,	of	course,	not	be	excluded	that	the	limb	
patterning	pathways	are	affected	 in	a	different	ways	 in	mouse	and	humans.	More	
importantly,	there	is	a	significant	overlap	in	the	phenotypic	characteristics	between	
Delangin-deficient	mouse	model	 and	 the	CdLS	patients.	 The	 complex	 and	broad	
spectrum	of	 symptoms	observed	 in	 the	mice	 has	 an	 incomplete	 penetrance	 and	
variable	 expression	 which	 is	 in	 agreement	 with	 features	 seen	 in	 human	 patients.	
In	 the	CdLS	 patients	 symptoms	 vary	 from	mild	with	 no	 obvious	 defects,	 through	
moderate	ones	where	growth	and	mental	health	is	affected,	to	very	prominent	cases	
with	a	combination	of	limb	truncation,	severe	mental	and	growth	retardation.	
The	behavior	of	 the	Delangin-deficient	mice	 is	also	 impaired.	Although	we	did	
not	perform	extensive	analysis	it	was	obvious	that	the	mice	have	difficulties	in	coping	
with	new	environments.	Overall,	our	results	suggest	that	Delangin-deficient	mice	can	
be	used	as	a	valuable	model	for	investigating	the	mechanisms	underlying	Cornelia	
de	Lange	Syndrome.
Even	though	the	understanding	of	the	function	of	Delangin	in	higher	organisms	
is	 improving,	 the	 molecular	 mechanism	 through	 which	 Delangin	 acts	 is	 still	 not	
clear.	In	mammalian	cells,	the	function	of	most	Cohesin	factors,	including	Cohesin	
and	Delangin	were	 investigated	by	RNA	interference.	However,	 the	most	desirable	
alternative	 system	 to	 study	 gene	 function	 and	 pathogenesis	 of	 the	 syndromes	 in	
mammalian	organism	is	undoubtedly	KO	mouse.	To	date,	the	only	mouse	models	
that	were	 generated	 are	 null	mutants	 of	 the	meiosos	 specific	 subunits	 Rec8	 and	
SMC1B,	which	are	both	sterile	(Revenkova	et	al.,	2004;	Xu	et	al.,	2005).	With	respect	
to	 Cohesin	 interacting	 factors,	 PDS5B-/-	 mice	 are	 reported	 to	 have	 overlap	 with	
congenital	anomalies	also	found	in	CdLS	patients	(Zhang	et	al.,	2007).	
The	analysis	of	chromosome	segregation	in	the	different	types	of	cells	coming	
from	Delangin-deficient	mice	did	not	show	obvious	abnormalities	in	sister	chromatid	
cohesion.	This	result	is	consistent	with	reports	of	the	lack	of	sister	chromatid	cohesion	
defect	in	cells	from	CdLS	patients	(Tonkin	et	al.,	2004;	Vrouwe	et	al.,	2007)	or	only	
mild	cohesion	defect	in	40%	of	CdLS	patients	(Kaur	et	al.,	2005).	In	our	experiment,	
both	 isoforms	 of	 the	 Delangin	 (A	 and	 B)	 are	 inactivated	 so	 the	 possibility	 of	 the	
redundancy	with	the	alternative	isoform	is	excluded.	One	of	the			possibilities	is	that	
Premature	Sister	Chromatid	Separation	 	 (PSCS)	occurs	 in	particular	 cells	 that	we	
have	 not	 analyzed	 even	 though	we	 included	 several	 types	 of	 the	 cells:	 ES	 cells,	
Mouse	Embryonic	 Fibroblasts	 (MEFs)	 from	 embryonic	 tissues	 and	B-	 and	 T-cells	
from	adult	tissues.	The	lack	of	PSCS	in	our	mouse	model	favors	a	hypothesis	that	
defects	present	 in	CdLS	patients	are	 related	 to	Cohesin-mediated	 functions	other	
than	sister	chromatid	cohesion.	We	also	did	not	detect	aneuploidy,	often	seen	as	a	
consequence	of	premature	chromatid	segregation.	Aneuploidy	often	leads	to	tumor	
formation	 in	organisms	with	 this	 type	of	 chromosome	 instability.	 The	 incidence	of	
a	tumor	formation	in	the	Delangin-deficient	mice	was	very	low,	(to	date	only	in	one	
animal).	 This	 is	 	 in	 agreement	 with	 the	 infrequent	 occurrence	 of	 tumors	 in	 CdLS	
individuals,	 only	 four	 cases	 being	described	 in	 the	 literature	 (DuVall	 and	Walden,	
1996;	Maruiwa	et	al.,	1988;	Sugita	et	al.,	1986).
The	Cohesin	complex	 is	 involved	in	DNA	double-strand	break	(DSB)	repair	by	
84 Chapter	3
homologous	 recombination	during	 the	S-and	G2	phase	of	 the	cell	 cycle	 (Sjogren	
and	Nasmyth,	2001).	Inactivation	of	SCC2	(Delangin)	or	one	of	the	Cohesin	subunits	
results	in	a	reduced	efficiency	of	post-replicative	DSB	repair	in	G2	/M.	In	the	studies	
presented	by	Strom	et	al.	 	 (Strom	et	al.,	2004)	 	and	Unal	et	al.	 (Unal	et	al.,	2004)	
was	demonstrated	 that	 the	 local	enrichment	of	Cohesin	depends	on	 the	Delangin	
(SCC2/SCC4)	 complex.	More	 recent	 studies	 in	 cells	 from	CdLS	 patients	 showed	
increased	DNA	damage	sensitivity	(Vrouwe	et	al.,	2007).	The	implication	of	Delangin	
and	Cohesin	homologues	in	the	DNA	damage	responses	raises	the	question	whether	
the	cells	derived	from	the	Delangin-deficient	mice	have	a	similar	defect	and	such	a	
defect	is	indeed	found.
Nipped-B,	 the	Delangin	homologue	 in	Drosophila,	participates	 in	mitotic	sister	
chromatid	cohesion	and	regulates	the	transcriptional	control	of	cut	and	ultrabithorax	
genes,	which	are	involved	in	development	(Dorsett	et	al.,	2005;	Rollins	et	al.,	2004;	
Rollins	et	al.,	1999).	Since	Delangin	acts	through	Cohesin,	the	mutations	that	affect	
Delangin	 are	 reflected	 on	 Cohesion	 targets.	 Misregulation	 of	 a	 single	 gene	 can	
have	 severe	 downstream	 effect	 especially	 during	 development.	 The	 expression	
of	 a	 number	 of	 genes	 crucial	 for	 development,	 such	 as	 homeotic	 genes,	 could	
be	very	 sensitive	 to	 the	presence	of	Cohesin	around	 the	promoters.	Recent	work	
strongly	suggests	that	Cohesin	is	involved	in	gene	regulation	during	developmental	
processes	in	higher	organisms.	For	instance,	Cohesin	enhances	gene	expression	in	
the	case	of	the	zebrafish	transcriptional	factor	runx	involved	in	cell	fate	determination	
of	hematopoietic	and	other	 lineages	 (Horsfield	et	al.,	 2007).	 If	we	 think	about	 the	
possibility	 that	 Delangin	 mutation	 causes	 inappropriate	 loading	 or	 positioning	 of	
Cohesin	on	its	target,	in	this	case	runx	gene,	the	consequence	is	deregulation	of	runx	
gene	expression	and	runx	downstream	targets.
	 In	 another	 scenario,	 chromatin	 organization	 can	also	be	affected.	Studies	 in	
human	 and	 mouse	 cells	 have	 shown	 that	 Cohesin	 accumulates	 at	 sites	 bound	
by	CTCF,	a	protein	with	 insulator	activity	 	 that	 is	 important	 for	 the	communication	
between	enhancers	and	promoters	(Parelho	et	al.,	2008;	Stedman	et	al.,	2008;	Wendt	
et	al.,	2008).	Although	functional	studies	showing	this	directly	are	missing,	it	may	be	
possible	that	Cohesin	assists	in	the	process	of	holding	the	chromatin	loops	together	
and	 attracting	 particular	 sequences	 to	 affect	 gene	 regulation.	 In	 that	 case,	 and	
assuming	that	Delangin	mutations	affect	Cohesin	dynamics	of	regulatory	sequences	
that	organize	chromatin	domains,	it	would	cause	abnormal	regulation	of	different	sets	
of	the	genes.			Nevertheless	the	observation	that	mutations	in	SMC1	and	SMC3	are	
associated	with	milder	abnormalities	in	comparison	to	Delangin	mutations	suggests	
that	it	may	have	additional	roles	to	those	discussed	above.	
85Chapter	3
ReFeRenCeS
Bhuiyan,	Z.	A.,	Klein,	M.,	Hammond,	P.,	van	Haeringen,	A.,	Mannens,	M.	M.,	Van	Berckelaer-Onnes,	
I.	and	Hennekam,	R.	C.	(2006).	Genotype-phenotype	correlations	of	39	patients	with	Cornelia	De	Lange	
syndrome:	the	Dutch	experience.	J	Med	Genet	43,	568-75.
Borck,	G.,	Zarhrate,	M.,	Bonnefont,	J.	P.,	Munnich,	A.,	Cormier-Daire,	V.	and	Colleaux,	L.	 (2007).	
Incidence	and	clinical	features	of	X-linked	Cornelia	de	Lange	syndrome	due	to	SMC1L1	mutations.	Hum	
Mutat	28,	205-6.
Ciosk,	R.,	Shirayama,	M.,	Shevchenko,	A.,	Tanaka,	T.,	Toth,	A.,	Shevchenko,	A.	and	Nasmyth,	K.	
(2000).	Cohesin’s	binding	to	chromosomes	depends	on	a	separate	complex	consisting	of	Scc2	and	
Scc4	proteins.	Mol	Cell	5,	243-54.
Deardorff,	M.	A.,	Kaur,	M.,	Yaeger,	D.,	Rampuria,	A.,	Korolev,	S.,	Pie,	J.,	Gil-Rodriguez,	C.,	Arnedo,	
M.,	Loeys,	B.,	Kline,	A.	D.	et	al.	 (2007).	Mutations	 in	cohesin	complex	members	SMC3	and	SMC1A	
cause	a	mild	variant	of	cornelia	de	Lange	syndrome	with	predominant	mental	retardation.	Am	J	Hum	
Genet	80,	485-94.
Donze,	D.,	Adams,	C.	R.,	Rine,	J.	and	Kamakaka,	R.	T.	(1999).	The	boundaries	of	the	silenced	HMR	
domain	in	Saccharomyces	cerevisiae.	Genes	Dev	13,	698-708.
Dorsett,	 D.	 (2007).	 Roles	 of	 the	 sister	 chromatid	 cohesion	 apparatus	 in	 gene	 expression,	
development,	and	human	syndromes.	Chromosoma	116,	1-13.
Dorsett,	D.,	Eissenberg,	J.	C.,	Misulovin,	Z.,	Martens,	A.,	Redding,	B.	and	McKim,	K.	(2005).	Effects	
of	sister	chromatid	cohesion	proteins	on	cut	gene	expression	during	wing	development	in	Drosophila.	
Development	132,	4743-53.
DuVall,	G.	A.	and	Walden,	D.	T.	(1996).	Adenocarcinoma	of	the	esophagus	complicating	Cornelia	
de	Lange	syndrome.	J	Clin	Gastroenterol	22,	131-3.
Essers,	J.,	Hendriks,	R.	W.,	Swagemakers,	S.	M.,	Troelstra,	C.,	de	Wit,	J.,	Bootsma,	D.,	Hoeijmakers,	
J.	H.	 and	Kanaar,	 R.	 (1997).	Disruption	 of	mouse	RAD54	 reduces	 ionizing	 radiation	 resistance	 and	
homologous	recombination.	Cell	89,	195-204.
Gillis,	L.	A.,	McCallum,	J.,	Kaur,	M.,	DeScipio,	C.,	Yaeger,	D.,	Mariani,	A.,	Kline,	A.	D.,	Li,	H.	H.,	
Devoto,	M.,	Jackson,	L.	G.	et	al.	(2004).	NIPBL	mutational	analysis	in	120	individuals	with	Cornelia	de	
Lange	syndrome	and	evaluation	of	genotype-phenotype	correlations.	Am	J	Hum	Genet	75,	610-23.
Gruber,	S.,	Arumugam,	P.,	Katou,	Y.,	Kuglitsch,	D.,	Helmhart,	W.,	Shirahige,	K.	and	Nasmyth,	K.	
(2006).	Evidence	that	loading	of	cohesin	onto	chromosomes	involves	opening	of	its	SMC	hinge.	Cell	
127,	523-37.
Hartman,	T.,	Stead,	K.,	Koshland,	D.	and	Guacci,	V.	(2000).	Pds5p	 is	an	essential	chromosomal	
protein	required	for	both	sister	chromatid	cohesion	and	condensation	in	Saccharomyces	cerevisiae.	J	
Cell	Biol	151,	613-26.
Hirano,	M.	and	Hirano,	T.	(2006).	Opening	closed	arms:	long-distance	activation	of	SMC	ATPase	by	
hinge-DNA	interactions.	Mol	Cell	21,	175-86.
Hirano,	T.	(2006).	At	the	heart	of	the	chromosome:	SMC	proteins	in	action.	Nat	Rev	Mol	Cell	Biol	7,	
311-22.
Horsfield,	J.	A.,	Anagnostou,	S.	H.,	Hu,	J.	K.,	Cho,	K.	H.,	Geisler,	R.,	Lieschke,	G.,	Crosier,	K.	E.	and	
Crosier,	P.	S.	(2007).	Cohesin-dependent	regulation	of	Runx	genes.	Development	134,	2639-49.
Ireland,	M.,	Donnai,	D.	and	Burn,	J.	 (1993).	Brachmann-de	Lange	syndrome.	Delineation	of	 the	
clinical	phenotype.	Am	J	Med	Genet	47,	959-64.
Jackson,	L.,	Kline,	A.	D.,	Barr,	M.	A.	and	Koch,	S.	(1993).	de	Lange	syndrome:	a	clinical	review	of	
310	individuals.	Am	J	Med	Genet	47,	940-6.
Kaur,	M.,	DeScipio,	C.,	McCallum,	J.,	Yaeger,	D.,	Devoto,	M.,	Jackson,	L.	G.,	Spinner,	N.	B.	and	
Krantz,	I.	D.	(2005).	Precocious	sister	chromatid	separation	(PSCS)	in	Cornelia	de	Lange	syndrome.	Am	
J	Med	Genet	A	138,	27-31.
Krantz,	I.	D.,	McCallum,	J.,	DeScipio,	C.,	Kaur,	M.,	Gillis,	L.	A.,	Yaeger,	D.,	Jukofsky,	L.,	Wasserman,	
86 Chapter	3
N.,	Bottani,	A.,	Morris,	C.	A.	et	al.	(2004).	Cornelia	de	Lange	syndrome	is	caused	by	mutations	in	NIPBL,	
the	human	homolog	of	Drosophila	melanogaster	Nipped-B.	Nat	Genet	36,	631-5.
Lechner,	 M.	 S.,	 Schultz,	 D.	 C.,	 Negorev,	 D.,	 Maul,	 G.	 G.	 and	 Rauscher,	 F.	 J.,	 3rd.	 (2005).	 The	
mammalian	heterochromatin	protein	 1	binds	diverse	nuclear	 proteins	 through	a	 common	motif	 that	
targets	the	chromoshadow	domain.	Biochem	Biophys	Res	Commun	331,	929-37.
Losada,	A.	(2007).	Cohesin	regulation:	fashionable	ways	to	wear	a	ring.	Chromosoma	116,	321-9.
Maruiwa,	 M.,	 Nakamura,	 Y.,	 Motomura,	 K.,	 Murakami,	 T.,	 Kojiro,	 M.,	 Kato,	 M.,	 Morimatsu,	 M.,	
Fukuda,	S.	and	Hashimoto,	T.	(1988).	Cornelia	de	Lange	syndrome	associated	with	Wilms’	tumour	and	
infantile	haemangioendothelioma	of	the	liver:	report	of	two	autopsy	cases.	Virchows	Arch	A	Pathol	Anat	
Histopathol	413,	463-8.
Michaelis,	C.,	Ciosk,	R.	and	Nasmyth,	K.	 (1997).	Cohesins:	 chromosomal	proteins	 that	prevent	
premature	separation	of	sister	chromatids.	Cell	91,	35-45.
Musio,	A.,	Selicorni,	A.,	Focarelli,	M.	L.,	Gervasini,	C.,	Milani,	D.,	Russo,	S.,	Vezzoni,	P.	and	Larizza,	
L.	(2006).	X-linked	Cornelia	de	Lange	syndrome	owing	to	SMC1L1	mutations.	Nat	Genet	38,	528-30.
Nasmyth,	K.	and	Haering,	C.	H.	(2005).	The	structure	and	function	of	SMC	and	kleisin	complexes.	
Annu	Rev	Biochem	74,	595-648.
Parelho,	V.,	Hadjur,	S.,	Spivakov,	M.,	Leleu,	M.,	Sauer,	S.,	Gregson,	H.	C.,	Jarmuz,	A.,	Canzonetta,	
C.,	Webster,	Z.,	Nesterova,	T.	et	al.	(2008).	Cohesins	functionally	associate	with	CTCF	on	mammalian	
chromosome	arms.	Cell	132,	422-33.
Pauli,	A.,	Althoff,	F.,	Oliveira,	R.	A.,	Heidmann,	S.,	Schuldiner,	O.,	Lehner,	C.	F.,	Dickson,	B.	J.	and	
Nasmyth,	K.	(2008).	Cell-type-specific	TEV	protease	cleavage	reveals	cohesin	functions	in	Drosophila	
neurons.	Dev	Cell	14,	239-51.
Revenkova,	E.,	 Eijpe,	M.,	Heyting,	C.,	Hodges,	C.	A.,	Hunt,	 P.	A.,	 Liebe,	B.,	 Scherthan,	H.	 and	
Jessberger,	 R.	 (2004).	 Cohesin	 SMC1	 beta	 is	 required	 for	 meiotic	 chromosome	 dynamics,	 sister	
chromatid	cohesion	and	DNA	recombination.	Nat	Cell	Biol	6,	555-62.
Revenkova,	E.	and	Jessberger,	R.	(2006).	Shaping	meiotic	prophase	chromosomes:	cohesins	and	
synaptonemal	complex	proteins.	Chromosoma	115,	235-40.
Rollins,	R.	A.,	Korom,	M.,	Aulner,	N.,	Martens,	A.	and	Dorsett,	D.	(2004).	Drosophila	nipped-B	protein	
supports	sister	chromatid	cohesion	and	opposes	the	stromalin/Scc3	cohesion	factor	to	facilitate	long-
range	activation	of	the	cut	gene.	Mol	Cell	Biol	24,	3100-11.
Rollins,	R.	A.,	Morcillo,	P.	and	Dorsett,	D.	(1999).	Nipped-B,	a	Drosophila	homologue	of	chromosomal	
adherins,	participates	in	activation	by	remote	enhancers	in	the	cut	and	Ultrabithorax	genes.	Genetics	
152,	577-93.
Russell,	K.	L.,	Ming,	J.	E.,	Patel,	K.,	Jukofsky,	L.,	Magnusson,	M.	and	Krantz,	I.	D.	(2001).	Dominant	
paternal	transmission	of	Cornelia	de	Lange	syndrome:	a	new	case	and	review	of	25	previously	reported	
familial	recurrences.	Am	J	Med	Genet	104,	267-76.
Sakai,	K.	and	Miyazaki,	J.	(1997).	A	transgenic	mouse	line	that	retains	Cre	recombinase	activity	in	
mature	oocytes	 irrespective	of	 the	cre	 transgene	transmission.	Biochem	Biophys	Res	Commun	237,	
318-24.
Schuldiner,	O.,	Berdnik,	D.,	Levy,	J.	M.,	Wu,	J.	S.,	Luginbuhl,	D.,	Gontang,	A.	C.	and	Luo,	L.	(2008).	
piggyBac-based	mosaic	screen	identifies	a	postmitotic	function	for	cohesin	in	regulating	developmental	
axon	pruning.	Dev	Cell	14,	227-38.
Seitz,	L.	C.,	Tang,	K.,	Cummings,	W.	J.	and	Zolan,	M.	E.	(1996).	The	rad9	gene	of	Coprinus	cinereus	
encodes	a	proline-rich	protein	required	for	meiotic	chromosome	condensation	and	synapsis.	Genetics	
142,	1105-17.
Sjogren,	 C.	 and	 Nasmyth,	 K.	 (2001).	 Sister	 chromatid	 cohesion	 is	 required	 for	 postreplicative	
double-strand	break	repair	in	Saccharomyces	cerevisiae.	Curr	Biol	11,	991-5.
Stedman,	W.,	Kang,	H.,	Lin,	S.,	Kissil,	J.	L.,	Bartolomei,	M.	S.	and	Lieberman,	P.	M.	(2008).	Cohesins	
localize	with	CTCF	at	 the	KSHV	latency	control	 region	and	at	cellular	c-myc	and	H19/Igf2	 insulators.	
Embo	J	27,	654-66.
Strom,	L.,	Karlsson,	C.,	Lindroos,	H.	B.,	Wedahl,	S.,	Katou,	Y.,	Shirahige,	K.	and	Sjogren,	C.	(2007).	
Postreplicative	formation	of	cohesion	is	required	for	repair	and	induced	by	a	single	DNA	break.	Science	
317,	242-5.
87Chapter	3
Strom,	 L.,	 Lindroos,	 H.	 B.,	 Shirahige,	 K.	 and	 Sjogren,	 C.	 (2004).	 Postreplicative	 recruitment	 of	
cohesin	to	double-strand	breaks	is	required	for	DNA	repair.	Mol	Cell	16,	1003-15.
Sugita,	K.,	Izumi,	T.,	Yamaguchi,	K.,	Fukuyama,	Y.,	Sato,	A.	and	Kajita,	A.	(1986).	Cornelia	de	Lange	
syndrome	associated	with	a	suprasellar	germinoma.	Brain	Dev	8,	541-6.
Thiru,	A.,	Nietlispach,	D.,	Mott,	H.	R.,	Okuwaki,	M.,	Lyon,	D.,	Nielsen,	P.	R.,	Hirshberg,	M.,	Verreault,	
A.,	Murzina,	N.	V.	and	Laue,	E.	D.	(2004).	Structural	basis	of	HP1/PXVXL	motif	peptide	interactions	and	
HP1	localisation	to	heterochromatin.	Embo	J	23,	489-99.
Tomonaga,	T.,	Nagao,	K.,	Kawasaki,	Y.,	Furuya,	K.,	Murakami,	A.,	Morishita,	J.,	Yuasa,	T.,	Sutani,	T.,	
Kearsey,	S.	E.,	Uhlmann,	F.	et	al.	(2000).	Characterization	of	fission	yeast	cohesin:	essential	anaphase	
proteolysis	of	Rad21	phosphorylated	in	the	S	phase.	Genes	Dev	14,	2757-70.
Tonkin,	 E.	 T.,	Wang,	 T.	 J.,	 Lisgo,	 S.,	 Bamshad,	M.	 J.	 and	Strachan,	 T.	 (2004).	NIPBL,	 encoding	
a	 homolog	 of	 fungal	 Scc2-type	 sister	 chromatid	 cohesion	 proteins	 and	 fly	Nipped-B,	 is	mutated	 in	
Cornelia	de	Lange	syndrome.	Nat	Genet	36,	636-41.
Toyoda,	Y.,	Furuya,	K.,	Goshima,	G.,	Nagao,	K.,	Takahashi,	K.	and	Yanagida,	M.	(2002).	Requirement	
of	chromatid	cohesion	proteins	rad21/scc1	and	mis4/scc2	for	normal	spindle-kinetochore	interaction	in	
fission	yeast.	Curr	Biol	12,	347-58.
Unal,	E.,	Arbel-Eden,	A.,	Sattler,	U.,	Shroff,	R.,	Lichten,	M.,	Haber,	J.	E.	and	Koshland,	D.	(2004).	
DNA	damage	response	pathway	uses	histone	modification	to	assemble	a	double-strand	break-specific	
cohesin	domain.	Mol	Cell	16,	991-1002.
van	Haaften,	G.,	Romeijn,	R.,	Pothof,	J.,	Koole,	W.,	Mullenders,	L.	H.,	Pastink,	A.,	Plasterk,	R.	H.	and	
Tijsterman,	M.	 (2006).	 Identification	of	conserved	pathways	of	DNA-damage	 response	and	 radiation	
protection	by	genome-wide	RNAi.	Curr	Biol	16,	1344-50.
Vrouwe,	M.	G.,	Elghalbzouri-Maghrani,	E.,	Meijers,	M.,	Schouten,	P.,	Godthelp,	B.	C.,	Bhuiyan,	Z.	
A.,	Redeker,	E.	J.,	Mannens,	M.	M.,	Mullenders,	L.	H.,	Pastink,	A.	et	al.	(2007).	Increased	DNA	damage	
sensitivity	of	Cornelia	de	Lange	syndrome	cells:	evidence	for	impaired	recombinational	repair.	Hum	Mol	
Genet	16,	1478-87.
Watrin,	E.,	Schleiffer,	A.,	Tanaka,	K.,	Eisenhaber,	F.,	Nasmyth,	K.	and	Peters,	J.	M.	(2006).	Human	
Scc4	is	required	for	cohesin	binding	to	chromatin,	sister-chromatid	cohesion,	and	mitotic	progression.	
Curr	Biol	16,	863-74.
Weitzer,	S.,	Lehane,	C.	and	Uhlmann,	F.	(2003).	A	model	for	ATP	hydrolysis-dependent	binding	of	
cohesin	to	DNA.	Curr	Biol	13,	1930-40.
Wendt,	K.	S.,	Yoshida,	K.,	Itoh,	T.,	Bando,	M.,	Koch,	B.,	Schirghuber,	E.,	Tsutsumi,	S.,	Nagae,	G.,	
Ishihara,	K.,	Mishiro,	 T.	 et	 al.	 (2008).	Cohesin	mediates	 transcriptional	 insulation	by	CCCTC-binding	
factor.	Nature	451,	796-801.
Xu,	H.,	Beasley,	M.	D.,	Warren,	W.	D.,	van	der	Horst,	G.	T.	and	McKay,	M.	J.	(2005).	Absence	of	
mouse	REC8	cohesin	promotes	synapsis	of	sister	chromatids	in	meiosis.	Dev	Cell	8,	949-61.
Zhang,	B.,	 Jain,	 S.,	 Song,	H.,	 Fu,	M.,	Heuckeroth,	R.	O.,	 Erlich,	 J.	M.,	 Jay,	 P.	 Y.	 and	Milbrandt,	
J.	(2007).	Mice	lacking	sister	chromatid	cohesion	protein	PDS5B	exhibit	developmental	abnormalities	
reminiscent	of	Cornelia	de	Lange	syndrome.	Development	134,	3191-201.
88 Chapter	4
89Chapter	4
Chapter	 4	 Interactions	 in β-globin	 locus:	 the	 role	 of	
Cohesin
Sanja Krpic,	Erik	Splinter,	Thamar	Van	Dijk,	Wilfred	van	IJcken,	Erik-Jan	
Rijkers,	Christel	Kockx	and	Frank	Grosveld
Manuscript in preparation
90 Chapter	4
91Chapter	4
.
IntRODuCtIOn:
The	 genome	 appears	 to	 be	 organized	 in	 chromatin	 loops	 that	 demarcate	
“domains”.	Such	an	organization	allows	efficient	packaging	and	interactions	in	the	
constricted	space	of	the	nucleus.	It	would	also	separate	regulatory	elements	in	cis,	
although	recent	data	indicate	that	there	is	extensive	interaction	between	very	distant	
regions	in	cis	and	even	in	trans.	Nevertheless	an	organization	in	loops	would	favor	
interactions	 between	 cis-regulatory	 elements	 on	 the	 same	 loop	 and	 diminishing	
the	 influence	of	more	distant	elements	on	other	 loops	 thereby	maintaining	proper	
expression	 domains	 and	 patterns	 in	 a	 lineage	 specific	 manner.	 This	 task	 is	
accomplished	by	 chromatin	 elements	 that	 demarcate	 expression	 domains	 (Dillon	
and	Sabbattini,	2000)	where	functional	gene	expression	domains	define	the	functional	
unit	of	eukaryotic	gene	regulation.	These	elements	are	often	referred	to	as	insulators	
due	to	their	ability	to	block	enhancer	or	silencer	signals	when	physically	positioned	
between	the	cis-regulatory	element	and	the	promoter	of	the	gene	(Bell	et	al.,	2001;	
Ohlsson	et	al.,	2001).
Insulators	are	best	exemplified	by	 the	gypsy	element	 in	Drosophila	 (Capelson	
and	Corces,	2005).	The	Gypsy	insulators	are	occupied	in	a	sequence	specific	manner	
by	SUHW	and	Mod	 (Mdg4)	which	 recruit	 other	 factors	 (Pai	 et	 al.,	 2004).	Multiple	
gypsy	sites	and	associated	proteins	cluster	together	to	form	“insulator	bodies”	with	
the	effect	of	organizing	nearby	chromatin	into	loop	domains	(Capelson	and	Corces,	
2006).	 In	 vertebrates,	 a	 similar	 function	 is	 associated	 with	 the	 chromatin	 binding	
protein	CTCF	(CCCTC-binding	factor).	It	is	the	prototype	vertebrate	protein	exhibiting	
insulator	activity	 	as	an	enhancer	blocker	or	as	a	barrier	against	 inactivation	 from	
nearby	 heterochromatin	 in	 transfection	 assays	 (Bell	 and	 Felsenfeld,	 2000;	 Bell	 et	
al.,	1999;	Recillas-Targa	et	al.,	2002;	West	et	al.,	2002).	In vivo,	CTCF	appears	to	be	
involved	in	the	formation	of	chromatin	loops	(Burke	et	al.,	2005;	Splinter	et	al.,	2006;	
Tolhuis	et	al.,	2002).	It	 is	very	stably	bound	to	the	chromatin	(Galjart	et	al	personal	
comm.,)	and	appears	to	be	essential	for	the	maintenance	of	chromatin	structure.	This	
property	is	used	to	achieve	allele	specific	gene	expression	at	imprinted	loci.	CTCF	
binds	to	the	imprinting	control	region	(ICR)	of	the	H19/insulin-like	growth	factor	(Igf2)	
locus	on	the	maternally	inherited	allele.	On	the	paternal	copy	the	ICR	is	methylated	
preventing	CTCF	binding	resulting	in	the	formation	of	a	different	loop	(Szabo	et	al.,	
2004),	which	is	in	effect	abolishing	its	insulator	function	(Bell	and	Felsenfeld,	2000).	
The	 mouse	 β-globin	 locus	 is	 situated	 on	 chromosome	 7	 and	 contains	 four	
functional	genes:	εγ, βh1, βmaj		and	 βmin	(from	5’to	3’).	During	primitive	eryhropoiesis,	
yolk	sac	derived	erythroid	cells	express	mostly	εy and βh1,	while	the	expression	of	
βmaj and βmin	 is	 low.	 In	 the	murine	β-globin	 locus,	 three	CTCF-binding	 sites	 have	
been	 identified	 upstream	 (HS-85,	HS-62	 and	HS5)	 and	 one	 downstream	 (3’HS1)	
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of	the	β-globin	 locus	(Bulger	et	al.,	2003;	Farrell	et	al.,	2002;	Splinter	et	al.,	2006).	
All	the	CTCF	sites	are	in	contact	with	each	other	(Palstra	et	al.,	2003;	Splinter	et	al.,	
2006)	maintaining	a	compact	domain	structure	that	is	dependent	on	CTCF.	Depletion	
of	CTCF,	or	the	disruption	one	of	its	DNA-binding	site	destabilize	these	long-range	
interactions	(Splinter	et	al.,	2006).
Genome-wide	approaches	have	resulted	in	the	identification	most	or	all	the	CTCF	
binding	sites	in	human	genome.	The	sites	correlate	strongly	with	regions	containing	
genes	in	line	with	an	important	role	of	CTCF	in	gene	regulation	in	cis	(Kim	et	al.,	2007)	
and	perhaps	even	in	trans	(Ling	et	al.,	2006).
Other	proteins	known	to	“organize”	DNA	are	the	Cohesins.	The	Cohesin	complex	
is	 best	 known	 for	 its	 role	 in	 holding	 sister	 chromatids	 together	 after	 eukaryotic	
DNA	replication.	This	allows	 the	spindle	 to	 recognize	pairs	of	 replication	products	
for	segregation	 into	opposite	directions	during	mitosis.	The	complex	 is	conserved	
from	 yeast	 to	 humans	 and	 is	 composed	 of	 two	 SMC	 (Structural	 Maintenance	 of	
Chromosomes)	subunits	SMC1	and	SMC3,	and	two	non-SMC	subunits,	Scc1/Rad21	
and	Scc3,	which	together	form	a	ring-shape	complex	that	is	essential	for	cohesion	
between	sister	chromatids	(Gruber	et	al.,	2003).
Cohesin	 is	 initially	 loaded	 onto	 chromosomes	 at	 separate	 places	 along	 the	
genome	by	Scc2	(Lengronne	et	al.,	2004)	and	 its	orthologs	(Gillespie	and	Hirano,	
2004;	Seitan	et	al.,	2006).	The	genomic	 location	of	Cohesin	have	been	studied	 in	
several	species	by	chromatin-immunoprecipitation	followed	by	hybridization	to	DNA	
microarrays	 (ChIP-on-chip).	 In	 yeast,	 Cohesin	 binds	 approximately	 every	 10	 kbp	
and	is	localized	almost	exclusively	between	genes	that	are	transcribed	in	opposite	
directions.	Changes	in	transcription	lead	to	repositioning	of	Cohesin	(Lengronne	et	
al.,	2004).	In	contrast,	ChIP-on-chip	data	from	D.melanogaster cell	lines	indicate	that	
Cohesin	has	a	clear	preference	for	active	over	inactive	genes,	with	Cohesin	binding	
occurring	over	active	transcriptional	units	as	well	as	untranscribed	regions	(Misulovin	
et	 al.,	 2008).	 Cohesin	 binds	 between	 a	 remote	 wing	 margin	 enhancer	 and	 the	
promoter	at	the	cut	locus.	Although	it	is	not	known	how	Cohesin	interacts	with	DNA,	
reduction	of	the	SMC1	level	increases	cut	expression	in	the	developing	wing	margin	
(Dorsett	et	al.,	2005).	Recently,	four	groups	mapped	numerous	Cohesin-binding	sites	
in	mammalian	chromosomes	and	found	substantial	overlap	with	CTCF	(Parelho	et	
al.,	2008;	Rubio	et	al.,	2008;	Stedman	et	al.,	2008;	Wendt	et	al.,	2008).	After	important	
finding	of	overlapping	binding	sites	of	CTCF	and	Cohesin,	one	of	the	key	questions	
that	follow	is	if	there	is	functional	significance	of	shared	binding	sites	with	respect	to	
gene	regulation.
Here	we	show	that	subsets	of	the	CTCF	binding	sites	are	shared	with	Cohesin	
in	the	mouse	genome.	We	have	focused	specifically	on	CTCF	and	Cohesin	binding	
sites	 in	 the	mouse	 β-globin	 locus	 and	 surrounding	 sequences	 in	 erythroid	 cells.	
Previously,	it	was	shown	that	CTCF	function	in	the	formation	of	chromatin	loops	using	
two	 independent	 lines	of	evidence.	The	removal	of	most	CTCF	protein,	as	well	as	
targeted	disruption	of	a	CTCF-binding	site,	resulted	in	destabilization	of	long-range	
contacts	between	cognate	binding	sites	in	the	β-globin	locus	(Splinter	et	al.,	2006).	
Since	Cohesin	and	CTCF	share	binding	sites	 in	β-globin	 locus	we	were	interested	
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to	know	whether	Cohesin	is	required	for	the	long-range	interactions	in	this	locus	at	
the	shared	CTCF/Cohesin	binding	sites.	We	show	 that	Cohesin	binding	 is	 indeed	
required	in	a	CTCF	dependent	manner.	
ReSuLtS
Identification of Cohesin and CtCF binding sites by ChIP-on chip
Cohesin	and	CTCF	binding	sites	were	identified	by	Chromatin	Immunoprecipitation	
(ChIP)	in	mouse	I/11	cells.	I/11	cells	are	erythroid	progenitor	cells	established	from	
fetal	 livers	of	p53-/-	mice.	The	cells	can	be	expanded	 indefinitely	 in vitro	and	after	
exposure	 to	 physiologically	 relevant	 stimuli	 such	 as	 erythropoietin,	 they	 undergo	
terminal	differentiation	into	enucleated	erythrocytes	in	a	synchronized	manner	(von	
Lindern	et	al.,	2001).	The	choice	of	I/11	cells	was	based	on	their	ability	to	faithfully	
recapitulate	 the	 erythroid	 differentiation	 program	 in vivo.	 Analysis	 of	 this	 erythroid	
line	show	 that	upon	 induction	 (maturation)	β-globin	gene	expression	 increases	 to	
reach	the	high	transcription	level	in vivo	(Dolznig	et	al.,	2005).	Furthermore,	increased	
expression	rates	of	β-major	in	I/11	cells	coincides	well	with	increased	LCR-β-major	
interaction	frequencies	(Kooren	et	al.,	2007)	supporting	this	line	to	be	a	good	model	
to	study	the	conformational	dynamics	 in	the	β-globin	 locus.	For	ChIP	analysis,	we	
initially	used	oligonucleotide	tiling	arrays	for	mouse	chromosomes	3,	7	and	13	(an	
Affymetrix	set	of	arrays)	since	we	are	particularly	interested	in	binding	sites	in	mouse	
β-globin	locus	on	chromosome	7.
		 We	performed	a	ChIP-on-chip	analysis	on	non-induced	and	induced	I/11	cells	
using	an	SMC1	antibody,	to	bring	down	the	Cohesin	complex,	and	a	CTCF	antibody,	to	
bring	down	CTCF.	ChIP-on-chip	analysis	revealed	a	nonrandom	distribution	of	SMC1	
(Cohesin)	and	CTCF	binding	sites	across	3	mouse	chromosomes.	Detailed	analysis	
showed	as	expected	that	there	is	an	overlap	of	CTCF	and	SMC1	binding	sites.	Since	
we	are	particularly	interested	in	the	β-globin	gene	and	surrounding	sequences,	we	
focused	on	binding	sites	on	chromosome	7	(110,000,000-112,000,000	coordinates	
build	Build	37.1	assembly	by	NCBI).	For	visualization	of	the	data	we	have	used	IGB	
(Integrated	Genome	Browser)	 from	Affymetrix	 (data	not	shown)	or	UCSC	genome	
browser.	
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Identification of Cohesin and CtCF binding genome-wide by Solexa 
sequencing 
The	ChIP-on-chip	experiments	were	not	pursued	further	since	this	method	has	
several	limitations	including	the	large	sets	of	arrays	needed	to	cover	the	mammalian	
genome,	its	potential	bias	introduced	by	DNA	amplification	(Bernstein	et	al.,	2007)	and	
its	limited	quantitative	range.	The	technique	gives	many	false	positive	and/or	negative	
results.	For	example,	we	screened	more	than	25	sites	that	appeared	to	be	positive	
for	CTCF	and/or	Cohesin	by	conventional	qPCR	and	only	2	showed	enrichment.	To	
overcome	this	problem	we	switched	to	Chip-sequencing	using	a	Solexa	1G	Genome	
Analyzer.	 It	 performs	massive	 parallel	 sequencing	 to	 directly	 sequence	 the	 ends	
of	ChIP-DNA	after	sonication.	 It	 is	clearly	a	more	comprehensive,	quantitative	and	
reproducible	method	to	analyze	protein	target	sites	in	large	mammalian	genomes.
Supplementary	Figure	1
The	 graph	 shows	 a	 typical	 example	 of	 Solexa-sequencing	 analysis	 of	 the	 overlap	 of	 2	 randomly	
chosen	CTCF	and	SMC3	(Cohesin)	binding	sites	with	relevant	controls	on	the	chromosome	1	and	
chromosome	9.	The	data	are	presented	like	profile	tracks	in	UCSC	genome	browser.	The	SMC	and	
its	control	track	are	shown	in	blue	and	purple,	the	CTCF	track	and	its	control	in	red	and	green.	The	
horizontal	axis	shows	the	coordinates	on	chromosomes	1	and	9	(Mouse	Build	37.1).	The	vertical	axis	
shows	the	number	of	overlapping	sequences	scored	at	a	particular	position.
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		 The	 identification	 of	Cohesin	 and	CTCF	binding	 sites	by	ChIP-sequencing	
was	 done	 as	 described	 above	 for	 the	 ChIP-on-chip	 analysis.	 The	 quality	 of	 the	
chromatin	precipitation	was	confirmed	by	using	real-time	quantitative	PCR	analysis	
of	known	target	sites	before	further	analysis	using	the	Solexa	1G	Genome	Analyzer.	
The	 sequencing	 procedure	 requires	 a	 one-step	 adaptor	 ligation	 and	 limited	 PCR	
amplification	(18	cycles)	of	ChIP	DNA	molecules	followed	by	cluster	generation	and	
sequencing-by-synthesis	 (Described	 in	Materials	 and	Methods).	 One	 sequencing	
run	 produced	 between	 2-6	million	 sequence	 tags	 of	 36bp	 each.	 Since	 the	ChIP-
Sequencing	is	analogous	to	direct	counting	of	the	molecules	in	the	ChIP-DNA	sample,	
it	requires	minimal	normalization.	
Again,	similar	to	ChIP-on-chip	analysis	we	could	detect	overlap	between	CTCF	
and	Cohesin	binding	sites.	In	Supplementary	Figure	1,	an	example	is	given	of	two	
overlapping	 sites	 situated	at	 the	chromosome	1	and	9	with	 relevant	 controls	 and	
the	positions	along	 the	chromosomes	 (Mouse	Build	37.1).	 The	statistical	 analysis	
showing	 the	 degree	 of	 CTCF	 and	 Cohesin	 overlap	 in	 the	 mouse	 genome	 is	 in	
progress.	We	also	identified	many	sites	that	were	occupied	by	one	or	the	other	protein.	
Interestingly,	there	was	extensive	overlap	of	CTCF	binding	sites	with	an	independent	
study	performed	on	mouse	ES	cells	using	the	same	Chip-sequencing	method	(Chen	
et	al.,	2008).
In	the	β-globin	locus	we	detected	the	previously	identified	CTCF	binding	sites.	
They	are	present	at	the	3’HS1,	 in	the	LCR	(5’HS5/cHS4)	and	the	5’	sites	(HS-62.5	
and	HS-85)	(Bulger	et	al.,	2003;	Farrell	et	al.,	2002)	and	two	new	sites	B1	and	B2	(see	
below).		For	simplicity,	only	3’HS1	and	HS-85	sequence	are	depicted	in	the	Figure	
1A.		We	could	detect	CTCF	at	all	4	known	binding	sites	while	SMC3	was	enriched	
only	at	3’HS1.	The	validation	of	these	binding	sites	is	presented	in	Figure	1B,	which	
shows	the	relative	enrichments	of	SMC1	and	SMC3,	and	CTCF	and	Rad21	at	CTCF	
binding	sites.	Clearly,	all	3	Cohesin	subunits	show	enrichment	only	at	3’HS1	while	
CTCF	is	enriched	at	all	4	sites.	The	negative	control,	the	β-globin	promoter	shows	no	
binding	for	all	4	proteins.		As	mentioned	above,	we	detected	positive	signal	for	SMC3	
and	CTCF	at	two	novel	locations	in	the	β-globin	locus	that	have	not	been	reported	
before.	Interestingly,	both	“new”	CTCF	binding	sites	also	bind	Cohesin.	The	position	
and	relative	enrichment	for	CTCF	and	Cohesin	at	these	sites	is	shown	in	Figures	1A	
and	C.	Interestingly,	B1	is	situated	within	the	β-globin	(major)	gene	in	the	third	exon.	
The	additional	site	B2,	was	mapped	13	kilobases	upstream	of	3’HS1.	
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Figure	1
A		_	Schematic	of	CTCF	binding	sites	in	β-globin	locus:	HS-85,	HS-62,	HS5	and	3’HS1.
B1	and	B2	 (newly	 identified	binding	sites)	are	also	shown	with	 their	 relative	positions	 to	 the	other	
sites.	
At	the	HS-85	and	3’HS1	binding	sites,	the	sequences	identified	by	Solexa-sequencing	are	depicted	
by	simple	 lines	(instead	of	 real	sequences).	The	CTCF	consensus	binding	motif,	with	surrounding	
sequences	is	also	included.	At	the	3’HS1	binding	motif,	the	upper	sequence	(TATA)	represents	the	
position	of	the	mutated	CTCF	consensus	sequence	(Splinter,	Heath	et	al.	2006).	
B	_	Chromatin	immunoprecipitation	(ChIP)	using	antibodies	against:	SMC1,	SMC3,	Rad21,	CTCF	and	
an	antibody	control.	Plotted	are	relative	enrichments	measured	for	the	sites	in	β-globin	locus.	
C	_	Chromatin	immunoprecipitation	(ChIP)	using	antibodies	against	SMC3,	CTCF	and	an	Ab	control.	
Plotted	are	relative	enrichments	measured	for	the	sites	in	the	β-globin	locus.		
D	_	Chromatin	immunoprecipitation	(ChIP)	using	antibodies	against	CTCF,	SMC3	and	a	non	relevant	
Ab	(control).	Plotted	are	the	relative	enrichments	measured	for	the	two	different	alleles	3’HS	Wild	Type	
and	3’HS1	mutated.		
The	relative	enrichments	are	normalized	to	amylase.
In	all	panels	the	standard	error	is	indicated	(from	3	independent	ChIP	experiments,	2	Q-PCR	each).	
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Cohesin binding to 3’HS1 in the β-globin locus is dependent on 
CtCF
Since	 CTCF	 and	 Cohesin	 binding	 sites	 have	 a	 high	 degree	 of	 overlap,	 we	
examined	whether	CTCF	is	required	for	Cohesin	binding	at	a	shared	site.	To	answer	
this,	we	used	a	disrupted	3’HS1	CTCF	binding	site	of	which	4	conserved	nucleotides	
in	the	in	the	core	CTCF-binding	site	were	mutated	(Splinter	et	al.,	2006).	Chromatin	
immunoprecipitation	was	performed	on	fetal	livers	from	embryos	carrying	a	mutation	
in	the	3’HS1	site	in	one	of	its	alleles	while	the	other	allele	was	intact.	The	two	alleles	
can	be	distinguished	by	different	sets	of	primers	that	specifically	amplify	each	allele.	
The	binding	of	CTCF	to	the	mutated	allele	was	completely	abolished	and	interestingly,	
Cohesin	was	also	no	longer	able	to	bind	(Figure	1D).	Both	CTCF	and	Cohesin	were	
enriched	normally	at	the	normal	allele	with	the	preserved	CTCF	binding	site.	
These	data	demonstrate	that	Cohesin	binding	at	the	3’HS1	site	directly	depends	
on	 the	presence	of	CTCF,	suggesting	 that	CTCF	 is	 required	 for	 the	enrichment	of	
Cohesin	at	its	binding	sites.	However	we	were	unable	to	detect	a	direct	interaction	
between	 CTCF	 and	 any	 of	 the	 Cohesin	 subunits	 (data	 not	 shown).	 Possibly	 the	
interaction	is	weak	or	Cohesin	and	CTCF	interact	only	transiently.	Alternatively	they	
may	interact	indirectly	via	other	proteins	or	DNA.	
the role of Cohesin in the organization of β-globin locus
To	address	the	question	whether	Cohesin	is	required	for	the	organization	of	β-
globin	locus	we	performed	a	set	of	experiments	where	non–induced	I/11	cells	were	
depleted	for	CTCF	or	Cohesin	by	lentiviral	transduction	with	shRNA.	We	used	several	
constructs	 for	 each	 protein	 that	 were	 successful	 in	 reducing	 the	 amount	 of	 the	
proteins	and	each	gave	a	similar	cell	phenotype/result.	We	followed	the	dynamics	
of	the	knockdown	during	5	days	and	we	were	able	to	deplete	CTCF	protein	to	more	
than	95%	as	shown	by	Western	blot	(Figure	2A,	left	panel,	day	3	and	5	time	points).	
Interestingly,	the	cells	were	still	viable	and	progressed	through	the	cell	cycle	although	
at	a	slower	rate	when	compared	to	mock	transfected	control	cells	(data	not	shown).	
Cohesin	was	depleted	 up	 to	 70%	by	 transduction	with	 shSMC3	RNA	 (Figure	 2A,	
right	panel)	when	the	cells	were	still	viable	and	dividing.	Depletion	of	more	then	70%	
caused	massive	cell	death.	The	simultaneous	depletion	of	both	of	the	proteins	was	
not	successful	since	it	gave	rise	to	massive	cell	death	(not	shown),	hence	we	have	
used	incomplete	knock	down	of	Cohesin	(Figure	2A,	right	panel).	
As	expected	in	Cohesin	depleted	samples	Cohesin	is		not	bound	to	3’HS1	it	is	
in	(Figure	2B,	left	panel).	In	the	same	sample,	CTCF	was	enriched	at	3’HS1	to	a	level	
similar	 to	 that	seen	 in	 the	WT	control	suggesting	 that	Cohesin	does	not	 influence	
CTCF	binding	to	its	site.	In	contrast,	CTCF	depletion	disturbs	Cohesin	binding	(Figure	
2B,	right	panel),	it	is	no	longer	bound	to	3’HS1	even	though	the	level	of	SMC	protein	
is		not	reduced	(not	shown).	This	result	agrees	with	the	mutation	result	above	and	
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shows	that	CTCF	is	necessary	for	proper	positioning	of	Cohesin	at	its	binding	sites.
Since	previous	experiments	have	shown	that	depletion	of	CTCF,	or	the	disruption	
of	 its	DNA	binding	site	destabilize	 specific	 long-range	 interactions	 (Splinter	et	 al.,	
2006)	we	asked	the	question	what	the	contribution	of	Cohesin	is	to	range	interactions	
in	the	β-globin	locus	using	a	3C	interaction	analysis	(Splinter,	Heath	et	al.	2006).	We	
were	unfortunately	not	able	 to	 include	 the	2	newly	 identified	CTCF/	Cohesin	 sites	
(B1	and	B2)	in	this	analysis	since	they	are	surrounded	by	repetitive	DNA	sequences	
that	 prevent	 a	 proper	 primer	 design.	 We	 analyzed	 the	 known	 contacts	 within	 β-
globin	DNA	in	erythroid	cells	 lacking	CTCF	(not	shown,	Splinter,	Heath	et	al	2006)	
or	SMC3	(Cohesin)	protein.	 In	case	of	the	SMC3	Knock	Down	CTCF	is	still	bound	
to	 3’HS1	 (Figure	 2B)	 and	 hence	 any	measured	 effects	 will	 be	 exclusively	 due	 to	
Cohesin	depletion.	The	3C	relative	crosslinking	frequencies	of	the	different	interacting	
fragments	are	shown	in	Figure	2C.	All	the	data	are	corrected	for	HS2/HS3	interactions	
(Figure	2C,	upper	right),	which	are	neighboring	hypersensitive	sites	situated	in	the	
LCR	of	β-globin	locus	and	which	do	not	bind	CTCF	or	Cohesin.	Calreticulin,	a	non-
related	locus	that	is	irrelevant	for	globin	gene	expression,	behaves	the	same	in	all	the	
samples	(Figure	2C,	upper	left	panel).	Surprisingly,	without	Cohesin,	HS-85	seems	
to	lose	its	interaction	with	other	CTCF	binding	sites	both	when	tested	for	interactions	
with	3’HS1	(Figure	2C,	middle	left)	and	HS5	(Figure	2C,	middle	right).	The	remainder	
of	 the	 chromatin	 hub	 interactions	 appear	 not	 to	 be	 affected	 or	 are	 even	 slightly	
increased	their	relative	crosslinking	frequencies	as	shown	in	Figure	2C,	(bottom	left,	
3’HS1-HS5	interactions	or	bottom	right	3’HS1-HS-65).	We	conclude	that	Cohesin	is	
essential	for	long	range	interactions	at	the	shared	CTCF	sites.
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Figure	2
A	_	Western	blot	from	I/11	CTCF	and	SMC3	Knock	Down	cells.	In	the	left	panel,	2	time	points	of	3	(2	
lines)	and	5	days	are	shown.	SMC3	KD	after	5	days	is	shown	in	the	right	panel.	
B	_	Chromatin	immunoprecipitation	(Chip)	using	antibodies	against	SMC3,	CTCF	and	a	non	relevant	
Ab	(control).	Plotted	are	the	relative	enrichments	measured	for	the	3’HS1	site	in	WT	cells	and	SMC3KD	
(left)	and	CTCFKD	(right)	cells.	The	relative	enrichments	are	normalized	to	amylase.	In	all	panels	the	
standard	error	(from	2	independent	ChIP	experiments,	2	Q-PCR	each)	is	indicated.
C	_	3C	analysis	showing	crosslinking	frequencies	in	non-induced,	induced	I/11	cells	and	SMC3	KD	
cells	 (non	 induced)	between	different	CTCF	binding	sites.	The	 interactions	are	normalized	 to	HS2/
HS3	primers,	neighboring	hypersensitive	sites	in	LCR	that	do	not	bind	any	of	these	proteins.		CalR-
calreticulin	non-related	locus	that	is	irrelevant	for	globin	gene	expression
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DISCuSSIOn
The	present	study	investigated	the	role	of	Cohesin	in	long	range	interactions	in	
the	β-globin	locus.		It	was	previously	shown	that	CTCF	binds	a	number	of	sites	in	the	
mouse	β-globin	locus	and	that	CTCF	is	directly	involved	in	the	chromatin	architecture	
of	this	locus	(Splinter	et	al.,	2006).	One	of	the	CTCF	binding	sites,	3’HS1	is	also	highly	
enriched	 for	Cohesin.	Cohesin	complexes	are	 known	 to	mediate	 sister	 chromatid	
cohesion	which	is	essential	for	proper	chromosome	separation	and	post-replicative	
DNA	repair.	In	addition,	it	was	recently	suggested	to	also	regulate	gene	expression	
and	long-range	gene	interaction	through	its	enrichment	at	CTCF	binding	sites.	CTCF,	
the	prototype	vertebrate	 insulator	protein,	had	already	been	strongly	 implicated	 in	
mediating	gene	regulation,	chromatin	structure	and	organization	of	gene	loci	before	
this	discovery.	Thus	 its	 link	with	Cohesin	suggests	 that	cohesion	may	also	have	a	
gene	regulatory	function.
The	requirement	of	Cohesin	for	sister	chromatid	cohesion	after	DNA	replication	
is	well	documented,	but	a	function	of	Cohesin	in	gene	regulation	is	less	clear	even	
though	several	studies	in	yeast,	Drosophila	and	zebrafish	have	indicated	that	Cohesin	
directly	influences	transcription.	For	example,	in	Zebrafish,	a	genetic	screen	revealed	
that	embryos	lacking	Rad21,	one	of	the	Cohesin	subunits,	fail	to	develop	differentiated	
blood	cells	because	of	a	lack	of	runx3	expression	(Horsfield	et	al.,	2007).	
In	human	cells,	Cohesin	sites	are	present	in	introns	(35%),	in	intergenic	regions	
(50%)	or	in	the	regions	that	are	directly	up-stream	or	down-stream	from	the	genes	
(13%).	Compared	with	an	overall	frequency,	Cohesin	sites	are	enriched	in	the	regions	
adjacent	to	the	genes	(Wendt	et	al.,	2008),	 favoring	the	possibility	 that	 these	sites	
have	a	role	 in	gene	regulation.	Since	Cohesin	accumulates	at	CTCF-binding	sites,	
it	 is	 tempting	 to	 speculate	 that	 Cohesin	 stabilizes	 the	CTCF-mediated	 interaction	
probably	 by	 encircling	 CTCF	 formed	 loops.	 In	 our	 study,	 we	 clearly	 show	 that	
depletion	of	CTCF	or	mutation	in	a	CTCF	binding	motif	completely	abolishes	Cohesin	
association	to	common	binding	sites.	This	observation	suggests	that	CTCF	binding	
sites	are	“meeting	points”	for	those	two	factors	although	it	is	still	not	clear	what	the	
functional	relevance	of	 the	shared	sites	 is.	 It	 is	also	not	clear	what	keeps	Cohesin	
at	 CTCF	 binding	 sites	 since	 there	 are	 also	 nonshared	 sites.	 Most	 of	 the	 studies	
(including	ours)	show	that	there	is	no	direct	interaction	between	CTCF	and	Cohesin.	
If	correct,	it	suggests	other	proteins	are	involved	in	keeping	Cohesin	at	CTCF	sites	
and	their	identification	would	be	the	next	step	in	revealing	how	Cohesin	and	CTCF	
functionally	interact.	It	would	also	be	very	interesting	to	understand	why	Cohesin	is	
found	at	a	subset	of	the	CTCF	binding	sites	and	not	at	the	other	sites	despite	some	
discrepancies	among	different	studies	about	the	percentage	of	shared	binding	sites.	
What	is	so	special	about,	for	example	3’HS1	in	β-globin	locus	that	binds	Cohesin,	
compared	to	other	CTCF	binding	sites.	If	we	exclude	the	possibility	that	Cohesin	is	
found	at	this	site	only	because	of	an	experimental	set	up	(example’s.	better	cross-
linking	at	3’HS1	when	compared	to	other	sites),	there	is	a	clear	difference	in	Cohesin	
binding	to	3’HS1	compared	to,	for	example	HS5	and	HS-85.
Another	serious	obstacle	to	understanding	the	functional	relevance	of	Cohesin	
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and	CTCF	 shared	binding	 sites	 is	 the	 lack	 of	 knowledge	 about	 the	 interaction	 of	
Cohesin	with	DNA.	 The	 commonly	most	 accepted	 “ring”	model,	 proposes	 that	 a	
tripartite	 ring	 formed	 by	 SMC1,	 SMC3	 and	 SCC1/Rad21	 encircles	 two	 10-nm	
chromatin	fibers	but	is	not	contacting	the	DNA	directly	(Haering	et	al.,	2002).	Perhaps	
such	a	ring	 is	formed	during	the	transient	 interaction	of	DNA	strands	in	cis	 (CTCF	
mediated?)	and	slides	along	the	chromatin	fiber	until	is	“locked”	by	CTCF	to	stabilize	
specific	interactions.
If	we	postulate	that	Cohesin	stabilizes	CTCF	mediated	interactions,	one	would	
then	expect	that	removal	of	Cohesin	would	influence	the	conformation	of	the	locus	
by	decreasing	the	interactions	between	CTCF	sites.	In	our	3C	experiments,	Cohesin	
depletion	appears	 to	 influence	 the	 interaction	between	CTCF	binding	sites	 in	 two	
opposing	 ways.	 First	 Cohesin	 depletion	 prevents	 the	 HS-85	 site	 from	 contacting	
with	 the	 remainder	of	 the	CTCF	binding	sites.	However,	and	perhaps	surprisingly,	
3’HS1	which	is	the	actual	Cohesin	binding	site,	does	not	lose	its	contacts	but	it	even	
increases	relative	cross-linking	frequencies	with	HS5	while	that	with	HS-65	remains	
more	or	less	the	same.	It	is	important	to	note	that	Cohesin	was	still	present	(around	
30%)	in	this	experiment.	One	possible	explanation	is	that	a	decreased	concentration	
of	 Cohesin	 results	 in	 the	 selective	 loss	 of	 “weaker”	 interactions,	 i.e.	 the	 HS-85.	
Although	the	experiment	should	be	extended	into	a	more	detailed	analysis	that	also	
takes	the	novel	B1	and	B2	sites	into	account,	it	is	tempting	to	speculate	about	other	
possibilities.	For	example	other	 factors	might	stabilize	 loops	 formed	by	CTCF	and	
these	 	 compete	with	Cohesin	mediated	 interactions.	 This	would	 also	 explain	why	
when	 the	 interactions	 with	 HS-85	 are	 lost	 other	 interaction	 frequencies	 increase	
(Figure	3C).	Such	interactions	may	be	stabilized	by	factors	such	as	the	Ldb1	complex	
(Meier,	Krpic	et	al.	2006;	Song,	Hou	et	al	2007)	independent	of	Cohesin.	
It	should	also	be	noted	that	 the	newly	 found	sites	B1	and	B2	may	provide	an	
explanation	why	 in	our	previous	experiments	of	mutating	 the	3’HS1	CTCF	site	did	
not	result	in	a	change	of	gene	expression	of	the	β-globin	expression,	its	function	in	
β-gene	expression	may	be	minor	compared	to	these	novel	sites.
Finally	perhaps	the	most	interesting	conclusion	from	this	work	is	that	a	cohesion	
mediated	loop	i.e.	between	5’HS	-85	and	3’HS1,	is	formed	by	sites	where	only	one	of	
the	partner	sites	(3’HS1)	binds	Cohesin.			
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MAteRIALS AnD MetHODS
Culturing I/11 cells:
Primary	 fetal	 liver	 cells	were	 isolated	 from	p53-/-	mice	as	described	 (Splinter,	
Heath	 et	 al	 2006).	 We	 maintained	 proliferating	 I/11	 cells	 in	 (StemPro-34	 SFM,	
Invitrogen)	 containing	 0.5	 units/ml	 of	 erythropoietin,	 100	 ng/ml	 stem	 cell	 factor	
and	1mM	dexamethasone.	Proliferating	cells	were	expanded	and	kept	at	a	density	
between	1.5x106	and	3x106	cells/ml.	To	induce	differentiation,	proliferating	cells	were	
washed	 twice	with	Hank’s	balanced	 salt	 solution	and	seeded	at	 2x106	 cells/ml	 in	
differentiation	medium	containing	5	units/ml	of	erythropoietin	and	1mg/ml	transferrin	
(Sigma-Aldrich).	During	differentiation,	cells	were	kept	at	densities	of	2-6	x106	cells/ml.	
Differentiation	status	was	monitored	by	measuring	cellular	size	distribution	using	an	
electronic	cell	counter.	Differentiated	cells	were	harvested	after	72h	to	120h.	The	size	
distribution	ranged	between	7-8	mm	when	differentiated	and	9-11mm	when	not.
Chromatin Immunoprecipitation (ChIP):
ChIP	 analyses	 were	 performed	 as	 described	 in	 the	 Upstate	 protocol	 (www.
upstate.com)	except	that	cells	were	cross-linked	using	2%	formaldehyde	for	5	min	
at	room	temperature.	Real-time	PCR	quantification	of	precipitated	DNA	sequences	
(average	 fragment	 size	300bp)	was	performed	on	a	BioRad	MyIQ	machine	using	
Platinum	TaqDNA	polymerase	(Invitrogen)	and	SYBR	Green	(Sigma-Aldrich)	under	
the	following	cycling	conditions:
2	min	at	94	oC,	44	cycles	of	30s	at	94	oC,	30s	at	55		oC,	1min	at	72		oC	during	which	
measurements	were	taken,	and	79	times	30s	at	55	oC	for	melting	curves.	Enrichment	
was	calculated	relative	to	2	control	genes	(amylase	and	necdin)	and	all	values	were	
normalized	to	input	measurements.	The	ChIP	DNA	was	used	for	real-time	PCR,	ChIP-
on-Chip	analysis	and	Illumina	sequencing.
Antibodies
For	ChIP	and	Western	blot	analysis	the	following	antibodies	were	used:	CTCF	N3	
polyclonal	were	generated	as	described	(Hoogstraten	et	al.,	2002),			SMC1	(Bethyl	
A300-055A),	SMC3	(Bethyl	A300-060A),	Rad21	(Abcam	ab992).
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ChIP-on-Chip:
Probe Labeling and Microarray Hybridization
ChIP	 DNA	 was	 amplified	 and	 labeled	 according	 to	 the	 standard	 Affymetrix	
protocol	 (www.affymetrix.com/products/arrays/specific/mouse	 _tiling_2.affx).	 Ten	
micrograms	of	 labeled	products	were	hybridized	to	Affymetrix	mouse	tiling	2.0R	A	
and	C	arrays	(900897)	(Affymetrix,	Santa	Clara,	CA).	These	tiled	arrays	are	designed	
to	contain	25-bp	probes	located	at	35	nucleotide	resolution.
Affymetrix Data Analysis
The	scanned	output	files	were	analyzed	with	Tiling	Analysis	Software	version	1.1	
(Affymetrix,	Santa	Clara,	CA)	as	described	in		(Gao	et	al.,	2008).	Probes	were	mapped	
to	 mouse	 chromosomes	 according	 to	 NCBIv33	 (mm5)	 genome	 assembly.	 The	
samples	 (CTCF-non	 induced,	CTCF-induced,	SMC3-non	 induced,	SMC3-induced,	
IgG-non	induced,	IgG-induced	and	2	genomic	input	samples	from	non	induced	and	
induced	I/11	cells)	were	normalized	in	groups.	The	genomic	DNA	corresponding	to	
every	ChIP-enriched	 region	 identified	by	 tiling	 array	was	 retrieved	 from	 the	UCSC	
genome	browser	with	a	suitable	version	or	IGB	(Integrated	Genome	Browser)	from	
Affymetrix.	
ChIP DnA sample prep for Illumina sequencing
ChIP	DNA	was	prepared	for	Illumina	massive	parallel	sequencing	according	to	the	
Illumina	ChipSeq	protocol	(www.illumina.com).	In	brief,	10	ng	of	ChIP	DNA	was	end	
repaired	and	purified	with	a	QiaQuick	PCR	purification	kit	(Qiagen).	An	A	base	was	
added	to	the	3’	end	of	the	end	repaired	DNA	fragments	and	the	A-tailed	fragments	
were	purified	once	using	a	MinElute	PCR	purification	Kit	 (Qiagen)	 in	 10	ul	 of	EB.	
Illumina	provided	single	read	adaptors	were	ligated	to	the	end	of	the	DNA	fragments	
followed	by	a	MinElute	PCR	purification	(Qiagen).	Ligation	products	were	run	on	a	
2%	agarosegel	and	200	bp	(+/-	35	bp)	fragments	were	isolated	from	gel	by	the	GEL	
extraction	Kit	(Qiagen)	and	eluted	in	36	ul	EB.	The	size-selected	fragments	were	PCR	
amplified	by	Phusion	polymerase	and	subjected	to	the	following	conditions:	98	°C	
for	30	sec,	(98	°C	for	10	sec,	65	°C	for	30	sec	and	72	°C	for	30	sec)	for	18	cycles,	
and	72	°C	for	5	min.	PCR	fragments	were	purified	using	by	MinElute	PCR	purification	
Kit	 in	 15	ul	EB	 (Qiagen).	One	microliter	of	 each	sample	 library	was	quantified	on	
Bioanalyzer	(Agilent	Technologies)	using	a	DNA1000	assay.	A	10	nM	DNA	stock	in	
EB	was	prepared	for	each	sample.	
Cluster	generation	was	performed	according	 to	 the	 Illumina	Cluster	Reagents	
preparation	protocol	(www.illumina.com).	In	brief,	1ul	of	the	stock	was	denatured	with	
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NaOH,	diluted	to	3	pM	and	hybridized	onto	the	flowcell.	The	hybridized	fragments	
are	sequentially	amplified,	linearized	and	end-blocked	according	to	the	Single	read	
Sequencing	 user	 guide	 protocol	 (www.illumina.com).	 Sequencing	 reagents	 were	
prepared	 as	 described	 in	 the	Genome	Analyzer	 reagents	 protocol	 (www.illumina.
com).	After	hybridization	of	the	seq-primer	sequencing	by	synthesis	was	performed	
using	 the	Genome	Analyzer	 and	a	36-cycle	protocol	 according	 to	manufacturer’s	
instructions.	Images	are	analyzed	by	the	Illumina	GAP	pipeline.	
The	 raw	 data	 from	 the	 Illumina	 Genome	 Analyzer	 was	 processed	 using	 a	
combination	 of	 the	 IPAR	 (Integrated	 Primary	 Analysis	 Reporting	 Software)	 using	
version	1.0	of	the	GAP	(Genome	Analyzer	Pipeline),	Inc.			The	resultant	sequences	
were	 mapped	 against	 NCBI	 build	 37.1	 of	 the	 mouse	 genome	 using	 the	 ELAND	
alignment	software	(Anthony	J.	Cox,	Illumina	Inc.,	unpublished	work).
	
Chromosome Conformation Capture (3C)
3C	was	carried	out	as	described	(Tolhuis	et	al.,	2002).	Shortly,	formaldehyde	cross-
linked	chromatin	 from	non-induced,	 induced,	CTCF	depleted	and	SMC3	depleted	
cells	was	digested	with	HindIII	restriction	enzyme	overnight,	followed	by	ligation	with	
T4	DNA	 ligase	at	 16	 0C	 for	 4hr.	After	 reversing	 the	crosslinks,	genomic	DNA	was	
purified	by	phenol	extraction	and	ethanol	precipitation.	For	PCR	analysis,	the	linear	
range	of	amplification	was	for	the	samples	by	serial	dilution.	An	appropriate	of	DNA	
within	 the	 linear	 range	was	subsequently	used	 for	 the	experiments.	PCR	products	
were	run	on	2%	agarose	gels	and	quantified	on	a	Typhoon	imager.	All	data	points	
were	generated	from	an	average	of	3	different	experiments	performed	in	duplo.		
Lentivirus-Mediated CtCF and SMC3 RnA interference
Lentiviral	hairpin	RNA	 interference	plasmids	 (pLK0.1-CTCF	TRCN0000039019,	
pLK0.1-SMC3	TRCN00001090	05)	were	obtained	from	The	RNAi	Consortium	(Mission	
Sigma	Aldrich).	The	sequence	of	short	hairpin	RNA	targeting	the	mouse	CTCF	gene	
(GenBank	 accession	 no.	 NM_007794.1,	 NM_181322.2)	 was	
	5’CCGGGCAGAGAAAGTAGTTGGTAATCTCGAGATTACCAACTACTTTCTCTGCTTTTTG	3’
in	CDS	 region	 and	 SMC3	 gene	 (GenBank	 accession	 no.	NM_007790.2)	 was	
5’CCGGCCCTGTAATGTTACATTTCTACTCGAGTAGAAATGTAACATTACAGGGTTTTTG	3’			
in	3’UTR	region.				
Each	of	 these	vectors	had	been	sequence-verified.	Vectors	were	expanded	 in	
E.coli	and	purified.	Lentivirus	was	produced	by	transient	transfection	of	293T	cells	
according	to	standard	protocols	(Zufferey	et	al.,	1997).	293T	cells	were	transfected	
with	a	3:1:4		mixture	of	psPAX-2,	pMD2G-VSVG	and	a	transfer	vector	construct	using	
poly	(ethylenimine)(PEI).	After	24	hours	medium	was	refreshed	and	virus-containing	
medium	was	harvested	48h	and	72hr	after	transfection.	After	filtering,	the	virus	stock	
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was	concentrated	1000	times	Virus	activity/functionality	was	tested	by	serial	dilutions	
on	 I/11	 cells	 by	Western	 blot.	 GFP	 control	 construct	 was	 used	 for	 measuring	 of	
transduction	efficiency.	Transduced	cells	were	selected	with	puromycin	and	harvested	
every	day	for	WB	analysis,	and	4	and	5	day	for	additional	Chip	analysis	and	3C.
Primer sequences used for ChIP
(547)	HS-85-f:	GAGACTAAGTAATTCACCATGGG
(562)	HS-85-r:	GGATCTATCTTGATTGTCCTCC
(525)	HS-62-f:	GCACATGCCGTAGTTCTC
(526)	HS-62-r:	TCTGGAGTTCTCAGTTGTATGAC
(805)	HS5-f:		AACTAGAGAAAAAGAATGAGGCGTTT
(804)	HS5-r:		CTGGAGAATCCACACACCTAGGT
(529)	3’HS1-f:	AATCAGTGGAACACTTCTGC
(530)	3’HS1-r:	GTCTCAGGTTGTCAACTAAAGC
(654)	necdin-f:	GGTCCTGCTCTGATCCGAAG
(655)	necdin-r:	GGGTCGCTCAGGTCCTTACTT	
(99)	amylase-f:	CTCCTTGTACGGGTTGGT
(100)	amylase-r:	AATGATGTGCACAGCTGAA
B1-f:	CAGATGCTCTCTTGGGAAC
B1-r:	CCTGGGCAATATGATCGTG
B2-f:	AACTCTGGGAAACTCTGCC
B2-r:	GCTCTGAGGCATGTTCTC
Allele-specific primers at 3’HS1
1:(766)	3’HS1-f;	AGAGGAGGGCGGAAATCAGT
2:(530)	3’HS1-r:GTCTCAGGTTGTCAACTAAAGC	
3:(765)	3’HS1	mut-f:	GGAGGAGGGCGGAAATCAGC	
4:	(642)	3’HS1	mut-r:	GTCTCAGGTTGTCAA	CTAAACG
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Critical Role for the Transcription Regulator CCCTC-Binding
Factor in the Control of Th2 Cytokine Expression1
Claudia Ribeiro de Almeida,2*† Helen Heath,2‡ Sanja Krpic,‡ Gemma M. Dingjan,*
Jan Piet van Hamburg,* Ingrid Bergen,† Suzanne van de Nobelen,‡ Frank Sleutels,‡
Frank Grosveld,‡ Niels Galjart,3‡ and Rudi W. Hendriks3†
Differentiation of naive CD4� cells into Th2 cells is accompanied by chromatin remodeling at the Th2 cytokine locus allowing the
expression of the IL-4, IL-5, and IL-13 genes. In this report, we investigated the role in Th2 differentiation of the transcription
regulator CCCTC-binding factor (CTCF). Chromatin immunoprecipitation analysis revealed multiple CTCF binding sites in the
Th2 cytokine locus. Conditional deletion of the Ctcf gene in double-positive thymocytes allowed development of peripheral T cells,
but their activation and proliferation upon anti-CD3/anti-CD28 stimulation in vitro was severely impaired. Nevertheless, when
TCR signaling was circumvented with phorbol ester and ionomycin, we observed proliferation of CTCF-deficient T cells, enabling
the analysis of Th2 differentiation in vitro. We found that in CTCF-deficient Th2 polarization cultures, transcription of IL-4, IL-5,
and IL-13 was strongly reduced. By contrast, CTCF deficiency had a moderate effect on IFN-� production in Th1 cultures and
IL-17 production in Th17 cultures was unaffected. Consistent with a Th2 cytokine defect, CTCF-deficient mice had very low levels
of IgG1 and IgE in their serum, but IgG2c was close to normal. In CTCF-deficient Th2 cultures, cells were polarized toward the
Th2 lineage, as substantiated by induction of the key transcriptional regulators GATA3 and special AT-rich binding protein 1
(SATB1) and down-regulation of T-bet. Also, STAT4 expression was low, indicating that in the absence of CTCF, GATA3 still
operated as a negative regulator of STAT4. Taken together, these findings show that CTCF is essential for GATA3- and SATB1-
dependent regulation of Th2 cytokine gene expression. The Journal of Immunology, 2009, 182: 999–1010.
P rotection against pathogens relies on the ability of T cellsto give rise to various effector cell fates upon activation.Classically, naive CD4� T cells are thought to undergo
programmed differentiation into mainly two functionally distinct
subsets, termed Th1 and Th2 (for review, see: Refs. 1 and 2). Th1
cells, which produce IFN-�, are predominantly involved in cellular
immunity against intracellular pathogens. Two major signaling
pathways facilitate Th1 development, one involving IL-12/STAT4
and the other involving IFN-�/STAT1/T-bet (3–5). Th2 cells, pro-
ducing IL-4, IL-5, and IL-13, mediate humoral immunity and are
essential for the eradication of parasitic worms, but also mediate
allergic responses. Th2 cytokine production is dependent on the
transcription factor GATA3, which is rapidly induced by IL-4
through STAT6 (6–10). Recently, a distinct effector T cell subset
has been described, termed Th17. These cells produce IL-17 and
control a wide range of infections at mucosal surfaces and are
implicated in the pathogenesis of several autoimmune diseases first
thought to be caused by deregulated Th1 function (reviewed in
Ref. 2). In mice, both TGF-� and IL-6 are required to drive Th17
differentiation through activation of the orphan nuclear receptors
ROR�t and ROR� (11, 12). Differentiation of pathogenic Th17
cells is developmentally related to anti-inflammatory Foxp3� reg-
ulatory T (Treg)4 cells, which can be generated in vitro by stim-
ulation with TGF-� in the absence of IL-6 (13).
Subset-specific expression of cytokine genes in T cells involves
unique transcriptional, epigenetic, and structural mechanisms.
When naive T cells are stimulated with Ag, they show low tran-
scription of both IFN-� and Th2 cytokines (14, 15). Th2 cytokine
gene promoters and the Th2 locus control region come into close
spatial proximity to form a higher-order chromatin structure, sug-
gesting that early expression of the Th2 cytokines in naive T cells
is supported by an initial “poised” chromatin configuration (16).
Upon Th2 differentiation, a substantial increase in the transcrip-
tional activity of IL-4, IL-5, and IL-13 and concomitant silencing
of IFN-� are observed. The converse pattern of gene activation and
silencing is present in differentiating Th1 cells. Such polarized
patterns of cytokine gene expression are achieved through the ac-
tivation of cell type-specific transcription factors and chromatin
remodeling proteins which bind to cis-regulatory elements of cy-
tokine genes, thus initiating substantial and reciprocal alterations
in the chromatin structure of the IFN-� and Th2 cytokine loci
(reviewed in Refs. 17 and 18). Indeed, both STAT6 and GATA3
are responsible for the establishment and/or maintenance of the
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chromatin conformation changes in the Th2 cytokine locus of de-
veloping Th2 cells (16, 19). Particularly, because GATA3 can in-
duce chromatin-remodeling activity (20), it may facilitate the in-
teraction between the Th2 locus control region and the cytokine
gene promoters and thereby coregulate IL-4, IL-5. and IL-13 ex-
pression. In addition, Th2 cytokine expression requires special
AT-rich binding protein 1 (SATB1), which mediates the formation
of a densely looped, transcriptionally active chromatin structure at
the Th2 locus containing GATA3, STAT6, c-Maf, the chromatin-
remodeling enzyme Brg1, and RNA polymerase II (21).
The 11-zinc finger protein CCCTC-binding factor (CTCF) is a
ubiquitously expressed and highly conserved transcriptional regu-
lator implicated in many key processes within the nucleus, includ-
ing promoter activation and repression, hormone-responsive gene
silencing, and genomic imprinting (for review, see Ref. 22). CTCF
often binds in the vicinity of insulators, elements that affect gene
expression by preventing the spread of heterochromatin (acting as
“barrier”) and inhibiting inappropriate interactions between regu-
latory elements on adjacent chromatin domains (acting as “en-
hancer blocker”) (23). It has been shown that CTCF is required for
the enhancer-blocking activity of insulators (24). Consistent with a
role for CTCF as an insulator protein, we have shown that in the
mouse �-globin locus, CTCF mediates long-range chromatin loop-
ing and regulates local histone modifications (25). However,
CTCF binding is not always required for chromatin insulation (26,
27). Combined, these data establish CTCF as an important protein
involved in long-range DNA interactions and the regulation of
active and repressive chromatin marks.
Genome-wide mapping of CTCF binding sites (CBS) in the hu-
man genome identified �14,000 sites, whose distribution corre-
lated with genes but not with transcriptional start sites (28, 29).
Domains with few or no CTCF sites tend to include clusters of
transcriptionally coregulated genes, whereby these regions are of-
ten flanked by CTCF binding sites (28, 30). The genome-wide
analyses also revealed CTCF binding sites near genes displaying
extensive alternative promoter usage, including protocadherin �,
the Ig � L chain, and the TCR �/�- and �-chain loci. In mice,
CTCF binding was observed downstream of the TCR �/� and the
Ig H chain loci (31, 32). Very recently, CTCF was found to control
MHC class II gene expression and long-range chromatin interac-
tions between MHC class II promoter regions (33). These data
imply an important role for CTCF in lymphocytes, in particular in
the regulation of gene transcription in complex loci. We have re-
cently found that conditional inactivation of Ctcf early in thymo-
cyte development resulted in a severe arrest of early T cell devel-
opment (34). Our findings indicated that CTCF regulates cell cycle
progression of �� T cells in the thymus (34).
In this report, we investigated whether CTCF is important for
Th2 cytokine expression. Chromatin immunoprecipitation (ChIP)
assays revealed the presence of multiple CTCF binding sites in the
Th2 cytokine locus. We show that conditional deletion of the Ctcf
gene in the thymus, using CD4-Cre mice, allowed the generation
of peripheral T cells, albeit with reduced numbers. In vitro polar-
ization cultures of CTCF-deficient CD4� T cells revealed a Th2
cytokine expression defect, despite normal induction of the tran-
scription factors GATA3 and SATB1.
Materials and Methods
Mice
T cell-specific deletion of Ctcf was achieved by breeding Ctcff/f mice (34),
which were crossed on the C57BL/6 background for �10 generations to
CD4-Cre mice (35), which were provided by Dr. C. Wilson (University of
Washington, Seattle, WA). OT-II-transgenic mice have been described pre-
viously (36). Mice were genotyped by Southern blotting or by PCR using
Cre-specific primers. Mice were bred and maintained in the Erasmus MC
animal care facility under specific pathogen-free conditions and analyzed at
6–10 wk of age. Experimental procedures were reviewed and approved by
the Erasmus University committee of animal experiments.
RNA and protein analyses
Total RNA was extracted using the GeneElute mammalian total RNA
miniprep system (Sigma-Aldrich). Primers spanning at least one intron-
exon junction were designed either manually or using the ProbeFinder
software (Roche Applied Science). Probes were chosen from the universal
probe library (Roche Applied Science) or designed manually (GATA3,
Gapdh) and purchased from Eurogentec. Quantitative real-time PCR was
performed using an Applied Biosystems Prism 7700 sequence detection
system. To confirm the specificity of the amplified products, samples were
separated by standard agarose gel electrophoresis. Threshold levels were
set and further analysis was performed using the SDS version 1.9 software
(Applied Biosystems). Obtained cycle threshold values were normalized to
cycle threshold values of Gapdh or �-actin. Each PCR was performed at
least in triplicate. Primer sequences and PCR conditions used are available
on request.
Nuclear extracts were prepared and analyzed by Western blot (37). Abs
specific for CTCF (N3) and fibrillarin have been previously described (34).
Alternatively, anti-CTCF antiserum was purchased from Millipore. Anti-
DNMT1 was from Abcam and anti-UBF, anti-SATB1, and anti-fibrillarin
were from Santa Cruz Biotechnology. Primary Ab incubation was done
overnight at 4°C in TBS containing 5% (w/v) BSA and 0.15% (v/v) Non-
idet P-40. Blots were incubated with secondary goat anti-rabbit or mouse
Abs coupled to HRP (GE Healthcare). Signal detection was performed
using ECL (Amersham Biosciences). Western blots were scanned and
quantified using the gel macro function in ImageJ (W. S. Rasband, National
Institutes of Health, Bethesda, MD; http://rsb.info.nih.gov/ij/).
ChIP assay
ChIP followed by ultrahigh-throughput DNA sequencing on I11 erythroid
cells was performed using a Solexa 1G Genome Analyser (38). ChIP anal-
ysis of CTCF binding in the Th2 cytokine locus was performed as de-
scribed in the ChIP Assay Kit protocol (Upstate Biotechnology) using the
anti-CTCF Abs listed above or IgG as control. Quantitative real-time PCR
(Bio-Rad IQ5) on immunoprecipitated DNA was performed using SYBR
Green (Sigma-Aldrich) and Platinum Taq DNA Polymerase (Invitrogen).
Enrichment was calculated relative to Necdin and values were normalized
to input measurements. The sequences of the primers used were as follows:
CBS-1F, 5�-GGTCTTAGCAGGTTCCCAA-3�; CBS-1R, 5�-CGTTCGG
TAAGACAAGCAC-3�; CBS-2F, 5�-CACTCAGCACCTTACCTG-3�;
CBS-2R, 5�-CCTGGGCTAAATGAATCAGT-3�; CBS-3F, 5�-AGGCA
CAGTGTAGAAGTGT-3�; CBS-3R, 5�-GTCTCTCTTCCAGTCCAGTT-
3�; CBS-4F, 5�-GGCACTTGTAACGCTCTAA-3�; CBS-4R, 5�-CCCTG
ACCAACATCTCCAA-3�; CBS-5F, 5�-ATTGTGGAGGCTGGCAAG-
3�; CBS-5R, 5�-GGTGACAGCCCAAATAAGT-3�; CBS-6F, 5�-CCA
CATCCACCTGTCACTT-3�; CBS-6R, 5�-CTGTTTCACATCCATC
GCA-3�; CBS-7F, 5�-CAGGCTTGTATCATCACCA-3�; and CBS-7R,
5�-TTCTTGAGGGACAGCACT-3�.
Flow cytometric analyses
Preparation of single-cell suspensions and mAb incubations for four-color
cytometry has been previously described (39). All mAbs were purchased
from BD Biosciences except for PE-conjugated anti-granzyme B (GB12;
Caltag Laboratories), anti-GATA3 (Hg-3-31; Santa Cruz Biotechnology),
allophycocyanin-conjugated anti-Foxp3 (FJK-16s; eBioscience), biotinyl-
ated anti-IL-13 (R&D Systems), and allophycocyanin-conjugated IL-10
(JES5-16E3; eBioscience).
For intracellular detection of cytokines, cells were restimulated with
plate-bound anti-CD3 (10 �g/ml in PBS; 145-2C11) or PMA (50 ng/ml;
Sigma-Aldrich) plus ionomycin (500 ng/ml; Sigma-Aldrich) in the pres-
ence of GolgiStop (BD Pharmingen) for 4 h. Cells were harvested and
stained extracellularly, followed by standard intracellular staining using
paraformaldehyde and saponin. Foxp3 expression was evaluated by intra-
cellular staining using a Foxp3 buffer set (eBioscience).
Cell cycle status of T cell cultures was determined after fixing in ice-
cold ethanol and subsequent staining in PBS containing 0.02 mg/ml pro-
pidium iodide, 0.1% v/v Triton X-100, and 0.2 mg/ml RNase. Doublet cells
were excluded by measuring peak area and width. CFSE labeling of cells
was performed as described elsewhere (40).
Samples were acquired on a FACSCalibur or FACS LSRII flow cytom-
eter and analyzed using CellQuest (BD Biosciences) or FlowJo (Tree Star)
research software.
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In vitro T cell cultures
For in vitro T cell stimulations and Th1/Th2 polarization cultures, naive
CD62L�CD4� or CD8� T cells were purified by cell sorting using a
FACSVantage VE equipped with Diva Option and BD FACSDiva soft-
ware (BD Biosciences). The purity of obtained fractions was �98%.
For ChIP experiments, CD4� T cells from C57BL/6 mice were obtained
through incubation with biotinylated mAbs (BD Pharmingen) specific for
CD11b (M1/70), Gr-1 (RB6-8C5), Ter119 (Ly-76), TCR�� (GL3), B220
(RA3-6B2), NK1.1 (PK136), and CD8 (53-6.7), followed by streptavidin-
conjugated microbeads and autoMACS purification according to the man-
ufacturer’s instruction (Miltenyi Biotec). The purity of CD4� T cell frac-
tions was confirmed by FACS to be �95%.
T cell fractions were cultured at a concentration of 1 � 106 cells/ml in
IMDM (BioWhittaker) containing 10% heat-inactivated FCS, 5 � 10�5 M
2-ME, 100 U/ml penicillin, and 100 �g/ml streptomycin. Stimulation was
with plate-bound anti-CD3 (145-2C11) and anti-CD28 (37.51) mAbs
(coated at 10 �g/ml each at 4oC overnight) or PMA (50 ng/ml) plus iono-
mycin (300 ng/ml). For Th1-polarizing conditions, anti-IL-4 (10 �g/ml;
11B11) and IL-12 (10 ng/ml) were added to the medium. Th2-polarizing
cultures included anti-IFN-� (5 �g/ml; R4-6A2,), anti-IL-12 (5 �g/ml;
C17.8), and IL-4 (10 ng/ml). Treg- and Th17-polarizing conditions in-
cluded TGF-� (3 ng/ml), anti-IL-4, and anti IFN-�. Th17-polarizing con-
ditions additionally contained IL-6 (20 ng/ml). For Th0 conditions, no
cytokines or mAbs were added. For differentiation of CD8� effector T
cells, only rIL-2 (5 ng/ml) was added to the medium. For Th0, Th1, and
Th2 cultures, cells were supplemented with IL-2 (5 ng/ml) on day 3 after
activation and expanded up to day 7 under the same cytokine conditions as
the primary cultures. In Th17 cultures, cells were restimulated with PMA
plus ionomycin at day 3, supplemented with TGF-� and IL-6 and expanded
up to day 5. All cytokines were from R&D Systems.
Stimulation of OT-II-transgenic CD4� T cells was conducted in the
presence of bone marrow-derived dendritic cells (BM-DC). Briefly, BM
single-cell suspensions were prepared from C57BL/6 femurs and seeded at
2 � 106 per petri dish in complete IMDM and 200 ng/ml murine GM-CSF
(BioSource International). On days 3 and 6, 200 ng/ml murine GM-CSF
was added in 10 ml of fresh IMDM. On day 8, the nonadherent cells
consisting of immature and mature BM-DC were harvested. For in vitro T
cell proliferation studies, 0.2 � 106 CFSE-labeled OT-II-transgenic naive
CD4� T cells were cocultured with 0.2 � 106 BM-DC previously pulsed
with OVA peptide323–339 (50 �g/ml) in complete IMDM. At day 4, cul-
tured T cells were harvested for proliferation analysis.
ELISA
In vitro-polarized Th2 cells were harvested after 7 days in culture and
washed twice with culture medium. Cells were resuspended (1.5 � 106
cells/ml) in fresh culture medium containing PMA (50 ng/ml) plus iono-
mycin (300 ng/ml). Three days later, supernatants were harvested and an-
alyzed for the presence of cytokines using eBioscience (IL-4 and IL-5) and
R&D (IL-13) ELISA systems.
Total serum Ig levels were determined by subclass-specific sandwich
ELISA, as described; IgE was induced by i.p. injection of 10 �g of 2,4,6-
trinitrophenyl-keyhole limpet hemocyanin (TNP-KLH) precipitated on
alum (41).
Statistical evaluations
All statistical evaluations were done with Student’s t test.
Results
CTCF binding sites in the Th2 cytokine locus
CTCF binding sites in the human Th2 locus have recently been
identified in CD4� T cells (30). Taking into account that CTCF
binding sites are largely invariant between cell types (28), we first
used ChIP coupled to ultrahigh-throughput DNA sequencing data
obtained in mouse I11 erythroid cells (S. Krpic and F. Grosveld,
manuscript in preparation) to gain insight into CTCF binding in the
murine Th2 cytokine locus. We identified four CTCF binding sites
(CBS-1, CBS-3, CBS-6, and CBS-7) encompassing the 200-kb
region containing the Il5, Rad50, Il13, Il4, and Kif3a genes (Fig.
1A). These sites, as well as three other CTCF binding sites (CBS-2,
CBS-4, and CBS-5), have been reported to be occupied in mouse
embryonic stem cells (42). We subsequently analyzed CTCF-bind-
ing to CBS-1 to CBS-7 in cultured Th1 and Th2 cells by ChIP. For
these experiments, MACS-purified CD4� T cells from spleen and
lymph nodes were stimulated with anti-CD3/CD28 under Th1-po-
larizing conditions (with IL-12 and anti-IL-4 Abs) or Th2-polar-
izing conditions (with IL-4, anti-IL-12, and anti-IFN-� Abs) for 7
days. Quantitative real-time PCR analyses showed that CTCF
binding to CBS-1, CBS-3, CBS-6, and CBS-7 was significantly
increased when compared with IgG control, both in Th1- and Th2-
polarized cells (Fig. 1B). A similar enrichment at these sites was
also found in PMA/ionomycin- activated Th1- and Th2-polarized
cells (data not shown). Thus, the Il-4, Il-5, and Il-13 genes in the
Th2 locus are flanked by CBS-6 and CBS-7 upstream of the Il-5
gene and CBS-1 downstream of the Il-4 gene, within the Kif3a
gene. Interestingly, CBS-3 is located in the intergenic region be-
tween the Il-13 and Il-4 genes, close to a conserved noncoding
sequence, designated CNS-1, which has been shown to be critical
FIGURE 1. CTCF binding sites in the
murine Th2 cytokine locus. A, Schematic
representation of the Th2 cytokine locus and
CTCF binding sites (CBS-1 to CBS-7). CBS
were identified by a bioinformatics approach
in combination with ChIP assays. B, ChIP
analysis in Th1 and Th2 cells. Analysis was
performed with CTCF (f) or IgG (�) Abs
in 7-day polarized Th1 or Th2 cells. Mean
values and SD are given for two ChIP ex-
periments; �, p � 0.05 and ��, p � 0.01.
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for GATA3 binding and Th2 cytokine expression (43, 44). Our
data indicate that the CTCF protein binds to CBS-1, CBS-3,
CBS-6, and CBS-7, irrespectively, of Th1 or Th2 polarization.
Conditional deletion of the Ctcf gene in T lymphocytes
To study CTCF function in vivo, we generated a conditional Ctcf
allele (Ctcff) by inserting a loxP site upstream of exon 3 and a loxP
site along with a lacZ reporter downstream of exon 12 (Fig. 2A)
(34). We bred Ctcff/f mice to mice carrying a Cre-encoding trans-
gene under the control of the CD4 promoter (35). Southern blotting
showed almost complete deletion of the Ctcf gene in the thymus of
CD4-Cre Ctcff/f mice, whereas in the spleen Ctcf deletion was only
partial, reflecting the presence of many non-T lineage cells (Fig.
2B). To evaluate the onset of Ctcff gene deletion, we analyzed
thymocyte subpopulations for expression of the Ctcf-lacZ fusion
transcript, using fluorescein-di-�-D-galactopyranoside as a substrate
FIGURE 2. Conditional targeting of the mouse Ctcf gene. A, Simplified map of the WT murine Ctcf locus and modified alleles. Top line, WT Ctcf allele,
with exons shown as solid boxes, and position of HindIII sites (H) and the Southern blot probe (arrow) indicated. Middle line, Floxed Ctcf allele (Ctcff).
Two targeting cassettes were inserted into the Ctcf gene via consecutive rounds of homologous recombination. The first cassette contained LoxP sites (Œ)
flanking a PMC1-driven neomycin resistance gene (neor), the second cassette contained LoxP sites flanking a PGK-driven puromycin resistance gene
(puror), followed by a splice acceptor-lacZ cassette (SA-LacZ). Bottom line, deleted Ctcf gene (Ctcf�) generated after complete Cre-mediated recombination
at the outermost loxP sites. For details on constructs and targeting, see Heath et al. (34). The small horizontal lines underneath each allele represent HindIII
fragments recognized by the probe in the Southern blot analysis of B below. B, Southern blot analysis of CD4-Cre recombinase activity. HindIII-digested
genomic DNA from thymus and spleen of mice of the indicated genotypes was analyzed by hybridization with a CTCF locus-specific probe (see
A). The positions of the WT, Ctcff/f (flox), and Ctcf�/� (del) alleles are indicated (asterisk indicates a polymorphic WT allele from the FVB
background). C, Western blot analysis of sorted naive CD62L�CD4� and CD8� T cell fractions from nontransgenic (�) or CD4-Cre-transgenic (�)
Ctcff/f mice were analyzed for CTCF. DNMT1 and UBF were used as loading controls. D, Flow cytometric analysis of lacZ expression in CTCF
conditionally deleted mice. LacZ expression was analyzed in conjunction with cell surface markers. The indicated cell populations were gated and
lacZ expression data are displayed as histogram overlays of CD4-Cre Ctcff/f mice (green) on top of the background signals in WT mice (black). ISP,
Immature SP.
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in conjunction with cell surface markers. Consistent with the re-
ported CD4-Cre activity at the double-negative (DN) stage (45),
Ctcf deletion was initiated in DN cells (DN2 to DN4) and com-
pleted from the immature single-positive (ISP) cell stage onward
(Fig. 2D). Despite efficient deletion of the Ctcf gene in the thymus,
residual CTCF protein was still detectable in purified fractions of
peripheral naive CD62L�CD4� and CD8� T cells (�25% of con-
trol; Fig. 2C), indicating that CTCF is a remarkably stable protein
in resting naive T cells.
To examine the effects of Ctcf deletion on T cell development,
thymocyte subpopulations from 6- to 8-wk-old CD4-Cre Ctcff/f
mice and wild-type (WT) littermates were analyzed by flow cy-
tometry. CD4-Cre Ctcff/f mice displayed low thymic cellularity,
with reduced numbers of double-positive (DP), CD4, and CD8
single-positive (SP) cells, when compared with WT controls (Fig.
3, A and B). The CD4�CD8� thymocyte fraction had a relative
increase of CD3lowCD69low ISP cells and a decrease of
CD3�CD8� SP cells. Consistent with impaired thymic SP cell
production, the numbers of mature CD4� and CD8� T cells in
spleen and lymph nodes of CD4-Cre Ctcff/f mice were signifi-
cantly reduced (Fig. 3, A and C, and data not shown). Further-
more, the numbers of �� T cells in the spleens of CD4-Cre
Ctcff/f mice were increased (Fig. 3C).
In summary, in CD4-Cre Ctcff/f mice, �� T cell development is
partially arrested at the DP stage, resulting in a significant reduc-
tion of the numbers of peripheral CD4� and CD8� T cells.
Defective TCR/CD3-mediated proliferation of CTCF-deficient
CD4� and CD8� T cells
To investigate cellular activation of CTCF-deficient T cells, we
performed in vitro stimulation experiments with highly purified
naive CD62L�CD4� and CD8� peripheral T cells. We evaluated
their ability to go through sequential cell divisions by CFSE la-
beling and observed severely reduced proliferation of anti-CD3/
CD28-activated CTCF-deficient CD4� T cells at day 3 (Fig. 4A).
Proliferation was not only defective when standard conditions of
10 �g/ml anti-CD3/anti-CD28 were used, but also when we in-
creased either of the two (or both) Ab concentrations to 50 �g/ml
(data not shown). Next, the capacity of CTCF-deficient CD4� T
cells to proliferate upon a more physiological, Ag-specific stimu-
lation was investigated by crossing CD4-Cre-Ctcff/f mice with OT-
II-transgenic mice, which harbor a TCR specific for OVA peptide.
Upon activation by OVA peptide323–339-pulsed APC, survival of
nondividing (WT and CTCF-deficient OT-II-transgenic CD4� T
cells was similar, but we noticed a severe proliferation defect in the
absence of CTCF (Fig. 4A). Although anti-CD3/CD28-activated
FIGURE 3. Defective TCR�� lineage development in CTCF-deficient mice. A, Flow cytometric analyses of the indicated cell populations in thymus
or spleen fromWT and CD4-Cre Ctcff/f mice. Expression profiles of surface markers are shown as dot plots and the percentages of cells within the quadrants
or gates are given. B and C, Absolute numbers of the indicated thymic and splenic T cell subpopulations. Each symbol represents one individual animal
and lines indicate average values. Values of p of significant differences between WT and CD4-Cre Ctcff/f mice are indicated.
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CTCF-deficient CD8� T cells were able to undergo cell division,
they lagged behind WT cells by approximately one cell cycle, and
cell recovery was reduced when compared with WT CD8� T cells
(Fig. 4A).
PMA bypasses proximal TCR signaling events and directly acti-
vates protein kinase C signaling (46). Under conditions where PMA
was added as a costimulatory signal with anti-CD3, CTCF-deficient
cells showed defective proliferation. However, when T cells were
stimulated by PMA and the calcium ionophore ionomycin (which
raises the intracellular level of Ca2�), we observed significant prolif-
eration of CTCF-deficient CD4� and CD8� T cells (Fig. 4A).
Consistent with limited cell division observed in the CFSE ex-
periments, anti-CD3/CD28-stimulated CTCF-deficient CD4� T
cell cultures showed diminished cell recovery and an almost com-
plete lack of cells in the S-G2-M phase of the cell cycle (Fig. 4B).
Although CTCF-deficient PMA/ionomycin-stimulated CD4� or
CD8� T cell cultures exhibited lower expansion rates, their cell
cycle profiles at day 3 were similar to those from WT cells (Fig.
4B). In vitro proliferation of CD4-Cre Ctcff/f T cells did not reflect
a specific expansion of rare cells that have escaped CTCF deletion,
as CTCF protein levels were severely reduced both in CD8� (Fig.
4C) and in CD4� T cell cultures (see Fig. 9C).
Taken together, these findings demonstrate that conditional de-
letion of the Ctcf gene in DP thymocytes allows development of
peripheral T cells, but their activation and proliferation upon anti-
CD3/anti-CD28 stimulation in vitro is severely impaired. Never-
theless, when TCR signaling is circumvented with phorbol ester
and ionomycin, CTCF-deficient T cells have the capacity to pro-
liferate, indicating that in this context loss of CTCF can be com-
pensated for by signaling molecules or nuclear factors induced by
PMA/ionomycin. These results therefore indicate that CTCF is not
absolutely required for cell proliferation.
Defective TCR/CD3-mediated activation of CTCF-deficient
CD4� and CD8� T cells
Next, we investigated whether defective proliferation of CTCF-
deficient T cells was caused by impaired cellular activation.
Binding of IL-2 to its receptor is a critical event in the initiation
of T cell proliferation, since it regulates transition of the cell
cycle from G1 into S phase (47). Therefore, we investigated
FIGURE 4. Impaired anti-CD3�-medi-
ated proliferation of CTCF-deficient T
cells. A, CFSE profiles of T cell cultures
of sorted CD62L�CD4� and CD8� T
cell populations fromWT mice (gray his-
tograms) in comparison to cultures from
CD4-Cre Ctcff/f mice (black line). Cells
were activated by the indicated stimuli
and cultured for 3 days (or 4 days for
OT-II CD4 T cells). Dotted lines indicate
the fluorescence intensity of unstimu-
lated cells. B, Cellular expansion in
3-day cultures upon anti-CD3/CD28 or
PMA/ionomycin stimulation (upper
part). Symbols represent the expansion
values of cultures from individual mice,
whereby cell numbers at the start of the
culture were set to one; lines indicate av-
erage values. Values of p of significant
differences between WT and CD4-Cre
Ctcff/f mice are indicated; n.s., not signif-
icant. The lower part shows the cell cycle
status of the indicated cultures, whereby
DNA content was examined by pro-
pidium iodide (PI) staining. The percent-
ages of cycling cells (S-G2-M phase) are
shown. C, Western blotting analysis of
naive CD62L�CD8� T cells from WT or
CD4-Cre-transgenic Ctcff/f mice cultured
for 5 days and examined for CTCF lev-
els. Fibrillarin was used as a loading
control.
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whether CTCF-deficient T cells had an IL-2 production defect or
impaired IL-2R induction. We found that upon stimulation with
anti-CD3/CD28 or PMA/ionomycin, the absence of CTCF did not
affect IL-2 production in CD4� or CD8� T cells, as analyzed by
intracellular cytokine staining at day 3 (Fig. 5A). By contrast, in-
duction of the IL-2 receptor CD25 on CTCF-deficient CD4� and
CD8� T cells was severely impaired, when activated by plate-bound
anti-CD3/CD28 (Fig. 5B). When activated by PMA/ionomycin,
CTCF-deficient CD4� T cells displayed a partial defect in CD25 up-
regulation, while in CD8� T cells CD25 induction was normal.
Expression of CD69, an �30-kDa glycoprotein induced in ac-
tivated T cells, was hampered in CTCF-deficient CD4� T cells
upon TCR stimulation, but was normal in CD8� T cells or in
PMA/ionomycin-stimulated CTCF-deficient T cells. Finally, anal-
yses of forward scatter values of stimulated cells showed that cell
size increases in CTCF-deficient cells were limited, particularly
upon anti-CD3/CD28 stimulation, whereby CD4� cells were more
affected than CD8� cells (Fig. 5B).
From these findings, we conclude that anti-CD3/CD28 treatment
does not elicit proper activation of CTCF-deficient peripheral T
cells, in terms of induction of CD25, CD69, and cell size increase,
whereby CD4� T cells are somewhat more affected than CD8� T
cells. However, when T cells are stimulated by PMA/ionomycin,
expression levels of CD25 and CD69 are largely in the normal
ranges.
CD4-Cre Ctcff/f mice have severely reduced serum levels of
IgG1 and IgE
Concentrations of Ig subclasses in the serum of CD4-Cre Ctcff/f
mice were reduced, except for IgM and IgG3, which are T cell
FIGURE 6. Serum Ig analysis in CTCF-deficient mice. A, Serum con-
centrations of Ig isotypes displayed as average values plus SD. Mice were
2 mo of age. B, Total IgE serum concentrations in nonimmunized mice
(left) and in immunized mice 7 days after i.p. injection with 10 �g TNP-
KLH (right).
FIGURE 5. Impaired cellular activation of CTCF-de-
ficient T cells. A, Analysis of IL-2 expression in anti-
CD3/CD28 and PMA/ionomycin-stimulated cultures
of sorted CD62L�CD4� and CD8� T cell fractions
from WT and CD4-Cre Ctcff/f mice. At day 3, cells were
restimulated for 4 h before intracellular flow cytometric
analysis. Total living cells were gated and CD4/IL-2 and
CD8/IL-2 profiles are displayed as dot plots and the per-
centages of cells within the quadrants are given. Data
shown are representative of four mice per group. B, Phe-
notypic characteristics of anti-CD3/CD28 or PMA/iono-
mycin-stimulated CD4� and CD8� T cells. CD25,
CD69, and forward scatter profiles are displayed as his-
togram overlays of WT (gray histograms) and CD4-Cre
Ctcff/f cultures (bold lines). The percentages shown rep-
resent the fractions of the cells within the indicated
marker in WT (gray) or CD4-Cre Ctcff/f (black, bold)
cultures. Data shown are representative of four to six
mice per group.
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independent and IgA which requires TGF-� expression (Fig. 6A).
This does not necessarily mean that CTCF-deficient CD4� T cells
produce normal levels of TGF-�, since this cytokine is secreted by
many cell types.
Interestingly, serum levels of the IL-4-dependent isotype IgG1
were more affected than those of the IFN�-dependent isotype
IgG2c (�10 and �60% of WT, respectively). Serum concentra-
tions of the IL-4-dependent isotype IgE were also lower in the
absence of CTCF (Fig. 6B). Moreover, when Th2-mediated re-
sponses were tested in vivo by injection of a low dose of TNP-
KLH in alum (10 �g), we observed an increase in the concentra-
tion of total IgE in WT mice at day 10, but not in CD4-Cre Ctcff/f
animals (Fig. 6B). Thus, the absence of CTCF resulted in a severe
deficiency for the Th2-dependent subclasses IgG1 and IgE in the
serum, whereas the Th1-dependent subclass IgG2c was only mod-
erately affected. CD4-Cre Ctcff/f mice also had very low levels of
IgG2b in the serum. Because class switch recombination to IgG2b
is thought to be regulated by various cytokines including IFN-�
and TGF-�, but not by Th2 cytokines, the IgG2b deficiency cannot
be explained by a selective Th2 defect.
Th2 cytokine defect in CD4-Cre Ctcff/f mice
Next, we performed in vitro polarization cultures to investigate
whether CTCF is specifically required for differentiation of Th2
effector cells. Sorted naive CD62L�CD4� T cells from spleen
and lymph nodes were stimulated with anti-CD3/CD28 or
PMA/ionomycin under Th0 conditions (without additional cy-
tokines or Abs), Th1-polarizing conditions (with IL-12 and anti-
IL-4), or Th2-polarizing conditions (with IL-4, anti-IL-12, and
anti-IFN-�) for 7 days. Under these conditions, anti-
CD3/CD28-stimulated WT CD4� T cell fractions manifested a
�10- to 100-fold expansion in 7 days (Fig. 7A). Consistent with
the observed severely defective proliferation of anti-
CD3/CD28-stimulated CTCF-deficient CD4� T cells, we found
that the expansion of these cells at day 7 was negligible. Importantly,
replacing anti-CD3/CD28 by PMA/ionomycin stimulation resulted in
significant expansion of CTCF-deficient T cell cultures (�2–10 times
at day 7; Fig. 7A), enabling the analysis of Th1 and Th2 development
in vitro. Under these conditions, WT Th cultures showed an �10- to
30-fold expansion (Fig. 7A).
FIGURE 7. CTCF regulates Th2 cytokine expression. A, Expansion of Th0, Th1, and Th2 cultures 7 days after stimulation with anti-CD3/CD28 or
PMA/ionomycin. Symbols represent the expansion values of cultures from individual mice, whereby cell numbers at the start of the culture were
set to 1. Lines indicate average values. Values of p of significant differences between WT and CD4-Cre Ctcff/f mice are indicated. B, Flow cytometric
analysis for intracellular expression of IFN-� and IL-4 in the indicated T cell cultures after stimulation with PMA/ionomycin. CD4� T cells were
gated and expression profiles are displayed as dot plots. The percentages of cells within the quadrants are given. Mean fluorescence values for IL-4
were 138 and 75 for WT and CD4-Cre Ctcff/f IL-4� Th2 cells, respectively. C, Flow cytometric analysis for intracellular expression of the indicated
cytokines after stimulation with PMA/ionomycin. Total cells and CD4� T cells were gated and expression profiles are displayed as CD4/IL-5 and
IL-10/IL-13 dot plots, respectively. D, Cytokine levels of WT (�) and CD4-Cre Ctcff/f (f) Th2 cultures supernatant after stimulation with
PMA/ionomycin. Mean values and SD are given for two seven mice analyzed per group; �, p � 0.05 and ��, p � 0.01. E, Quantitative RT-PCR
analysis of expression of the indicated cytokines in different T cell cultures (WT, �; CD4-Cre Ctcff/f, f). Expression levels were normalized for
GAPDH and are expressed as arbitrary units, whereby the values in WT Th2 cells were set to 1. Mean values and SD are given for four mice analyzed
per group; �, p � 0.05 and ��, p � 0.01.
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In Th1-polarized cultures, CTCF-deficient T cells produced
moderately reduced levels of IFN-� when compared with WT T
cells, as determined by intracellular flow cytometry (Fig. 7B). The
proportions of IFN-�� cells were 55 � 15% (n � 7) and 23 � 6%
(n � 4; p � 0.005) in WT and CTCF-deficient Th1 cultures, re-
spectively. Remarkably, CTCF-deficient T cells showed a more
severe IL-4 production defect in Th2-polarized cultures. Both the
frequency of IL-4� T cells (51 � 11% (n � 7) in WT and 9 � 4%
(n� 4; p� 0.00005) in CTCF-deficient cultures) and intracellular
IL-4 signals per cell were significantly reduced in the absence of
CTCF (Fig. 7B). Additional intracellular flow cytometry analyses
showed that in CTCF-deficient Th2 cell cultures IL-5 production
was not detectable and IL-10 and IL-13 were severely reduced
(Fig. 7C). Consistent with these findings, in the supernatants of
Th2-polarized cultures, production of IL-4, IL-5, and IL-13 was
significantly reduced in the absence of CTCF, as determined by
ELISA (Fig. 7D). Finally, quantitative RT-PCR analysis of day 7
cultures showed that in CTCF-deficient Th2 cultures transcription
of the IL-4, IL-5, and IL-13 cytokines was strongly reduced (Fig.
7E). We also analyzed transcription of the Il-10 gene, which is not
located within the Th2 locus, and found that in the absence of
CTCF IL-10 expression was very low, both in Th1 and Th2
cultures.
Thus, in CTCF-deficient Th2 polarization cultures in vitro, tran-
scription of IL-4, IL-5, and IL-13 was strongly reduced. By con-
trast, CTCF deficiency had a moderate effect on IFN-� production
in Th1 cultures.
Th17 and Treg differentiation in CD4-Cre Ctcff/f mice
The observed Th2 cytokine defect in CTCF-deficient Th2 cells
prompted us to investigate whether differentiation toward alternative
CD4 T cell fates, including Th17 and Treg cells, was possible in the
absence of CTCF. We activated sorted naive CD62L�CD4� T cells
with PMA/ionomycin and cultured them under Th17 conditions (in
the presence of TGF-�, IL-6, anti-IFN-�, and anti-IL-4) or Treg con-
ditions (with TGF-�, anti-IFN-�, and anti-IL-4). As examined in
CSFE experiments, we observed significant proliferation of CTCF-
deficient CD4� T cells under Th17 and Treg conditions at day 3 (Fig.
8A). When Th17 cultures were analyzed for intracellular cytokines at
day 5, we found that the expression of IL-17 in CTCF-deficient T
cells reached values that were similar to those found in WT T cells
(�8%, n� 6; Fig. 8B). In addition, we noticed a small but consistent
population of IFN-�� cells in CTCF-deficient Th17 cultures, which
was not detected in WT Th17 cultures.
When naive WT CD62L�CD4� T cells were cultured under
Treg conditions for 3 days, a large majority of cells (85 � 2%,
FIGURE 8. CTCF is not essential for
Th17 or Treg differentiation. A, CFSE
profiles of Th0, Th17, and Treg cultures
of sorted CD62L�CD4� T cell popula-
tions from WT mice (gray histogram) in
comparison to cultures from CD4-Cre
Ctcff/f mice (black line). Cells were acti-
vated with PMA/ionomycin and cultured
for 3 days. Dotted lines indicate the flu-
orescence intensity of unstimulated cells.
B, Flow cytometric analysis for intracel-
lular expression of IFN-� and IL-17 in
Th0 and Th17 cultures after stimulation
with PMA/ionomycin. CD4� T cells
were gated and expression profiles are
displayed as dot plots. The percentages
of cells within the quadrants are given. C,
Flow cytometric analysis for intracellular
Foxp3 and IL-17 expression in PMA/
ionomycin-stimulated Treg cultures.
CD4� T cells were gated and expression
profiles are displayed as dot plots. D,
Flow cytometric analysis for intracellular
Foxp3 and membrane CD25 with quan-
tification of CD25�Foxp3� Treg cells in
spleen and mesenteric lymph nodes in
vivo. Data shown are representative of
four to six mice per group.
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n � 3; Fig. 8C) expressed Foxp3, the transcription factor associ-
ated with Treg differentiation (48). Such Foxp3� cells were also
present in Treg cultures of CTCF-deficient T cells, albeit that the
proportions were slightly lower (62 � 2%; n � 3). Furthermore,
the proportions of naturally occurring CD25�Foxp3�CD4� Treg
cells in spleen and lymph nodes in vivo were not different between
WT and CTCF-deficient mice (Fig. 8D).
As a control, we also evaluated IFN-� and granzyme B expres-
sion in day 7 cultures of anti-CD3/CD28- or PMA/ionomycin-
stimulated CD62L�CD8� T cells. We found that production of
IFN-� and granzyme B was only moderately affected (data not
shown).
Collectively, these findings show that differentiation of CTCF-
deficient T cells into IL-17-producing Th17 cells is apparently nor-
mal and lack of CTCF has limited effects on differentiation of Treg
and CD8� T cells. We therefore conclude that the absence of
CTCF does not result in a global defect in effector T cell
differentiation.
GATA3 and SATB1 expression in CD4-Cre Ctcff/f Th2 cells
Because Th2 cytokine production depends on the transcription fac-
tor GATA3 (6–10), we evaluated its expression in the T cell cul-
tures. As determined by intracellular flow cytometry, GATA3 ex-
pression appeared unaffected in CTCF-deficient Th2 cultures (Fig.
9A), excluding the possibility that Th2 cytokine production was
impaired due to defective GATA3 induction. Furthermore, the
CTCF-deficient Th2 cultures displayed clear features of Th2- po-
larized cells, including low mRNA levels of T-bet and STAT4
(Fig. 9B). Since GATA3 has the capacity to inhibit STAT4 tran-
scription (49), the finding of low STAT4 expression levels suggest
that in the absence of CTCF GATA3 still operated as a negative
regulator of STAT4. In CTCF-deficient Th1 cultures, T-bet ex-
pression was reduced when compared with WT (Fig. 9B), which is
consistent with the observed reduction in IFN-� expression. Next
to GATA3, SATB1 has also been implicated in Th2 locus expres-
sion (21). SATB1 was specifically induced, both in WT and
CTCF-deficient Th2 cultures (Fig. 9C).
Taken together, these data indicate that differentiating CTCF-
deficient Th2 cells show impaired expression of Th2 cytokines
IL-4, IL-5, and IL-13, but nevertheless up-regulate the Th2-spe-
cific factors GATA3 and SATB1 and down-regulate T-bet and
STAT4.
Discussion
The differentiation process of naive CD4� T cells to Th1 or Th2
cells is critically dependent on coordinated transcriptional regula-
tion of cytokine gene loci (18). To investigate whether CTCF reg-
ulates transcription of cytokine-encoding genes, we studied mice
in which CTCF was conditionally deleted in the T cell lineage. Our
data indicate that CTCF deficiency affects differentiation of Th2
effector cells by impairing T cell activation as well as Th2 cytokine
production. Activation and proliferation of CTCF-deficient CD4
and CD8 cells upon anti-CD3/anti-CD28 stimulation in vitro was
severely hampered. However, when TCR signaling was circum-
vented with phorbol ester and ionomycin, we observed prolifera-
tion of CTCF-deficient T cells, enabling the analysis of Th cell
differentiation. We found that in CTCF-deficient Th2 polarization
cultures, transcription of IL-4, IL-5, and IL-13 was strongly re-
duced. By contrast, CTCF deficiency had only a modest effect on
IFN-� production in Th1 cultures and did not appear to affect Th17
differentiation and IL-17 production. In CTCF-deficient Th2 cul-
tures, cells were polarized toward the Th2 lineage, as the key tran-
scriptional regulators GATA3 and SATB1 were induced and T-bet
and STAT4 were down-regulated. Nevertheless, expression of
IL-4, IL-5, and IL-13 remained strongly inhibited in these other-
wise Th2-polarized cells. We therefore propose that CTCF plays a
major role in the GATA3- and SATB1-dependent regulation of the
expression of genes within the Th2 cytokine locus.
We found that CTCF-deficient CD4� and CD8� T cells have
severely defective activation and proliferation in response to anti-
CD3/CD28 stimulation. Nevertheless, one of the most important
downstream events, production of IL-2, was not noticeably af-
fected, ruling out global defects in TCR clustering, actin polymer-
ization, or activation of NFAT, NF-�B, and JNK cascades (50, 51).
The finding that PMA/ionomycin stimulation bypassed the CD3/
CD28-signaling defect suggests that the presence of CTCF is im-
portant for signaling events downstream of the TCR which are
necessary for full T cell activation. In this context, we found that
PMA/ionomycin partially (in CD4� T cells) or completely (in
CD8� T cells) rescued the defective induction of IL-2R expression
in CTCF-deficient T cells observed upon anti-CD3/CD28 stimu-
lation (Fig. 5B). Additional experiments are required to clarify
whether CTCF controls gene expression of specific proteins in-
volved in proximal signaling events (induced upon TCR stimula-
tion) that regulate IL-2R induction.
FIGURE 9. GATA3 and SATB1 are induced in CTCF-deficient Th2
cultures. A, Flow cytometric analysis for intracellular GATA3 protein ex-
pression in PMA/ionomycin-stimulated T cell cultures. CD4� T cells were
gated and for the indicated mice expression profiles are displayed as his-
tograms overlays of Th1 (gray histograms) and Th2 cultures (bold lines).
B, Quantitative RT-PCR analysis of GATA3, T-bet, and STAT4 expression
in different T cell cultures from WT (�) or CD4-Cre Ctcff/f mice (f).
Expression levels were normalized for GAPDH and are expressed as ar-
bitrary units, whereby expression in WT Th1 cells (T-bet, STAT4) or Th2
cells (GATA3) was set to 1. Mean values and SD are given for four mice
analyzed per group. C, Western blotting analysis of SATB1 and CTCF
protein levels in PMA/ionomycin-stimulated T effector cell cultures at day
7. Fibrillarin was used as a loading control.
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The in vitro Th1 polarization cultures showed that CTCF-defi-
cient Th1 effector cells produced significant amounts of IFN-�, but
expression was reduced when compared with WT. Also, in anti-
CD3/CD28-stimulated CTCF-deficient CD8� T cells, we found
that the proportion of IFN-�� cells was �60% of that in WT cells
(C. R. de Almeida, unpublished data). In contrast, we observed a
small cloud of IFN-�� cells in Th17 cultures from CTCF-deficient
T cells, which was not detectable in WT Th17 cultures, indicating
that IFN-� expression is not reduced under all culture conditions.
Therefore, we conclude that the observed reduction of IFN-� pro-
duction in CTCF-deficient Th1 cells does not necessarily implicate
CTCF in transcriptional regulation of the IFN-� locus, as de-
creased IFN-� production may well result form reduced expression
of essential transcription factors such as T-bet and STAT4
(Fig. 9B).
Our analysis of CTCF binding in the Th2 cytokine locus re-
vealed four CBS: three sites flanking the Th2 locus (CBS-6 and
CBS-7 upstream of the Il-5 gene, CBS-1 downstream of Il-4,
within the Kif3a gene) and one site in the intergenic region be-
tween Il-13 and Il-4 (CBS-3), irrespective of Th1 or Th2 polar-
ization. CBS-3 is located near the conserved noncoding sequence
CNS-1, which is critical for Th2 cytokine expression and binds the
C-terminal zinc finger of GATA3 (43, 44). However, because the
distance between CNS-1 and CBS-3 is �1 kb, it is not very likely
that CTCF binding to CBS-3 influences Th2 cytokine expression
by direct interaction with nuclear proteins recruited to the CNS-1
region.
Interestingly, CBS-3 is located at the constitutive hypersensitive
site HSS-3, which has been shown to be present both in naive
CD4� cells and Th1 and Th2 cells (43). Although nine SATB1
sites were identified in the mouse Th2 locus (21), none of these is
located near the CNS-1 region. Thus, SATB1 and CTCF binding
sites in the Th2 locus are interspersed. One of the possible expla-
nations for defective Th2 cytokine expression in the absence of
CTCF would be that CTCF is involved in chromatin organization
of the Th2 locus. In such a model, loss of CTCF would affect
SATB1-mediated looping of the Th2 locus and, consequently, Th2
cytokine expression. Indeed, studies in the chicken �-globin locus
have led to a model of CTCF-dependent enhancer-blocking func-
tion based on the interaction between CTCF and the nucleolar
protein nucleophosmin, whereby tethering of the insulator to a
nuclear structure prevents enhancer-promoter communication (52).
Moreover, SATB1 was originally identified as a matrix attachment
region DNA-binding protein (53), which possibly contributes to
chromatin loop organization (54). It would be interesting to inves-
tigate whether CTCF binding sites at the Th2 cytokine locus are
involved in the tethering of this 200-kb DNA region to subnuclear
sites, thereby allowing coordinated expression of Th2 cytokine
genes from a SATB1-dependent, transcriptionally active chroma-
tin structure.
However, mechanisms other than formation of chromatin loops
can also account for CTCF function and explain the defective Th2
cytokine expression observed in the absence of CTCF. Similar to
its role in the mouse �-globin locus (25), CTCF could function to
direct local histone modifications at the Th2 cytokine locus. In-
deed, high-resolution profiling of histone methylation in the human
genome showed that CTCF marks boundaries of histone methyl-
ation domains (30) and CTCF interaction with histones or histone-
modifying proteins have been reported (30, 52, 55, 56). Addition-
ally, CTCF has also been shown to interact with the large subunit
of RNA polymerase II (57), shown to be recruited to the Th2
cytokine locus upon Th2 cell activation (21). Finally, it remains
possible that the effect of CTCF on Th2 cytokine expression is
indirect. For example, CTCF could be an essential regulator of the
expression 1) of nuclear regulators other than GATA3 or SATB1
that are required for Th2 cytokine transcription or 2) of enzymes
involved in posttranslational modifications of Th2-specific tran-
scription factors.
The role for CTCF in the GATA3/SATB1-mediated regulation
of the Th2 cytokine locus may well parallel its recently described
role in the control of MHC class II gene expression and the for-
mation of long-distance chromatin interactions involving the
CIITA (33). In contrast, we reported that deletion of one CTCF
binding site in the mouse �-globin locus did not affect expression
of the �-globin genes (25). Thus, it is clear that CTCF has cell
type-specific functions. It was proposed that CTCF remains bound
to its �14,000 cognate binding sites irrespective of cell type (28).
It will be interesting to determine how CTCF performs cell type-
specific roles while remaining bound to its cognate sites. Equally
interesting are the questions how and which chromosomal inter-
actions, both in cis-and in trans, persist in the absence of CTCF.
Importantly, our experiments in mature CTCF-negative T cells
show they can proliferate and differentiate under appropriate con-
ditions and it is therefore feasible to address these issues using
CTCF knockdown or conditional targeting approaches.
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The	morphological	and	functional	diversity	of	multi-cellular	organisms	is	a	result	
of	the	precise	and	complex	regulation	of	the	genetic	information	at	different	stages	
of	 cellular	 differentiation.	 Hence,	 different	 levels	 of	 control	must	 exist	 to	maintain	
the	proper	spatio-temporal	expression	of	genes	throughout	the	process	of	cellular	
differentiation.	 In	 order	 to	 control	 this	 process,	 the	 eukaryotic	 genomes	 evolved	
several	regulatory	DNA	elements	that	ensure	proper	gene	regulation.	It	is	important	to	
understand	how	these	cis-regulatory	elements	communicate	over	large	distances	to	
control	gene	expression.	The	main	focus	of	the	research	described	in	this	thesis	was	
the	study	of	several	factors	that	have	a	role	in	long-range	interactions	and	chromatin	
organization.
In	this	Chapter,	I	will	discuss	the	specific	functional	interaction	between	Delangin	
and	Cohesin	in	more	detail	 to	provide	a	better	 insight	of	their	 involvement	 in	gene	
regulation.	A	growing	number	of	Cohesins	and	their	regulatory	proteins	have	been	
associated	with	human	developmental	disorders	that	are	therefore	also	referred	to	as	
“cohesinopathies”.	Cornelia	de	Lange	Syndrome,	caused	by	mutations	in	Delangin,	
or	 in	 rare	cases	 in	Cohesin	 subunits,	 is	a	heterogeneous	developmental	disorder.	
The	complex	phenotype	seen	in	humans	and	in	Delangin	mouse	model	(described	in	
Chapter	3)	suggests	that	Delangin	is	involved	in	different	developmental	processes	
and	provides	new	clues	to	the	underlying	molecular	mechanisms	of	this	disorder.
	 Although	 Cohesin	 was	 discovered	 as	 a	 protein	 that	 is	 required	 for	 sister	
chromatid	cohesion	in	mitotic	and	meiotic	cells,	recent	work	provides	clear	evidence	
that	at	least	some	of	the	functions	of	Cohesin	are	independent	of	its	role	in	cohesion.	
Interestingly,	Cohesin	shares	binding	sites	in	the	genome	with	another	multifunctional	
protein,	CTCF.	The	functional	relevance	of	Cohesin	and	CTCF	binding	to	the	same	
sites	in	the	genome	is	still	unclear.
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Delangin interactors
Delangin	was	 initially	 identified	as	a	developmental	 regulator	 in	Drosophila.	A	
genetic	screen	aimed	to	isolate	genes	involved	in	long-	range	interactions	between	
promoters	and	remote	enhancers	identified	Nipped-B,	a	regulator	of	the	Ultrabithorax 
and	cut	 genes	 (Rollins	 et	 al.,	 1999).	 Subsequent	 work	 revealed	 that	 Nipped-B	 is	
also	required	for	sister	chromatid	cohesion	(Rollins	et	al.,	2004)	and	it	was	shown	
that	Delangin	and	its	orthologues	are	required	for	Cohesin	to	bind	to	chromosomes	
(Arumugam	et	al.,	2003;	Ciosk	et	al.,	2000;	Gillespie	and	Hirano,	2004;	Seitan	et	al.,	
2006).	
The	role	of	Delangin	 in	Drosophila	 in	 long-range	gene	regulation	triggered	our	
interest	in	this	protein.	The	fact	that	Delangin	acts	through	Cohesin,	a	protein	that	is	
involved	in	many	diverse	cellular	processes,	makes	it	complicated	to	reveal	a	specific	
function	 in	a	distinct	process.	The	complexity	of	 the	processes	 involving	Delangin	
requires	both,	biochemical	and	genetic	approaches	to	clarify	the	function	of	Delangin	
in	mammals.	The	genetic	approach	is	described	in	Chapter	3,	while	a	biochemical	
approach	was	not	advanced	enough	 to	be	 included	and	will	be	described	 in	 this	
Chapter.	
Protein-protein	 interactions	are	crucial	 in	most	biological	processes,	 including	
gene	 regulation	and	cell	cycle	progression.	Most	proteins	 function	as	multiprotein	
complexes	or	 interact	with	multiprotein	complexes.	 Identification	of	protein-protein	
interactions	 in	 the	 context	 of	 their	 physiologically	 relevant	 complexes	 is	 therefore	
a	 key	 to	 fully	 understand	 the	 cellular	machinery.	Many	 experimental	 approaches,	
including	yeast	two-hybrid	analysis,	mass	spectrometry	and	affinity	purification	have	
been	developed	for	the	detection	and	identification	of	interacting	proteins	in	a	cellular	
context.	 	However	 all	 these	methods	 can	 result	 in	 considerable	 numbers	of	 false	
positive	and	negative	interactions.	
Fractionation	profiles	of	nuclear	extracts	isolated	from	murine	erythroid	leukemia	
(MEL)	cells	show	Delangin	to	be	present	in	complexes	of	high	molecular	weight.	In	
order	to	identify	Delangin	protein	partners,	we	used	streptavidin	pulldown	of	a	biotin-
tagged	Delangin	fusion	protein.	The	method	of	de	Boer	and	colleagues	(de	Boer	et	
al.,	2003;	Rodriguez	et	al.,	2005)	was	used	to	generate	cDNA	constructs	coding	for	
fusion	proteins	with	a	23-amino	acid	N-terminal	tag		that	can	be	biotinylated	in vivo.	
Because	of	the	large	protein	size,	we	were	unable	to	express	a	full-length	bio-tagged	
Delangin	in	MEL	cells.	We	therefore	designed	a	series	of	constructs	that	collectively	
specified	overlapping	fragments	from	the	conserved	C-terminal	region	of	Delangin.	
Both	isoforms	described	of	mammalian	Delangin	are	large	and	only	a	few	functional	
domains	have	been	identified.	A	C-terminal	domain,	that	is	strongly	conserved	and	
expected	 to	be	 functionally	significant,	was	 included	 in	 this	analysis.	This	domain	
contains	several	HEAT	repeats,	motifs	that	have	been	implicated	in	protein-protein	
interactions.	
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Delangin	has	been	reported	to	interact	with	several	proteins	of	different	functions.	
We	could	also	detect	heterochromatin	protein	1	(HP1),	a	known	interacting	partner	of	
Delangin	(Lechner	et	al.,	2005).	To	validate	Delangin	interactions,	we	carried	out	co-
immunoprecipitation	experiments	on	 the	endogenous	Delangin	and	putative	 inter-
actors.	 Unfortunately,	 in	 the	 reciprocal	 screen	 several	 of	 these	 did	 not	 appear	 to	
interact	with	Delangin	but	two	of	them	did:	Topoisomerase	II	α	and	Metastasis	Tumor	
Antigen	1	(MTA1).	What	could	be	the	functional	relevance	of	Delangin	interacting	with	
these	two	proteins?
Metastasis	 tumor	 antigen	 1	 (MTA1),	 a	 candidate	member	 of	 the	metastasis-
associated	 gene	 family,	 is	 a	 component	 of	 the	 nucleosome	 remodeling	 and	
deacetylating	 (NuRD)	 complex.	 The	 NuRD	 complex	 has	 been	 implicated	 in	 ATP-
dependent	 chromatin	 remodeling	 and	 transcriptional	 regulation.	 As	 a	 part	 of	 the	
NuRD	complex,	MTA1	is	thought	to	modulate	transcription	by	influencing	chromatin	
remodeling	 	 (Kumar	 et	 al.,	 2003;	 Toh	 et	 al.,	 1994).	 We	 were	 able	 to	 detect	 an	
interaction	 of	 endogenous	Delangin	 only	with	MTA1,	while	 the	 other	 components	
of	 the	NurRD	chromatin	 remodeling	complex	did	not	 interact	with	Delangin	 in	our	
experimental	setup.	A	recent	study	(Jahnke	et	al.,	2008)	showed	that	Delangin	forms	
stable	complexes	with	endogenous	HDAC1	and	HDAC3	(also	components	of	NuRD	
complex)	in	mammalian	cells.	Our	data,	in	combination	with	the	HDAC1/3	interaction	
data	 indicate	 a	 molecular	 connection	 with	 the	 chromatin	 remodeling	 machinery,	
although	we	still	miss	functional	evidence	to	that	effect.
The	discrepancy	between	an	interaction	of	Delangin	with	MTA1	(in	our	experiments)	
or	HDAC1/3	(Jahnke	et	al.,	2008)	may	be	due	to	different	direct	interactions	within	
two	 different	 systems.	 Another	 interesting	 set	 of	 interactions	 is	 found	 between	
Cohesin	 and	 a	 Chromatin-remodeling	 complex	 containing	 the	 ATPase	 SNF2h	 in	
human	cells	(Hakimi	et	al.,	2002).	Although	the	interplay	of	chromatin	structure	and	
histone	modification	with	Cohesin	 has	been	described,	 its	 precise	 function	 is	 not	
understood.	We	can	only	speculate	that	chromatin	structure	may	play	an	important	
role	in	determining	where	Delangin	binds	to	chromosomes	in	eukaryotic	cells.	Does	
Delangin	recognize	chromatin	regions	that	have	a	particular	chromatin	organization	
that	allows	Delangin	and	subsequent	Cohesin	binding?	Alternetively,	Delangin	triggers	
changes	in	chromatin	structure	that		allow	recruitment	of	Cohesin	to	specific	sites.	It	
would	be	interesting	to	investigate	these	possibilities	in	mammalian	cells.
In	 addition	 to	 its	 role	 in	 histone	 deacetylation	 and	 a	 strong	 correlation	 with	
metastatic	 potential	 (Nicolson,	 1998),	 MTA1,	 a	 ubiquitously	 expressed	 protein,	 is	
also	involved	in	the	regulation	of	other	cellular	pathways	including	hormonal	action,	
protein	stability	and	development	by	modifying	the	acetylation	status	of	crucial	target	
genes	(Manavathi	and	Kumar,	2007).	For	example,	it	was	shown	that	MTA1	drastically	
represses	transcription	of	the	BRCA1	gene	by	associating	with	the	previously	identified	
ERE	in	the	BRCA1	gene	promoter	via	ER α	(Molli	et	al.,	2008).	It	would	be	interesting	
to	 identify	 additional	 targets	 of	MTA1	and	correlate	 them	with	Delangin	 targets	 in	
the	genome	since	 the	direct	 interaction	of	Delangin	and	MTA1	 indicates	 that	 they	
might	act	together	to	regulate	gene	expression.	The	availability	of	complete	genome	
sequences	and	high-throughput	analysis	techniques	have	broadened	the	focus	from	
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single	 interactions	 to	 a	more	 complex	 picture.	ChIP-sequencing,	which	 combines	
chromatin	 immunoprecipitation	 (ChIP)	 with	 massively	 parallel	 DNA	 sequencing,	
can	be	used	to	precisely	map	global	binding	sites	 for	any	protein	of	 interest.	This	
technique	gives	numerous	opportunities	 for	 identification	of	binding	sites	of	many	
factors	 that	 bind	directly	 or	 indirectly	 to	DNA.	 In	 the	 case	of	 indirect	 binding,	 the	
use	of	protein-protein	cross-linkers,	 for	example	disuccinimidyl	glutarate	 (DSG),	 is	
required	before	DNA-protein	fixation.	Mapping	of	binding	sites	of	diverse	factors	will	
provide	a	better	understanding	of	functional	protein	complexes	and	their	formation	in	
the	crowded	cellular	environment.	
DNA	 Topoisomerase	 II	 α	 is	 another	 protein	 that	 was	 identified	 by	 mass-
spectrometry	 and	 confirmed	 to	 interact	 with	 endogenous	 Delangin.	 Interestingly,	
coimmunoprecipitation	 experiments	 indicate	 that	 HDAC1	 and	 HDAC2	 are	 also	
associated	with	Topo	II	α in vivo	under	normal	physiological	condition.	Complexes	
containing	Topo	II	α	possess	HDAC	activity,	and	complexes	containing	HDAC1	and	
HDAC2	possess	 Topo	 II	 activity	 (Tsai	 et	 al.,	 2000).	 This	molecule	 can	be	 another	
possible	link	of	the	Delangin	with	its	targets	at	the	genomic	level.
Cohesinopathies and Delangin
Recently,	a	growing	number	of	Cohesins	and	its	regulatory	proteins	have	been	
associated	with	human	developmental	disorders	that	are	therefore	also	referred	to	as	
“cohesinopathies”.		The	most	frequent	of	these	diseases	is	Down	syndrome	(trisomy	
21)	which,	 in	 the	majority	of	cases,	 is	caused	by	missegregation	of	chromosome	
21	during	meiosis	I	in	oocytes	(Gilliland	and	Hawley,	2005).	Maternal	age	correlates	
with	an	increased	frequency	of	unpaired	chromosomes	and	precociously	separated	
sister	chromatids	suggesting	that	the	defects	in	sister	chromatid	cohesion	may	be	
one	of	 the	causes	of	 nondisjunction	 (Pellestor	 et	 al.,	 2003).	Experimental	 support	
comes	from	the	observation	that	mice	in	which	the	meiosis-specific	Smc1β Cohesin	
subunit	was	mutated	show	age	related	defects	in	oocytes	(Hodges	et	al.,	2005).	It	is	
therefore	possible	that	defects	in	Cohesin,	or	Cohesin	regulators	including	Delangin,	
are	a	major	cause	of	Down	syndrome.	Why	these	effects	are	age	related	and	how	
they	occur	is	still	unclear.	Since,	in	females,	cohesion	is	established	during	prenatal	
development,	albeit	 has	 to	persist	 for	 several	decades.	During	 this	 time,	Cohesin	
is	probably	 reloaded	many	 times	since	 it	 is	hard	 to	believe	 that	Cohesin	 is	stably	
bound	for	such	a	long	time.	In	this	case,	Delangin	loads	Cohesin	de	novo	during	this	
period.	If	so,	it	would	be	interesting	to	address	if	and	how	Delangin	involved	is	in	this	
process.	
Cornelia	de	Lange	Syndrome	(CdLS)	is	associated	with	mutations	in	the	Delangin	
gene	in	humans.	Chapter	3	focuses	on	a	description	of	the	Delangin	KO	(Knockout)	
mouse	that	shows	a	complex	phenotype	similar	to	that	seen	in	Cornelia	de	Lange	
patients.	Surprisingly,	cell	proliferation	and	sister	chromatid	cohesion	appear	to	be	
normal	in	cells	derived	from	Delangin-deficient	mice.	We	therefore	suggest	that	the	
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abnormalities	present	in	Delangin-deficient	mice	and	CdLS	patients	are	caused	by	
Delangin	functions	other	than	sister	chromatid	cohesion.
A	reduced	dosage	of	Delangin	could	result	in	increased	apoptosis	during	early	
development,	with	a	loss	of	key	tissue	progenitor	cells	as	a	result.	Alternatively,	the	
partial	loss	of	Delangin	function	could	result	in	significant	transcriptional	deregulation	
of	 many	 genes.	 Hence,	 it	 is	 important	 to	 identify	 the	 genes	 whose	 transcription	
is	altered	when	Delangin	 function	 is	 impaired	or	 the	dose	 is	 reduced.	 It	 is	hard	 to	
predict	which	genes	might	be	the	targets	of	Delangin	loss-of-function	since	role	of	
the	Delangin	protein	is	probably	as	a	non-sequence-specific	chromosomal	protein	
which	regulates	DNA	structure	to	facilitate	transcription	of	many	genes.	Therefore,	it	
is	reasonable	to	expect	that	genes	with	an	altered	level	are	not	related	in	a	functional	
way	 but	 rather	 in	 structural	 way	 to	 Delangin.	 For	 example,	 by	 having	 regulatory	
enhancers	near	to	Cohesin	binding	sites.
Whole-genome	 mapping	 of	 Delangin	 binding	 sites	 in	 combination	 with	
transcriptional	profiling	should	reveal	target	genes	that	are	up-	or	down-regulated	in	
Delangin-deficient	mice	and	hopefully	provide	insight	into	the	defects	in	human	CdLS	
patients.	The	choice	of	tissue	for	RNA	extraction	is	important	since	the	transcriptional	
changes	should	be	monitored	 in	 the	organs	before	 they	are	affected	or	 in	organs	
that	are	not	affected	since	it	is	necessary	to	avoid	the	results	of	ongoing	pathological	
changes.	The	 importance	of	 the	 identification	of	 the	molecular	basis	 for	CdLS	will	
permit	accurate	DNA-based	diagnostics.	Some	understanding	of	the	genetic	basis	
of	CdLS	has	been	obtained	from	the	patients,	but	for	the	development	of	a	genetic	
test	and	therapeutic	treatments	studies	in	transgenic	animals	are	very	important.	
Cohesin and Delangin binding sites in eukaryotic genomes
The	data	from	yeast,	Drosophila	and	mammalian	cells	reveal	a	striking	diversity	
in	the	targeting	mechanisms	of	Cohesin	and	Delangin.	The	distribution	of	Cohesin	
appears	drastically	different	in	these	organisms,	and	the	positions	do	not	coincide	
with	the	position	of	Delangin	that	loads	it	onto	the	chromosomes.
Cohesin-binding	sites	were	first	identified	in	the	genome	of	the	budding	yeast.	
ChIP-on-chip	experiments	revealed	that	Cohesin	binds	to	discrete	Cohesin	attachment	
regions	 (CARs)	 on	 chromosome	 arms	 and	 to	 larger	 domains	 in	 the	 centromeric	
regions	(Tanaka	et	al.,	1999).	The	arm	sites	are	on	average	10	kb	apart	from	each	
other	(Laloraya	et	al.,	2000).	Although	CARs	do	not	have	specific	sequence	elements	
they	are	enriched	for	A/T	(Blat	and	Kleckner,	1999)	and	are	positioned	in	a	particular	
manner	 in	 intergenic	 regions	at	sites	of	convergent	 transcription	 in	budding	yeast	
(Glynn	et	al.,	2004;	Lengronne	et	al.,	2004).	One	would	expect	that	Delangin	required	
for	Cohesin	loading	onto	DNA,	would	share	a	binding	motif	with	Cohesin.	ChIP-on-
Chip	experiments,	in	combination	with	microscopic	observations,	revealed	that	the	
distribution	of	Cohesin	differs	from	Delangin’s	binding	pattern	in	yeast	(Lengronne	et	
al.,	2004)	and	probably	also	in	mammalian	cells.	
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An	interesting	explanation	of	these	results	is		that	Delangin	and/or	Cohesin	are	
relocated	 from	 the	 initial	 binding	 site	 once	 the	 loading	 reaction	 takes	place.	One	
possibility	 is	 that	Cohesin	 is	 removed	 from	DNA	and	subsequently	 reloaded.	This	
scenario	is	less	probable	since	Delangin	would	be	needed	for	reloading	of	Cohesin	
and	that	is	not	the	case	since	Delangin	is	not	found	at	the	final	destination.	Another	
possibility	 is	 that	Cohesin	 is	 relocated	 from	 a	Delangin	 site	 by,	 for	 example	RNA	
polymerase	II	transcriptional	machinery	(Bausch	et	al.,	2007;	Lengronne	et	al.,	2004)	
to	the	sites	of	convergent	transcription.	This	is	possible	only	if	Cohesin	rings	can	slide	
along	the	chromatin	fiber.	To	reveal	a	mechanism	that	can	explain	Cohesin	relocation	
from	one	site	to	another,	it	is	necessary	to	understand	how	Cohesin	interacts	with	a	
DNA	molecule.
Initial	models	suggested	that	the	ATPase	heads	of	SMC1	and	SMC3	may	directly	
contact	 DNA	 (Nasmyth	 et	 al.,	 2000).	 Consistent	 with	 this	 possibility,	 recombinant	
fragments	of	SMC3	and	purified	Cohesin	core	complexes	can	bind	to	DNA	 in vitro	
(Losada	and	Hirano,	2001)	with	a	 low	affinity	and	 in	an	ATP	 independent	manner	
unlike	Cohesin	 loading	 in vivo.	Therefore,	 it	 is	unknown	whether	 these	 interactions	
reflect	 how	Cohesin	 associates	 with	 DNA	 in vivo.	 According	 to	 the	 “ring”	model,	
Cohesin	 mediates	 sister	 chromatid	 cohesion	 by	 embracing	 sister	 chromatids.	 It	
has	been	suggested	that	a	tripartite	ring	formed	by	SMC1,	SMC3	and	Scc1/Rad21	
could	encircle	two	10-nm	chromatin	fibers	not	contacting	DNA	directly	(Haering	et	al.,	
2002).	This	hypothesis	is	attractive	since	it	can	explain	why	proteolytic	cleavage	of	
SMC3	or	Scc1/Rad21	causes	dissociation	of	Cohesin	from	DNA	(Gruber	et	al.,	2003)	
and	why		Cohesin	binds	to	DNA	in	a	sequence	independent	manner	in	yeast	cells.	
Furthermore,	if	Cohesin	subunits	are	covalently	linked	to	each	other,	Cohesin	cannot	
associate	with	DNA	meaning	that	a	Cohesin	ring	has	to	be	opened	to	be	loaded	onto	
DNA	(Gruber	et	al.,	2006).
If	Cohesin	encircles	chromatin	fibers	by	embracing	it	without	having	preference	
for	particular	sequences,	it	is	possible	to	explain	the	relocation	of	Cohesin	from	the	
initial	 loading	sites	 to	 its	 final	destination	without	opening	 the	 ring.	Furthermore,	 it	
would	be	interesting	to	find	out	why	Cohesin	is	relocated.	Is	it	because	it	presents	
an	obstacle	for	transcription	or	it	is	relocated	to	facilitate	transcription?	There	are	two	
possible	explanations	and	in	both	cases	Cohesin	relocation	is	a	consequence	of	the	
transcription	machinery	passing	through.	Transcriptional	elongation	may	be	directly	
responsible	for	displacing	Cohesin,	that	is	initially	loaded	randomly	but	transcription	
(and	possible	other	metabolic	processes)	may	push	Cohesin	to	regions	that	are	not	
actively	transcribed.	
In Drosophila,	Cohesin	preferentially	binds	to	transcribed	regions,	opposite	to	the	
situation	in	yeast.	Also,	in	contrast	to	the	situation	in	budding	yeast,	the	Drosophila 
Delangin	 ortholog	 Nipped-B	 has	 been	 reported	 to	 colocalize	 with	 Cohesin	 on	
chromosomes	(Misulovin	et	al.,	2008).	
In	mammalian	cells,	Delangin	binding	sites	are	yet	to	be	identified,	but	it	would	be	
interesting	to	see	whether	there	is	an	overlap	with	the	Cohesin	binding	pattern.	Chip-
sequencing,	a	great	tool	for	mapping	global	binding	sites	of	any	protein	of	interest	
could	be	used	to	profile	Delangin	binding	sites.	For	Cohesin,	yet	a	different	binding	
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pattern	 has	 been	 observed	when	 compared	 to	 that	 in	Drosophila	 (Parelho	 et	 al.,	
2008;	Wendt	et	al.,	2008).	In	human	cells,	Cohesin	sites	are	present	in	introns	(35%),	
in	intergenic	regions	(50%)	and	in	the	regions	that	are	directly	up-stream	or	down-
stream	from	the	genes	(13%).	Cohesin	sites	are	enriched	in	the	regions	adjacent	to	
the	genes	(Wendt	et	al.,	2008),	favoring	the	possibility	that	these	sites	have	a	role	in	
gene	regulation.	In	addition,	there	is	no	evidence	that	transcription	relocates	Cohesin	
like	in	yeast	(Parelho	et	al.,	2008;	Wendt	et	al.,	2008).
A	series	of	recent	studies	gave	exciting	new	insights	into	the	targeting	mechanisms	
and	gene	regulatory	functions	of	Cohesin	(Parelho	et	al.,	2008;	Rubio	et	al.,	2008;	
Stedman	et	al.,	2008;	Wendt	et	al.,	2008).	The	recent	mapping	of	CTCF	and	Cohesin	
binding	sites	in	several	systems,	including	the	erythroid	lineage	(unpublished	data),	
throughout	 mammalian	 genomes	 can	 be	 used	 to	 address	 the	 question	 of	 the	
importance	of	CTCF	and	Cohesin	cooperation	to	regulate	gene	transcription	through	
organizing	 chromatin	 structure.	 However,	 a	 convincing	 experiment	 that	 shows	 a	
direct	interaction	between	these	two	factors	is	still	missing	(van	de	Nobelen	unpubl.).	
It	has	been	reported	that	CTCF	interacts	with	Cohesin	directly	(Stedman	et	al.,	2008)	
but	such	an	interaction	could	not	be	detected	in	several	other	studies	including	ours.	
It	is	possible	that	the	interaction	is	weak	or	Cohesin	interacts	with	CTCF	transiently.	
Alternatively,	 indirect	 interactions	via	other	proteins	or	DNA	might	be	necessary	 to	
mediate	 their	 communication.	 More	 sensitive	methods	 in	 combination	 with	 Chip-
sequencing	should	be	used	to	answer	this	question.
The	knockdown	of	CTCF	substantially	reduced	the	association	of	the	Cohesin	
complex	with	 its	genomic	 target	 loci	but	not	 the	overall	 binding	on	 the	chromatin	
(Wendt	et	al.,	2008).	This	observation	suggests	that	CTCF	binding	sites	are	“meeting	
points”	 for	 those	 two	 factors.	 Depletion	 of	 CTCF	 binding	 motifs	 abolishes	 the	
association	(Stedman	et	al.,	2008)	while	Cohesin	depletion	had	no	(Parelho	et	al.,	
2008)	or	a	moderate	(Wendt	et	al.,	2008)	effect	on	CTCF	binding.
The	next	step	 is	of	course	 to	determine	 the	 functional	 relevance	of	CTCF	and	
Cohesin	 shared	 binding	 sites	 with	 respect	 to	 gene	 expression.	 CTCF	 was	 first	
described	for	its	role	in	regulation	of	the	c-myc	gene	(Lobanenkov	et	al.,	1990),	an	its	
role	in	insulation	was	later	demonstrated	for	multiple	vertebrate	insulators,	including	
the	β-globin	and	H19/Igf2	 locus.	Using	 reporter	assays,	Wendt	et	al.	showed	 that	
Cohesin	regulates	the	endogenous	H19/Igf2	insulator	in	HeLa	cells.
One	 question	 is	 how	 Cohesin	 contributes	 to	 the	 insulator	 function?	 One	 of	
the	 possibilities	 is	 that	 Cohesin	 stabilizes	 long-range	 chromosomal	 interactions	
mediated	 by	 CTCF.	 A	 generally	 accepted	 idea	 is	 that	 CTCF	 forms	 chromosome	
loops	 that	 facilitate	 some	 enhancer-promoter	 interactions	 and	 prevent	 others	
(Wallace	 and	 Felsenfeld,	 2007;	 Williams	 and	 Flavell,	 2008).	 The	 Chromosome	
Conformation	Capture	(3C)	assays	can	reveal	if	two	distant	DNA	fragments	are	held	
in	close	proximity	by	crosslinked	protein.	Using	this	technique,	several	laboratories	
demonstrated	CTCF-dependent	loops	in	different	loci	including	the	mouse	β-globin	
locus	 (Splinter	 et	 al.,	 2006).	 Since	 Cohesin	 accumulates	 at	 CTCF-binding	 sites,	
it	 is	 tempting	 to	 speculate	 that	 Cohesin	 stabilizes	 the	CTCF-mediated	 interaction	
probably	by	encircling	CTCF	formed	loops.	It	would	be	interesting	to	investigate	the	
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possibility	that	some	proportion	of	the	Cohesin	molecules	is	diverted	to	support	or	
regulate	 long-range	 interchromosomal	 loops.	Performing	3C	assays	 in	 the	 set	 up	
where	Cohesin	and/or	CTCF	are	depleted	should	answer	this	question.	Even	though	
the	mechanism	 remains	 to	be	clarified,	 it	 seems	 that	Cohesin	and	Delangin	have	
important	and	broad	functions	in	gene	regulation	and	development.	
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SuMMARy
Genetic	information	required	for	the	development	and	functioning	of	an	organism	
is	stored	in	billions	of	base	pairs	of	DNA.	In	eukaryotes,	DNA	is	organized	in	large	
units	 called	 chromosomes.	 These	 are	 the	 essential	 units	 for	 cellular	 division	 and	
must	be	replicated,	divided,	and	passed	successfully	to	the	daughter	cells.	They	are	
packaged	by	proteins	into	a	condensed	structure,	called	chromatin,	which	enables	
the	 very	 long	DNA	molecules	 to	 fit	 into	 the	 cell	 nucleus.	 Despite	 the	 compacted	
structure	of	the	DNA,	the	right	set	of	genes	is	transcribed.	Different	levels	of	control	
are	involved	in	the	regulation	of	proper	gene	expression	throughout	the	process	of	
cellular	differentiation.	Numerous	general,	cell-type	and	stage	specific	proteins	that	
bind	to	chromatin	and	DNA	coordinate	these	processes.	In	the	DNA	of	metazoans,	
long-range	 interactions	 between	 distant	 regulatory	 elements,	 and	 the	 genes,	 are	
responsible	 for	 the	specific	expression	of	many	developmentally	 regulated	genes.	
Often	 these	 interactions	occur	over	considerable	distances	as	 in	 the	some	cases	
control	elements	are	 located	hundreds	or	even	thousands	of	kilobases	away	from	
the	genes.	Over	the	last	few	years,	there	is	a	growing	interest	 in	distant	regulatory	
elements	and	the	factors	that	are	involved	in	the	regulation	of	the	interactions.	The	
main	focus,	of	research	described	in	this	thesis,	are	several	factors	that	have	a	role	
in	long-range	interactions	and	chromatin	organization.	
The	 first	chapter	gives	an	 introduction	of	several	mechanisms	 that	have	been	
proposed	for	long	distance	interactions.	The	roles	of	vertebrate	insulator	protein	CTCF	
(CCCTC	binding	factor)	and	Cohesin	in	long-range	interactions	are	also	addressed.	
In	addition	the	Cohesion	loading	factor	Delangin	and	the	Ldb1	transcription	factor	
complex	are	introduced	in	Chapter	1.
	In	Chapter	2	novel	binding	partners	of	Ldb1	are	described.	Ldb1,	a	ubiquitously	
expressed	LIM	domain	binding	protein,	 is	known	to	be	essential	 in	several	tissues	
during	development.	By	using	systems	biology	approach	we	have	identified	known	
and	many	new	binding	partners	of	Ldb1.	We	have	also	determined	their	importance	
for	hematopoietic	development,	especially	for	the	earliest	stages.	
To	better	understand	the	role	of	Delangin	in	mammals,	we	have	generated	mice	
lacking	this	gene	that	are	described	in	Chapter	3.	Delangin	is	a	protein	involved	in	
loading	of	Cohesin	onto	the	chromatin	and	hence	thought	to	be	important	for	sister	
chromatid	cohesion	and	chromatin	dynamics.	Homozygous	Delangin	mouse	mutants	
are	lethal	early	in	development	while	alive,	born	heterozygous	mice	exhibit	a	complex	
phenotype.	This	suggests	that	reduced	level	of	Delangin	can	cause	chromatin	defects	
early	 in	 development.	 The	 affected	mice	 have	 a	 severely	 reduced	 body	 size	 and	
abnormalities	in	many	organs.	Interestingly,	the	phenotype	resembles	to	those	seen	
in	patients	with	Cornelia	de	Lange	Syndrome	(CdLS)	that	have	mutations	in	the	same	
gene.	We	suggest	that	our	mouse	model	is	a	valuable	model	for	the	understanding	
of	the	molecular	mechanisms	behind	Cornelia	de	Lange	Syndrome.	
A	co-relation	of	functions	of	Cohesin,	and	CTCF	protein	is	presented	in	the	Chapter	
4.	We	show	 that	subset	of	CTCF	binding	sites	are	shared	with	Cohesin.	We	have	
specifically	focused	on	shared	binding	sites	in	the	mouse	β-globin	locus	in	erythroid	
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cells.	We	have	shown	that	Cohesin	binding	is	required	in	a	CTCF	dependent	manner.	
Since	Cohesin	and	CTCF	share	several	binding	sites	in	this	locus,	we	investigated	
whether	Cohesin	is	required	for	the	long-range	interactions.	
An	 interesting	 role	 that	CTCF	has	 in	 the	 Th2	 cytokine	 expression	 in	 T-cells	 is	
addressed	in	the	Chapter	5.	Chromatin	immunoprecipitation	(Chip)	assays	revealed	
the	presence	of	multiple	CTCF	binding	sites	in	the	Th2	cytokine	locus	in	the	T-cells	
(thymocites).	The	conditional	deletion	of	Ctcf	in	thymus,	which	allows	this	gene	to	be	
deleted	in	spatio-temporally	manner,	caused	Th2	cytokine	expression	defect.	
In	Chapter	6,	the	specific	functional	interactions	between	Delangin	and	Cohesin	
and	the	functional	relevance	of	shared	Cohesin	and	CTCF	binding	sites	are	discussed	
in	more	detail.	 In	 this	 chapter,	 I	 suggest	 that	different	 regulatory	mechanisms	are	
involved	in	their	functional	interactions.	The	last	chapter	is	concluded	with	a	number	
of	suggestions	for	future	experiments	to	further	elucidate	this	area	of	research.
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De	genetische	informatie	die	nodig	is	voor	de	ontwikkeling	en	het	functioneren	
van	 een	 organisme	 is	 opgeslagen	 in	 miljoenen	 DNA	 basenparen.	 In	 eukaryoten	
is	DNA	georganiseerd	 in	 grote	 structuren,	 genaamd	chromosomen.	Deze	 zijn	 de	
essentiële	eenheden	voor	celdeling	en	moeten	verdubbelen,	delen	en	op	de	juiste	
manier	verdeeld	worden	over	de	nieuwe	dochter	cellen.	De	chromosomen	worden	
door	middel	van	eiwitten	verpakt	in	een	compacte	structuur,	genaamd	chromatine.	
Dit	 zorgt	 er	 voor	 dat	 de	 lange	DNA	 strengen	 in	 de	 celkern	 passen.	Ondanks	 de	
compacte	structuur	van	het	chromatine,	kunnen	de	juiste	genen	worden	afgelezen.	Er	
zijn	verschillende	niveaus	van	controle	nodig	voor	de	regulatie	van	de	juiste	expressie	
van	genen	tijdens	het	proces	van	differentiatie.	Deze	processen	zijn	gecoördineerd	
door	 verscheidene	 algemene	 cel	 en	 stadium	 specifieke	 eiwitten	 die	 binden	 aan	
chromatine	en	DNA.	In	het	DNA	van	metazoans	zijn	interacties	tussen	verscheidene	
regulerende	elementen	en	hun	genen	verantwoordelijk	voor	de	specifieke	expressie	
van	 vele	 ontwikkelingsgereguleerde	 genen.	 Vaak	 vinden	 deze	 interacties	 plaats	
over	 grote	 afstanden,	 in	 sommige	 gevallen	 liggen	 de	 regulerende	 elementen	
zelfs	 honderden	en	 soms	wel	duizenden	 kilobasen	 van	de	desbetreffende	genen	
verwijderd.	Recentelijk	is	er	een	groeiende	interesse	in	deze	regulerende	elementen	
ontstaan	en	in	de	factoren	die	betrokken	zijn	bij	deze	interacties.	In	dit	proefschrift	
worden	een	aantal	 factoren	besproken	die	een	rol	spelen	 in	 interacties	over	 lange	
afstand	en	de	organisatie	van	chromatine.
In	 hoofdstuk	 1	 worden	 een	 aantal	 mechanismen	 besproken	 die	 van	 invloed	
zijn	op	interacties	over	lange	afstand.	De	rol	van	het	vertebraat	insulator	eiwit	CTCF	
(CCCTC	binding	factor)	en	Cohesin	worden	besproken	tesamen	met	Delangin,	en	
transcriptie	factor	complex	Ldb1.	Beiden	zijn	ook	betrokken	bij	interacties	over	lange	
afstand.
Hoofdstuk	 2	 beschrijft	 de	 nieuwe	 bindingspartners	 van	 Ldb1.	 Ldb1	 is	 een	
overvloedig	 tot	 expressie	 komend	 LIM	 domein	 eiwit,	 dat	 betrokken	 is	 bij	 de	
ontwikkeling	van	verschillende	weefsels.	Door	gebruik	 te	maken	van	een	systeem	
biologische	benadering	hebben	wij	reeds	bekende,	maar	ook	nieuwe	bindingpartners	
van	LDB1	geïdentificeerd.	Daarnaast	is	ook	de	rol	van	deze	nieuwe	partners	tijdens	
de	hematopoetische	ontwikkeling	bepaald,	en	dan	met	namen	in	de	vroege	stadia	
van	de	hematopoese.
Om	de	rol	van	Delangin	in	zoogdieren	beter	te	begrijpen,	hebben	we	knock-out	
muizen	 gemaakt,	 die	 beschreven	 staan	 in	 hoofdstuk	 3.	Delangin	 is	 een	 eiwit	 dat	
betrokken	 is	bij	het	 laden	van	cohesin	op	het	chromatine	en	speelt	daardoor	dus	
een	belangrijke	rol	in	zuster	chromatide	cohesie	en	in	overall	chromatine	dynamiek.	
Muizen	met	een	homozygote	Delangin	mutatie	zijn	vroeg	embryonaal	lethaal,	terwijl	
muizen	met	een	heterozygote	mutatie	een	complex	fenotype	hebben.	Dit	suggereert	
dat	een	gereduceerd	niveau	van	Delangin	al	voor	chromatine	defecten	kan	zorgen	
tijdens	de	vroege	ontwikkeling	van	de	muis.	De	heterozygote	muizen	zijn	een	stuk	
kleiner	dan	wild-type	muizen	en	hebben	afwijkingen	in	een	groot	aantal	organen.	Het	
fenotype	van	de	Delangin	muizen	lijkt	sterk	op	dat	van	Cornelia	de	Lange	Syndroom	
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(CdLS)	patiënten.	Deze	patiënten	hebben	een	mutatie	in	hetzelfde	gen.	Wij	denken	
daarom	dat	onze	muis	model	een	goed	model	is	om	het	moleculaire	mechanismen	
achter	het	Cornelia	de	Lange	Syndroom	te	bestuderen.	
In	hoofdstuk	4	presenteer	ik	de	co-relatie	tussen	de	functie	van	Cohesin,	bekent	
om	 zijn	 rol	 in	 zuster	 chromatide	 cohesie,	 en	 CTCF,	 het	meest	 bekende	 insulator	
eiwit.	 We	 laten	 zien	 dat	 een	 subpopulatie	 van	 CTCF	 bindingsplaatsen	 gedeeld	
wordt	met	Cohesin.	We	hebben	ons	met	namen	geconcentreerd	op	de	gedeelde	
bindingsplaatsen	binnen	het	β-globine	locus	in	rode	bloedcellen.	In	deze	cellen	laten	
we	zien	dat	cohesin	binding	afhankelijk	is	van	CTCF	.	Omdat	CTCF	en	Cohesin	een	
aantal	bindingsplaatsen	gemeen	hebben	in	de	β-globine	locus,	hebben	we	gekeken	
of	Cohesin	noodzakelijk	is	voor	lange	afstand	interacties.	
In	hoofdstuk	5	bespreken	we	de	interessante	rol	die	CTCF	speelt	in	de	expressie	
van	Th2	cytokine	in	T-cellen.	Chromatine	immunoprecipitaties	(Chip)	in	T-cellen	laten	
de	 aanwezigheid	 van	meerdere	 CTCF	 bindingsplaatsen	 binnen	 het	 Th2	 cytokine	
locus	zien.	De	conditionele	deletie	van	CTCF	in	de	thymus,	wat	ervoor	zorgt	dat	dit	
gen	op	een	specifieke	plek	en	tijd	kan	worden	gedeleteerd,	zorgt	voor	misregulatie	
van	Th2	expressie.	
In	 hoofdstuk	 6	 wordt	 de	 functionele	 interactie	 tussen	 Delangin	 en	 Cohesin	
besproken.	Ook	wordt	de	functionele	relevantie	van	de	gedeelde	Cohesin	en	CTCF	
bindingsplaatsen	 bediscussieerd.	 In	 dit	 hoofdstuk	 suggereer	 ik	 dat	 verschillende	
regulerende	mechanismen	betrokken	zijn	bij	hun	functionele	interacties.	Het	hoofdstuk	
wordt	beeindigd	met	een	aantal	suggesties	voor	toekomstige	experimenten	om	meer	
inzicht	in	dit	onderzoeksgebied	te	krijgen.	
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